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The development and potential value of a Crohn's disease Register is
described. This thesis establishes that this can be accomplished using a microcomputer
system. The wider clinical implications of the microcomputer development are also
described.
The introduction overviews the present knowledge of Crohn's disease,
examines the value and potential pitfalls associated with the establishment of a Register
and investigates the background to the development of computing in the medical field.
For clarity the Register's development has been conveniently divided into
medical and computing aspects. Much of the early work centred round the content of the
Register's database and on defining the diagnostic criteria required for entry to the
Register. A pilot scheme was introduced to evaluate the method of case ascertainment
prior to full retrospective data collection. A description of the computer system, its
philosophy and its facilities has also been given highlighting aspects of particular clinical
relevance.
The computer system's data enquiry and analysis facilities were then used to
investigate epidemiological aspects of the disease, overview the efficacy of investigative
techniques and monitor methods of treatment. The resultant findings are intended not
only to evaluate the medical content of the Register but also demonstrate the potential of
the computers facilities both in this phase and for future prospective data collection and
enquiry.
In discussion the more significant aspects of the Register's development and
retrospective data collection are highlighted and the practicalities of prospective
implementation considered. Finally the computer system is discussed in its wider context
and its value demonstrated by the growing variety of clinical applications which have used
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The recognition of the existence of Crohn's disease is relatively recent. This
can probably be explained by the lack of both autopsy and abdominal surgery in the
eighteenth and early nineteenth centuries. However, careful re-examination of old case
histories, such as the one described by G B Morgagni of Forli in 1769, may well represent
early cases of Crohn's disease. In 1813 Coombe and Saunders reported a case of a man
to The Royal College of Physicians of London who "had been for many years troubled
with flatulency and complaints of the bowels". He later developed colicky abdominal
pain several hours after meals and subsequently intestinal obstruction. At autopsy there
were skip areas in the colon and they described ... "the lower part of the ileum, as far as
the colon, was contracted for the space of three feet to the size of a turkey quill". A
description which may well represent the first narration of a case of Crohn's disease.
Several others including Abercrombie (1828) and Bristowe (1853) subsequently described
findings at autopsy which were similarly suggestive of those of classical Crohn's disease.
Dalziel in 1913 (Dalziel 1913) described a series of nine cases on whom he
had operated in Glasgow and whom he described as suffering from a new condition of
'chronic interstitial enteritis and not tuberculosis'. Of the nine operated upon four had
disease in the small bowel, two disease in colon and small bowel and the rest disease in
the colon alone. Nonetheless it was Crohn (1932) and his colleagues that attracted the
attention of their fellow physicians when on May IS1'1 1932 they reported 14 cases of
'terminal ileitis' at a meeting in New Orleans. Since then and perhaps inappropriately
Crohn et al have been attributed with the first true description of the disease.
Although the condition was initially described as a 'regional enteritis' it is
clear from the early literature that cases of segmental colitis had been recognised in the
1930's (Dalziel 1932 and Hurst 1935). Wells (1952) appears to be the first to describe
segmental colitis as a true colonic form of Crohn's disease, the pathology of which was
confirmed by Lockhart-Mummery & Morson's classical paper in 1960 (Lockhart-
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Mummery 1960). Since the initial description of regional enteritis many aspects of the
disease have been extensively studied in an effort to obtain a better understanding of the
disease process.
Much of the earlier work relates to the description of various features of the
disease such as the typical and more unusual radiological (Marshak 1968, Stanley 1971,
Goldberg 1979) and pathological (Lockhart-Mummery 1960, Cook 1973, Glass 1976)
appearances. The introduction of flexible endoscopy in the early 1960's has resulted in
similar descriptions of the features and the value of colonoscopy (Geboes 1975, Hogan
1980, Waye 1980).
A few have looked at the epidemiology of the disease and established
evidence of varying trends in incidence and prevalence within countries (Kyle 1971,
Maybury 1979, Ritchie 1981). Others have reviewed and summarised the frequency of
disease across continents (Kyle 1972, Maybury 1984). This has not been an easy task.
Firstly, the disease is not common and secondly, centres with a particular interest in the
disease tend to attract cases often referred because of some difficult or unusual problem;
thus a biased and ill-defined population is produced making valid epidemiological study
impossible.
Others have looked at specific groups of patients, for instance the elderly
(Carr 1982, Fabricus 1985) or those with perianal disease (Morson 1959, Fielding 1972,
Buchmann 1980) because they present with particular problems, or in whom the disease
process displays a distinctive pathogenesis.
Over recent years some large multicentre trials (National Co-operative
Crohn's disease study (NCCDS) 1978 & Malchow 1984) have been set up in an attempt to
rationalise the medical management of the Crohn's patient. However, many smaller
therapeutic trials have also been undertaken in an effort to prove the efficacy of various
medical regimes (O'Morain 1984, Jakobovits 1984, Schaffer 1984). Some have shown
improvement in certain areas of the disease for instance symptoms - elemental diets
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(Axelson 1977 and Goode 1976), total parenteral nutrition (Elson 1980) and in acute
exacerbation of the disease where prednisone given over 4 months (Summers 1979) have
been found to be effective in alleviating symptoms. Others have found that although
steroids help in acute disease there is no evidence that they either prevent relapse of
quiescent disease or recurrence after surgery (Bergman 1976, Smith 1978, Summers 1979).
Similarly, although sulphasalazine has been shown to be effective in ileocolic-colic disease
(Summers 1979, Van Hees 1981) it fared no better than placebo in ileal disease (Summers
1979) nor did it help prevent relapse or recurrence after resection (Lennard-Jones 1977,
Wenckert 1978). The value of immunosuppressive drugs such as azothiaprine and 6-
mercaptopurine either on their own or in combination with steroids or sulphasalazine
remains unproven although there is some evidence that these agents may help patients
with chronic active disease for whom it is difficult to withdraw steroids (Willoughby 1971,
Present 1980). More recent studies have shown that methyl prednisolone is the most
effective drug for active and inactive disease both in the small and large bowel - the
European Co-operative Crohn's Disease study (ECCDS) (Malchow 1984) - and that
metronidazole is helpful in colonic and perianal disease (Ursing 1975, Brandt 1982).
Although cyclosporin has been shown to be of benefit in some case reports (Allison 1984,
Bianchi 1984) further trials are required before the true efficacy of the drug can be
evaluated.
Following the early descriptions of the disease in the 1930's and 1940's
surgical resection was considered a curative procedure. Long term follow-up for as many
as 15 years however established that recurrence rates reaching 80% (Ward 1954)
occurred after multiple resection while Garlock (1954) reported a mortality rate of 16.4%
following bowel resection. This led to an increasing use of by-pass procedures which
reduced not only mortality but appeared to reduce the rate of recurrence. By the mid
60's the pendulum had again swung back in favour of resection prompted by reports from
Schofield (1965) and Atwell (1965). In recent years, although strictureplasty has been
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tried, resection has remained the preferred method of operative treatment despite the
fact that no fully randomised trial has been carried out to investigate the efficacy of
resection, exclusion by-pass or by-pass in continuity.
Despite this work many clinicians managing patients with the disease would
still agree that both medical and surgical treatment remains difficult and is often
influenced by personal experience rather than by sound scientifically based policy.
Much of the reason for what might be considered an unscientific approach to
the management of the disease has been attributed to the lack of knowledge available
regarding its aetiology.
Several avenues have been explored in an effort to identify possible
aetiological factors. Many attempts have been made to implicate transmissible infective
agents (Beeken 1980), some have identified viral agents (Farmer 1973, Stickland 1979)
while others have found bacterial and cell wall deficient organisms (Beekin 1973 and
Belsheim 1980). The presence of granulomatous lesions, particular clinical
manifestations, such as biliary and skin manifestations, and the fact that anti-inflammatory
and immunosuppressive agents are used in treatment has resulted in the immune system
being fully investigated (Jewell 1973, Mcpherson 1976, Mee 1979, Pugh 1979).
Nonetheless the exact nature of the primary or secondary involvement of these immune
mechanisms remains unclear. Dietary influences, in particular a high intake of refined
sugar (Maybury 1978, 1980) and genetic factors (Kisner 1973, Lewkonia 1976) have both
been implicated as other possible aetiological factors. Their true involvement however,
still requires further investigation and clarification.
Despite exhaustive studies of individual factors none seems to have emerged
as a single primary precipitant of the disease process. It is likely therefore that the
aetiology is multifactorial in origin and that a greater understanding of their relationships
may well be required before a more reasoned and scientific approach can be taken in
formulating treatment regimes.
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Overall, the extensive and valuable study of varying aspects of the disease has
to date produced findings and conclusions which have in the main only shown how little is
actually known about its pathogenesis. Indeed one could arguably suggest that much of
this work has only highlighted the complexity of the disease rather than provide answers
to the initial enquiry. This plus ambiguities in the definition of Crohn's disease and
Ulcerative Colitis has prompted some to take a further look at what constitutes a
diagnosis of Crohn's disease (Myren 1979). One approach to these types of question is to
collect and examine epidemiological data (Maybury 1984).
Careful review has shown that despite much interest in the disease only a
small number of sound epidemiological surveys of the disease have been reported
(Brahme 1975, Miller 1974, Kyle 1979, Hellers 1979 ) and have often not been
comparable. Reliable, up todate and consistent information on the epidemiology of the
disease is therefore not freely available. Even in Britain despite its comparatively high
standards of medical care and health service audit the incidence is subject to debate.
Indeed it is not even clear whether the incidence is increasing (Fee 1985), stable
(Maybury 1983) or decreasing (Kyle 1980) or whether the trends truly differ from area to
area. Although this variation in incidence could result from data which is not
comparable, for instance the use of different diagnostic criteria, or inaccurate data
collection either in case capture or in determining the at risk population it is clear that
further comparable studies are required to determine if there are real differences in
incidence in different parts of the country. A major element in the development of
comparable studies hinges on a uniform and generally accepted definition of what
constitutes a case of the disease.
This thesis describes the establishment of a system for the collection and
analysis of a basic epidemiological data set for Crohn's disease. The system has
established the extent of the condition, provided an overview and facilitated audit of the
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disease in Tayside. Furthermore it presents an opportunity to explore the pathogenesis of
the disease and to develop a mechanism with the potential to help in patient management.
It was clear from examining available epidemiological information that
several important considerations had to be taken into account before an appropriate data
set could be drawn up.
There are various definitions of Crohn's disease (Lennard-Jones 1976, Myren
1979) which probably accounts for the 16 eponymous terms which Fielding (1972) found
on review of the literature. Most definitions include clinical, radiological and
pathological features and only differ in minor respects while some take onset of symptoms
as opposed to date of diagnosis as the disease start point. A set of diagnostic criteria
therefore had to be defined clearly and efforts made to keep the criteria comparable with
other study groups. The criteria chosen for use in this Register are based on the
internationally agreed system drawn up by the OMGE group (Myren 1979). The scoring
system will be fully described in a subsequent chapter of this thesis.
Completeness and accuracy of data collection within a well defined
population was mandatory and much thought was given to the methods employed in case
ascertainment and confirmation of disease.
The approach eventually chosen was to collect and collate a basic
epidemiological data set linking more detailed information on specific aspects of the
condition. Crohn's disease as a chronic and sometimes debilitating disease carries a high
morbidity with a lower though not insignificant mortality. The natural history of the
disease therefore lends itself to an on-going data collection process. To match the
chronic nature of the disease a structured data set was created to permit the ongoing
collection of this information thereby enabling a patient's progress to be monitored over a
period of years. A dynamic and changing picture of Crohn's disease in the Tayside
population would then evolve over a period of years. The collection of data for
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epidemiological analysis should be a by-product of the clinical monitoring and
management process and would therefore benefit in quality and completeness from this
approach without duplication of effort and resources.
Although many difficulties exist in the development of disease registers of
this nature it was felt that this format remained the most appropriate.
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1.2 REGISTERS
The Oxford Dictionary defines a Register as 'A book in which regular entry
is made of details of any kind sufficiently important to be exactly recorded'. The verb is
defined as 'the setting down of facts in writing or to record information in a precise
manner'.
The 'Domesday Book' prepared in 1086 to ascertain the value and extent of
land managed by the King and his sub-tenants was probably one of the first and most
complete Registers ever prepared. It demonstrates many of the important aspects of any
Register as it contained only the vital parts of the total data initially collected, information
which was then used to good effect by the treasury in its daily administration.
Through the centuries the concept of Registers continued to develop as
their potential value was realised. In 1753 efforts to introduce the 'Census Bill' provoked
much resistance and resentment because of the threat to 'English liberty" and it was not
until 1800 that the first census act was passed which eventually led to the foundation of
the General Register office in 1836. This was the forerunner of the present day Registrar
Offices of England and Wales, and the separate Scottish Office which continue to collect
morbidity statistics on the population as a whole. These registers remain some of the
most complete because of the importance of much of the information collected; the birth
and death of an individual are unlikely to be overlooked.
The blind Register, one of the earliest and probably the first disease specific
Register, began its evolutionary development in 1911 (Saunders 1973) and continues to
provide valuable and accurate monitoring of the blind population.
Although formal British Cancer Registration began in 1930 (Stocks 1950) the
first efforts to collect information on malignant tumours probably began in 1728
(Clemensen 1965) but were hindered by the scarcity of available definitive diagnostic
techniques. Other notable developments were the advent of the Scottish Morbidity
Returns (e.g SMR1, SMR11, SMR2) set up in Scotland in 1961, the in-patient returns for
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England and Wales which audit hospital admissions for the whole country, and more
recently ischaemic heart disease registers such as the United Kingdom Cardiac Register
(English 1984) many of which were formed on the basis of the World Health Organisation
reports of 1969-70 (WHO 1969,1970).
There are many types of medically related registers. Weddell (1973) in a
review of registers classified these into seven types:
a. Registers to help in preventive medicine for example screening and
immunisation programmes.
b. Disease specific - which are common and include those for ischaemic heart
disease or malignant disease.
c. For use in treatment and patient management such as the Scottish Automated
Follow-Up Register (SAFUR) set up in 1967 to automate follow-up of thyroid
disease in Scotland (Hedley 1970).
d. Aid in after care of the handicapped, disabled or other compromised groups.
e. To monitor at risk populations such as the deaf, mentally retarded or chronic
sick.
f. To take note of such scarce resources and skills as rare blood types or
transplantation programmes.
g. Prospective studies which are many and varied, and were described as
difficult to run and often costly.
h. Specific information registers such as the poisons bureau and registers of
congenital defects.
This demonstrates the many topics that can be helped by a register and the
varied ways that this form of data collection can be put to use.
Registers are however recognised to be notoriously difficult not only to
implement but also to operate and manage successfully. This is mainly because they can
consume a large amount of resources, especially time, both in obtaining complete case
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ascertainment at the time of implementation and subsequently maintaining the register in
up to date and accurate fashion. It is therefore extremely important that firm objectives
are laid down regarding the expectations and functions of any proposed register.






Completeness of data collection is vital if a valid register is to be developed.
Few registers ever achieve this however, and those that do more often than not contain
information which is unlikely to be overlooked for example mortality data. Doll (1970)
reporting on cancer incidence in five continents found that all the cancer Registers were
incomplete - estimated shortfall varying from 2.5% to 15% - and pointed out that if
registration is to be considered to be complete it must involve collection of data from a
number of sources and must provide a means of cross checking to prevent duplication of
entries.
Also important is the extent to which cases are reported, a fact emphasised
by Crooks (1970) who commented that the United Kingdom blind Register was nearly
complete - estimated 3% not registered - because of the efforts of well co-ordinated
voluntary bodies and because there were financial benefits accruing to those registered.
Interestingly Chiazze (1966) comparing the completeness of registers against
specifically designed surveys of patients suffering from cancer found that surveys tend to
overestimate numbers while registers underestimate because of incomplete reporting.
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b) Accuracy
The validity and the value of information contained on a register is
dependant upon the quality of data capture. Cross checking of data from a number of
sources is essential to ensure accuracy and to avoid duplication of entries - for example a
clinical diagnosis should be confirmed by a histological diagnosis or post mortem
examination. Furthermore the quality of medical data and its subsequent collection
relates to the accuracy of clinical diagnosis, a factor which is dependant on the provision,
access and standard of medical services available to the population.
c) Usefulness
The objective of a register should be well defined (Weddell 1973) and should
provide information on such topics as the prevention and treatment of disease, provision
of after care, the evaluation and planning of services and monitoring the changing
patterns of disease. The specified objectives of a study therefore require to be examined
regularly and if the functioning register fails to meet the objectives changes should be
implemented or closure of the register considered. Importantly however, patient record
and recall systems should be designed to enable them to respond to changing
circumstances. The availability of such systems can itself bring changes in methods of
care, and treatment regimes.
The introduction of computer technology to data processing has enabled
information to be stored and analysed with minimal difficulty. With the opportunity to
collect large volumes of data the investigator must resist the temptation to collect quantity
at the expense of quality. Just as in retrospective data collection where each item
collected should serve a purpose the emphasis should be placed on the collection of data
vital to the fulfilment of the stipulated objectives of the register.
The potential value of a dynamic medical information system able to respond
to changing circumstances needs careful consideration before implementation and regular
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review in order to avoid possible closure from failure to meet it's objectives.
Furthermore the role of any new system should be examined in relation to existing
methods of clinical practice. Systems demanding radical changes in the behaviour of
clinicians particularly in respect of entry of data into computer systems run considerable
risk of failure. It is therefore essential that any such system should be developed primarily
to increase the efficiency or effectiveness of the service provided while the audit and
research should be considered an essential and invaluable by-product of the exercise.
The use of computers and their application to medical registers is reviewed
in the next chapter.
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1.3 COMPUTERS IN MEDICINE
The use of computers in medical practice is now firmly established yet it is
only 20 years since the first attempts to produce a system providing a full case record on a
computer. One of the first was the SWITCH system (Kennedy 1968) which used a record
tape to encode the data onto the computer and which was designed in an effort to provide
a database from which data retrieval and audit could be achieved. Further systems
followed such as COSTAR - a computerised ambulatory record system implemented in
the Massachussetts General Hospital - each based on a very large, complex, and by
today's standards, crude computer. The development in the 1970's of increasingly
complex integrated circuits led to the production of the microprocessor and high density
semiconductor memories. Hardware advanced rapidly following this development and
led to a marked reduction in size of each machine and a similar increase in power, speed
and sophistication.
Unfortunately the development of health care orientated systems appears to
have progressed along two separate paths. One has been concerned mainly with the
administration side, where large capital sums have been invested in 'mainframe' systems
to perform administrative tasks - for instance for the pay-roll, financial management or
stock control - and are often divorced from mainstream clinical practice. Indeed figures
for 1980 show that only 25% of health service computer related revenue expenditure in
both Scotland and England is directed at computer resources for patient management or
direct medical application (Herbert 1982). These systems have usually had priority over
the smaller clinically orientated projects which have commonly been set up by enthusiastic
clinicians with the help of donations from the pharmaceutical industry or friendly
societies. This historical quirk has resulted in the creation of two distinct types of health
care systems which often contain overlapping data sets. The co-ordinated development
and integration of these different systems should prevent a duplication of input of such
Introduction 14
data as patient identifying information. The diverse origins of these systems makes the
task of bringing the different types together extremely difficult. Only recently have groups
been set up at local and national level to oversee and co-ordinate computer related
activities. Unfortunately it will be some time before systems can work together as
components of an overall medical information network.
One thing is clear however, the continued development of clinically
orientated health care computer systems is assured with an ever growing list of general
and dedicated applications appearing in the literature. These systems have their origins
in one or a combination of simple audit ( for example age/sex register), management
administration (for example laboratory, patient administration and recall systems) and
research functions.
Many of the early systems were used to perform a simple audit, for example
SWITCH (Kennedy 1968) and inflammatory bowel disease registration (Rogers 1971),
and were used as simple data collection mechanisms which could then be audited thereby
providing data for research. Others were developed to test the value of computerisation
against the existing manual system - hypertensives (Bulpitt 1976). Later it was felt that
systems of computerised records may be of potential value in aiding patient management,
particularly in the situation where patients required essential periodic follow-up.
SAFUR set up in 1967 (Hedley 1970, Hedley 1970a) encompassing centres
throughout the North East of Scotland to aid in follow-up of patients with thyroid disease
was one of the first of these patient management orientated systems in this country.
Other conditions lending themselves to this form of structured patient record follow-up
were tackled, with hypertensive (Petrie 1985), diabetic (Watkins 1980, Jones 1983) and
psychiatric (Ancill 1985) groups being at the forefront of this development.
Patient orientated primary care systems have also been developed and are
being increasingly used in general practice (GPASS, VAMP, AIBES). Indeed some have
even been built around an automatic method of repeat prescribing for example GPASS.
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However systems are now being developed into true integrated packages designed to help
manage a combination of practice requirements with modules for registration, repeat
prescribing and accounting.
Much of the development work on clinically orientated patient record
systems has however centred round the development of computer assisted diabetic
Register and Information systems (Levy 1964, Watkins 1980, Jones 1983). These systems
have been implemented firstly in an effort to improve the standard and accuracy of
medical data collection over the traditional, often illegible, case record and secondly to
use that information for service planning and research to increase the standard of patient
care. Jones (1983) described several necessary requirements of such a diabetic system if
it were to meet the objectives of a register. The system should hold basic identifying
patient data along with social, demographic, clinical and therapeutic information which
should all be finked and available for use by other clinicians. The recent introduction of
the Korner data sets in England and Wales following the reports of the Korner steering
group on Health Service Information (Knox 1987) has more clearly defined the basic data
requirements of any data collection system and indeed overlaps the ideas previously
described by Jones. The use of the standard Korner data sets should now be considered
as mandatory. There should be a 'fail-safe' mechanism to prevent patients being lost to
follow-up while the increased use of automatic monitoring for certain groups of at risk
patients would require a reliable method of communication between hospital doctor,
patient and general practitioner. Hedley (1985) suggests that the correct implementation
of this type of system will encourage new methods of care firstly because some labour
intensive tasks can readily be performed by the computer for instance the creation of at
risk groups with certain clinical characteristics requiring closer monitoring and secondly
by measuring and assessing the efficacy of different follow-up regimes. The recent
introduction of diabetic shared care schemes is one example of this type of development.
These ideas are receiving further support, for instance the recent Anticipatory Care Team
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conference (ACT 1987) which highlighted the value of the 'Anticipatory Care Team'
strategy in cardiovascular risk screening.
There have however been some major problems associated with the
development and introduction of these computerised systems:-
a) Difficulties in changing the clinicians working practice.
b) Medicine is an inexact science and much information therefore requires
careful coding if accuracy and consistency of the data collected is to be
maintained.
c) Objectives within a particular application are often poorly defined.
d) Poor links between manual handwritten records and the computer
database. The database will only be as good as the information it has been
asked to store. Two major points arise here:
1. If little thought is involved in deciding what questions the users want
to answer from the database then inappropriate data may be collected
and vital data may be omitted from the database.
2. Data input is always a weak link in any computer system therefore
some form of validity checking is important to reduce this type of
operator error.
e) Difficulties of physical access to mini or mainframe computers for which
there is an increasing demand.
f) High costs of maintenance and purchase of hardware and even higher
costs involved in software development - often not recognised.
g) Problems of portability of data between different types of hardware and
operating systems. With the rapid development of hardware it is important
that data can be moved from an old to a new system with minimal difficulty.
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High volume sales of the rapidly developing Personal Computer (PC) in the
business world has resulted in a significant reduction in cost of what are now powerful
microcomputers. The cost of many are now well within the budget of hospital
departments. This, coupled with recent government policy following the Korner reports
(Korner 1985) suggesting a decentralisation of Health Service computer resources in the
short term, with eventual inter-communication with the next generation of mainframe
patient administration systems (PAS), has released funds enabling personal computers to
be bought by many departments for word processing, data management, audit and
research purposes.
Over the past few years there have been a growing number of reports in the
medical literature relating to the use of this microcomputer technology for a growing
number of medical applications. Many of these applications have been set up within the
confines of a research or academic environment or by the enthusiastic amateur (Large
1985, Benveniste 1985, Sellu 1986 Adams 1986) often with minimal resources. On the
other hand commercial enterprises having saturated the business end of the market have
now turned to smaller less lucrative areas such as the medical market, and are now
marketing a wide variety of often excellent systems, albeit at considerable cost.
Most area health authorities have had computing facilities for many years.
However most are mainframe orientated and many of the staff have neither the
experience nor the time to develop microcomputer systems. Although commercial
software houses produce excellent general purpose database management systems these
are aimed at the business user and have not proved to be so well suited to the clinical
situation which often requires a combination of clinical management, audit, follow-up,
research and analysis facilities.
The introduction of the much acclaimed but as yet not fully proven patient
administration systems (PAS) will have a major impact in health care computing. The
role of the microcomputer based sub-system within the PAS framework should be to
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complement these larger mainframe systems, extending their benefit to the clinical level.
This may well come about by using the microcomputer not only as a stand alone machine
but also as an intelligent distal terminal existing in symbiosis with the patient
administration systems.
Indeed it is the author's belief from this review that clinical audit at area level
should be based on unit audit systems. These system would collect data relevant to that
unit and produce as a byproduct information appropriate at area or district level. Subsets
of this data could then be passed 'upward' to a higher level information system (for
instance district level) which could subsequently pass a further more refined subset to
area or national level. This would be possible because much of the clinical audit required
at area level for resource planning and budget management is simply a byproduct of the
patient management process.
The introduction of a computer system such as that proposed for the
Register discussed in this thesis might therefore have some long term implications. A
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2.1 OBJECTIVES
To achieve the proposed objectives of a disease register containing a
computerised case record of each patient with Crohn's disease in Tayside with facilities to
help increase the understanding of the disease it was necessary to break the development
of the project into two major phases.
a) The generation of a suitable retrospective database containing information
which would act as a foundation for the eventual prospective implementation of
the register.
b) The development of a computer system on which to base the register.
Facilities within the system would be required not only to log and recall data but
also to permit data enquiry and analysis.
In this way the Register would not only contribute to the epidemiological
study of the disease but also have the potential to help in patient management.
Furthermore the database created would be a valuable research tool in its own right.
It was intended that the retrospective data collection, recording and
subsequent analysis would act as a pilot study enabling a full assessment of the value and
feasibility of the proposed register. Developing the register in this manner would also
prove a sound test for the computer programmes. Furthermore if the Register were to be
implemented prospectively the experience gained from the retrospective data collection
could be used to make improvements to the prospective database design.
The development of the Register was therefore divided into
a) The Medical aspects
b) The Computing aspects
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2.2 THE MEDICAL ASPECTS
The proposed aims of the Register were
a) to develop a mechanism which would provide an overall picture of
Crohn's disease in Tayside
b) to create a tool to help in patient management
c) to supply information on which further research might be based.
In order to achieve these aims a large volume of data would require to be
collected.
To help achieve these objectives and thereafter to assess the value of the
Register the generation of the database was divided into several convenient sections:-
1. defining the Register's diagnostic criteria
2. structuring the database
3. collecting data retrospectively
2.2.1 Diagnostic criteria
The validity of the register would depend on the accuracy of the data it
contained. The first step therefore was to decide on the criteria to be used by the
Register to determine what would constitute a diagnosis of Crohn's disease.
The separation of Crohn's disease and Ulcerative Colitis can be a difficult
task and is arguably one of the commonest diagnostic problems in gastroenterology. Up
to 20% of individuals thought to have Inflammatory Bowel Disease have been described
as 'unclassifiable' (Morson 1971); a finding which can be explained by individuals who
have for instance clinical features of Crohn's but radiographic evidence suggesting
Ulcerative Colitis. Most groups develop their own working diagnostic criteria which takes
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into account the recognised clinical, pathological, radiological and endoscopic features of
the disease (Kyle 1971, Lennard-Jones 1976, Lee 1981). Each places a different weighting
on individual criteria depending on their impression of the importance of that feature.
Recent work by the Organisation Mondiale de Gastroenterology (OMGE) has resulted
in the development of a scoring system for separating Crohn's disease from Ulcerative
Colitis (Myren 1979). This system is based on the probabilities of an individual with a
specific feature or group of features having either Crohn's disease or Ulcerative Colitis.
Indeed this group has suggested this scheme be adopted as a 'gold standard' which others
might follow in order to obtain a degree of uniformity between workers and to permit
direct comparison between groups. This method had a commendable predictive value of
93%, however it appeared to have one major flaw - it assumed that all those submitted to
the scoring system were suffering from Inflammatory Bowel Disease. This diagnosis is of
similar importance however, and on occasion is equally difficult to make.
In order to clarify this important distinction within the Register Inflammatory
Bowel Disease was defined as that patient group who were considered to have Crohn's or
Ulcerative Colitis. This may seem pedantic however it provides exclusion criteria for
those patients with for instance radiation proctitis and endometriosis who if submitted to
the OMGE scoring system may be classified as Crohn's or Ulcerative Colitis and hence
entered into the Register.
It was therefore decided to base the Register's diagnostic criteria on two
stage serial testing, firstly,
a) Is this a true case of Inflammatory Bowel Disease or some other Non-Specific
Colitis?
and secondly,
b) Is this Crohn's disease or Ulcerative Colitis?
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It was hoped that this would maximise specificity and positive predictive
value and although perhaps lowering the sensitivity of the diagnostic method it should
ensure that those noted to have positive tests did have Crohn's disease.
This serial testing would firstly produce a group considered to have
Inflammatory Bowel Disease who would then be further subdivided into those with
Crohn's disease and Ulcerative Colitis; the Crohn's group would then be admitted to the
Register.
The scoring system devised takes into account the individual's clinical,
radiological, endoscopic and pathological findings. Patients were considered to have
Inflammatory Bowel Disease if they had symptoms of the disease and had demonstrated
positive evidence of Inflammatory Bowel Disease in at least half of all performed relevant
investigations.
The developed scoring system attempts to take into account the relative
importance of the various traditional techniques used in the diagnosis of Crohn's disease
or Ulcerative Colitis. For instance greater weighting has been given to the pathological
and radiological findings as compared to endoscopic findings. The system is described
below.
A. Symptoms:-
Score one point for each bowel related symptom.
B. Endoscopy: -
Score 0 = no evidence Inflammatory Bowel Disease (IBD)
1 = some evidence IBD
2 = good evidence IBD
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C. Radiology:-
Score 0 = no evidence IBD
2 = some evidence IBD
4 = good evidence IBD
D. Pathology: -
Score 0 = no evidence IBD
1 = minimal evidence IBD
3 = good evidence IBD
5 = diagnostic of Crohn's / Ulcerative Colitis
A total patient score of 6 or above with half of all Crohn's related
investigations positive was arbitrarily considered to represent a case of Inflammatory
Bowel Disease (IBD) as opposed to an indeterminate or Non-Specific Colitis.
The scoring system was tested for accuracy by checking groups of patients
who were known to have either Crohn's, Ulcerative Colitis or Non Specific Colitis. The
predictive values using this scoring method were 98% and 100% for those who were
thought to have Crohn's disease and Ulcerative Colitis respectively and showed a
specificity of 100% for those thought not to have Inflammatory Bowel Disease (ie had
Non-Specific Colitis) (fig 2.1). Even though the test populations are small it is clear that
this simple test is a good indicator of Inflammatory Bowel disease. These findings will be
discussed more fully in a later section of this thesis (Chap 5).
If a patient met the criteria for Inflammatory Bowel Disease then the well
recognised OMGE group's score scheme was applied to separate those with Crohn's
disease from those with Ulcerative Colitis. A separate diagnostic proforma was designed
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Accuracy of diagnosis for Inflammatory Bowel Disease
Figure 2.1
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222 Content of the database
The appropriateness of the structure and content of the database was vital if
the data was to answer the questions posed by the users of the register. This indeed could
be considered the most important part of the Register's development. It must be borne in
mind that any data management and analysis system can only be considered as good as
the data it contains. The content of the database was conveniently divided into sections
each containing related data.
A. Epidemiological and General information
This section would contain basic information relating to a patient's history
and examination (appendix 2) and provide all the data required to produce an
epidemiological picture of the disease.
Basic identifiers such as name and address along with the patient's General
Practitioner identifiers would also be collected. This information would be crucial if the
Register was to function as a management tool where personalised letters, appointments
and reports could be produced as an integral part of the system.
B. Investigations
To create a more detailed picture of the disease and to monitor the natural
history of an individual's disease it was decided to keep a careful record of all the
commonly performed investigations. This would enable an accurate audit to be
performed and enable some measurement of the value of each investigation to be made at
different stages of the disease. Data was collected under four headings.
a) Pathology - To include both macroscopic and histological information on
specimens submitted as a consequence of or related to Crohn's disease.
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b) Radiology - Information on Crohn's related radiological investigations
plus their findings and diagnosis.
c) Haematology/Biochemical data - Parameters thought to be of most value
would be gathered in a sequential fashion.
d) Endoscopic information - All endoscopic procedures and their fmdings
would be logged in the Register.
Dates would be kept for each investigative sub-section to enable monitoring
and comparison of repeat investigations against time. Appendix 3 shows the detailed
investigation data collection form. Facilities within the computer system would be
developed to allow the data to be collected in a time related fashion thus creating a
chronological record of investigations for each individual on the register.
C. Treatment
Information relating to both medical and surgical treatment was also
included in a format which would permit regular update and recall. Data would be
collected on drug therapies and dietary manoeuvres, while surgical data would include
indications for and type of operation performed. Each treatment would have an
associated date enabling comparisons to be made with for instance date of diagnosis and
dates of recurrence. It was proposed that the prospective data collection would link
treatment information to a disease activity score enabling indirect measurement of the
efficacy of treatment and patients well-being over a period of time. Provision was
therefore made within the treatment file for collection of data relating to disease activity.
Many systems have been devised in order to measure the disease activity (Harvey 1980,
Elliot 1980) of patients with Crohn's disease. Some use objective measurements as an
indicator of activity (Van-Hees 1980) while others rely on more subjective assessment
(Best 1976). The activity index chosen is the well described Crohn's Disease Activity
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Index originally described by Best (1976). It would however be impossible to collect
disease activity in the initial retrospective data collection.
The data proforma used to collect treatment information is shown in
appendix 4.
D. Morbidity
Crohn's disease is a chronic disorder with little mortality but considerable
morbidity. Measurement of patient morbidity would give some idea of the distress and
inconvenience caused by symptoms over a period of time. It was therefore intended that
morbidity data should be collected periodically for all or groups of patients on the
Register. The data files were developed to include certain information relating to
morbidity (appendix 4).
Once decisions had been made as to the content of each section of the
database the information was expanded into a questionnaire which was designed for use
with a computer system. This resulted in the production of a proforma with 175 data
fields which contained a total of 507 data points. The data was conveniently divided into




4. treatment, disease activity and morbidity.
This would facilitate the generation of a database containing four data files.
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223 Retrospective Data Collection
The retrospective collection involved several important steps:-
A) defining the population on which the Register was to be based
B) determining the Crohn's cohort from the defined population and checking for
accuracy of diagnosis
C) collecting the appropriate information on questionnaire ready to enter into
the computerised register
A) Defining the population
One measure of the validity of a register is its completeness therefore the
first task was to identify the Crohn's population within a defined area.
Tayside Region is a good area in which to undertake epidemiological
research because of the static nature of the population. Census figures for the past





1921 388433 -6391 1.6%
1951 396194 7761 1.9%
1961 397820 1626 0.6%
1971 397605 215 .05%
1981 391846 -4348 1.1%
Table 2.1 Change in Tayside Population
During the period 1891-1981 there has been no change in the regional
boundaries while the largest swing of population between two ten year census points was
in 1931 when there was an increase of 11,134 which represented an increase of 2.9% from
the 1921 figure.
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Comparing age/sex distribution over the period of study further
demonstrates the static nature of the population.
total Males Females M/F ratio
population
1961 397820 187378 (47.1%) 210442 (52.9%) .471
1971 397605 189413 (47.6%) 208192 (52.4%) .476
1981 391846 186267 (47.5%) 205579 (52.5%) .475
Table 22 Change in Sex Distribution Population
The region covers a large area geographically and is divided into three
health districts each served by a hospital group. Dundee district, the main centre of
population, contains a teaching hospital group - Ninewells Hospital and Medical School,
Dundee Royal Infirmary and Kings Cross Hospital. Perth & Kinross district is provided
for by Perth Royal Infirmary while Angus district is served by Stracathro Hospital and
Arbroath Infirmary. Several smaller cottage hospitals supplement the bed compliment
within each district - each is rim by General Practitioners although most also have out¬
patient clinics staffed by visiting Consultants.
Due to the distribution of population and position of hospitals within the
Region it is unusual for General Practitioners to refer patients to hospitals outwith the
area. Consultants wishing further specialist opinion on patients with Crohn's disease
almost always refer to specialists within the teaching hospital group where there are
several consultants with a particular interest in Inflammatory Bowel Disease. This
situation is however complicated because some areas of neighbouring Fife region are
close to Perth Royal Infirmary and others to the Dundee teaching group of hospitals.
This results in some patients resident in Fife being referred to Tayside hospitals.
Statistics confirm that Tayside health authority is a net 'importer' of patients from in
particular Fife but also Grampian region. Calculation of the effective catchment
population for General Surgery in Tayside for 1983 for example revealed a figure of
445,210 some 50,000 more than the official resident population. The inpatient cross
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boundary flow for Crohn's disease and related disorders for patients in Tayside is shown
in fig 2.3 confirming that few patients are "exported" to other areas. This study has shown
that only 60% of those with a SMR1 diagnostic code of Crohn's will have the disease
reducing this cross boundary flow still further. Furthermore, the figures relate to
admission events some patients may therefore have several admissions. For technical
reasons the Information Services Division, from whom the figures were obtained, were
unable to provide figures for other than 1986.
patients imported patients exported
Crohn's disease 23 2
Idiopathic Colitis/ 24 7
Other non-infected colitis
Table 23 Cross Boundary Flow in Tayside for Crohn's & related disorders for 1986
Despite the difficulties associated with collecting data from patients referred
to a variety of hospitals it was decided that the Register should relate to all those Crohn's
patients living in Tayside or being seen in the Tayside group of hospitals. Provision would
be made in the database file structure to separate individuals into separate cohorts
depending on their place of residence. In order to achieve this objective the postcode
both at the time of diagnosis and the present time would be collected for each individual
admitted to the Register. This would enable the Register to develop from a well defined
population, thus meeting one prerequisite of any accurate epidemiological study, but
would also provide as large a cohort as possible for non-epidemiological enquiry.
The population defined, it was then necessary to choose a time interval on
which to base the retrospective data collection. Several factors required consideration
1) the period chosen should provide sufficient information to enable an
accurate and valid picture of Crohn's disease to be built up within Tayside. Furthermore
it should permit a comparison of trends following prospective data collection.
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2) Scottish inpatient morbidity information, which includes diagnostic
coding, has been collected since 1961. Over the years the format of collected data has
however changed. Before 1968 the information collected related to hospital number, date
of admission and discharge along with diagnostic coding. Tayside no longer has record of
a full pre 1968 inpatient index to enable patient records to be identified and examined in
those patients hospitalised with Crohn's disease before this time. Data retrieval on these
patients is therefore all but impossible unless further admissions have taken place in the
post 1968 period.
Since 1976 the Tayside Community Health Index (CHI) - initially developed
as the Master Patient Index - has been computerised. This patient index contains
inpatient disease codes based on the International Classification of Diseases (ICD),
obtained from the SMR1 discharge form, thus making it relatively easy to obtain
diagnostic information on all inpatients. Although the most recent outpatient contacts are
held on this system no note is kept of outpatient disease coding. This presented a
potential problem in defining the total Tayside Crohn's population. If individuals were
diagnosed purely on outpatient visits then they would not be identified in a search of the
CHI for those with a Crohn's diagnostic coding.
3) the International Classification of Disease (ICD) has changed twice over
the years 1965-1975, with several other minor revisions, fortunately the coding structure
for Crohn's disease has altered little over this period.
Taking these points into account it was decided to identify all patients in
Tayside who were either diagnosed or were known to be suffering from Crohn's disease
between 1968 and 1983. This would be achieved by obtaining information on disease
codes from
i) Tayside Community Health Index
ii) Scottish Common Services Agency
iii) Tayside General Practitioners
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B) Identifying and checking accuracy of population
Most agree that nearly all patients with Crohn's disease will be admitted to
hospital at some point (Langman 1981, Langman 1983), indeed Kyle (1981) found that all
patients in the Grampian series were admitted at some stage in their disease. The
majority of patients should therefore be 'captured' by using the International
Classification of Disease codes contained within the Scottish inpatient morbidity returns
(SMR1) for the area under study. There are however possible pitfalls in using inpatient
statistics alone for identifying and measuring the Crohn's population or any other disease
population. Firstly, some patients may never be admitted to hospital although this is
recognised to be uncommon in Crohn's disease. Secondly, some patients may have the
disease for many years before hospital admission is required and in a few the diagnosis
may only become apparent after hospital discharge and subsequent outpatient
investigation. Thirdly, there may be inaccuracies in the coding itself. Fourthly, repeat
admissions, lengthening of both out and inpatient waiting lists and improved medical
treatment may appear to alter, at least on paper, the frequency and incidence of disease.
Langman (1983) suggested that inpatient statistics of Crohn's disease, unlike
Ulcerative Colitis, give a reasonable index of the disease, however Smith from the
Clydesdale series (Smith 1975) reported the inpatient statistics to be wholly inaccurate
with a marked tendency to over diagnosis. In this series almost 50% of those labelled as
sufferers of Crohn's disease following a hospital admission were incorrectly coded. A
similar inaccuracy was also noted by Humphrey's (1975) in his series from Northern
Ireland. The accuracy of the SMR1 ICD diagnostic coding will vary between health
boards and may indeed vary between units depending on who completes the SMR1 form.
Inaccuracies such as these would be eliminated by examining the case records of those
deemed to have Crohn's disease by SMR1 returns, similarly patients with repeat
admissions could be identified during this search. However this would give no measure of
Developing the Register
the false negatives; those who had been incorrectly coded as Ulcerative Colitis or Non¬
specific Colitis but who in fact had Crohn's disease.
Most series take the date of diagnosis as the basis for calculating incidence
and prevalence rates. Using this data errors may arise from delays in reaching a
diagnosis. Kyle in the Grampian series (Kyle 1971) eliminated this inaccuracy by using
the onset of symptoms as the start point of the disease. It seemed that the best way of
obviating this problem yet permitting comparison with other series was therefore to
collect both date of symptom onset and date of diagnosis; this would also demonstrate any
differences in calculated rates between the different methods.
Identification of the Crohn's population was conveniently divided into three stages.
1. The first step was to test the accuracy of the SMR1 diagnostic coding
system for Ulcerative Colitis, Crohn's disease and Non Specific Colitis within Tayside. If
the numbers of false negatives in the Crohn's group and false positives in the Ulcerative
and Non-specific colitics were small then examining the case records of those with the
Crohn's ICD code should prove a valid method of identifying all the false positives.
Computer print-outs were obtained from the Tayside Health Board inpatient
statistics for the ICD codes of Ulcerative Colitis, Crohn's disease and Non- Specific
Colitis for the year 1980-81.
The records of the first 50 Patients from each group were examined for
diagnostic accuracy. All patients chosen were admitted to Dundee district hospitals, the
years 1980-81 being chosen as this would provide a follow-up period of sufficient length
for subsequent confirmation or otherwise of the original diagnosis.
The initial diagnosis was accurate in 90% of ulcerative colitics and 87.5%, of
non-specific colitics but was inaccurate in 24% of those labelled as Crohn's disease after
following each group for at least two years. Furthermore, of those given an incorrect
diagnosis during the 1981 admission only 2% of those with an Ulcerative Colitis and 6%
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of those with a Non-Specific Colitis coding were subsequently found to have Crohn's
disease. These figures suggested that within Tayside the inpatient SMR1 returns were
fairly accurate for those with Ulcerative Colitis and Non-Specific Colitis. Similarly of the
false positives in these groups who turned out to have Crohn's disease after two years of
follow-up,all eventually were found to have a Crohn's ICD coding following a subsequent
admission. The results of this short study are more fully described in Chapter 4.
2. In view of these figures it was felt acceptable to base the initial case
capture on inpatient Crohn's ICD coding particularly as so few individuals diagnosed
initially as Ulcerative Colitis or Non-Specific Colitis had subsequently turned out to have
Crohn's disease.
Print-outs were therefore obtained for all patients with Crohn's ICD coding
for the years 1967-83. Information for years 1967-74 was obtained from the Scottish
Common Services Agency while data for 1975-83 was obtained from the Tayside Health
Board Community Health Index. The case records of all patients listed on the printouts
were then obtained, examined and checked for diagnostic accuracy. If they met the
register's diagnostic criteria they were then submitted to the general retrospective data
collection.
3. It was felt that this procedure would capture all but a few Crohn's patients
who had not had a hospital admission. To identify the remainder of the patients the
ninety primary care practices in Tayside were mailed. The letters contained a list of
patients belonging to each practitioner within the practice deemed to have Crohn's
disease by the criteria laid down by the Register. General Practitioners were asked to add
any other patients within their practice whom they considered to be suffering from
Crohn's disease. The three practices with no apparent cases of Crohn's disease were also
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mailed with a letter explaining the purpose of the study and asking the Practitioners to
submit names of any patients within their practice whom they felt had Crohn's disease.
This particular method was chosen as it was thought that better practitioner
compliance would result if reliable information was provided. All the additions were then
checked using the recognised Register criteria, particular attention being paid to the date
of symptom onset and diagnosis as individuals whose diagnosis was made after 31 Dec
1983 were excluded from the Register.
As many as 15% of patients wait up to two years for a diagnosis (Kyle 1977)
to be made therefore the primary care mailing was not undertaken until September 85 in
order that the names of those with symptoms and / or diagnosis prior to 1983, but no
hospital admission until after 1983, might be obtained.
C) Retrospective collection of data
The case record of each potential Crohn's patient was identified and then
carefully examined by the author and a Register diagnosis obtained. It is arguable that an
independent assessor should also have validated the author's interpretation of the case
record data and hence his 'diagnostic accuracy'. The conclusions of the OMGE study
(Myren 1979) however, emphasise in particular the 'degree of congruence observed
amongst participating clinicians in respect of diagnosis' which though achieved with
structured proforma did not define the terminology used. With this in mind it was felt
that because a similar proforma was used in this study further observer validation was not
necessary.
This involved identifying those with IBD through the developed scoring
system and then applying the criteria laid down by the OMGE group to determine
whether this was Crohn's or Ulcerative Colitis. As investigations were included as an aid
to diagnosis a score of 10 or above was taken as the definition of a case of Crohn's while a
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score of < 10 placed the individual in the group classified as Ulcerative Colitis. All this
diagnostic information was entered onto a Registration form.
If an individual was deemed to have Crohn's disease further information
relating to epidemiology, radiology, pathology, endoscopy, biochemistry / haematology
and treatment was collected on the Register's main questionnaire (Appendix 5). This
information was also extracted from the patient record.
Once the questionnaire was complete all the information was entered into
the computer system.
The few individuals who did not meet the recognised diagnostic criteria but
in the view of both the clinician managing the case and myself were thought to have
Crohn's disease were also entered into the Register. Those who did not have Crohn's
disease were classified as either bowel related disease or as totally inappropriate coding
and no other information collected.
Calculated figures for the Crohn's population plus the accuracy of diagnosis
are fully discussed in chapter 5.
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2.3 THE COMPUTING ASPECTS
23.1 Design philosophy
The development of a computer system is a complex task. Ideally the
problem should first be defined and then broken into smaller sections for detailed
consideration. An overall specification can then be compiled of the functions the system
must perform. At this stage decisions can be made about the software design and
hardware requirements. Inevitably the final choice will be a compromise between costs,
availability, speed of operation and even personal preference.
The overall design philosophy of the system was therefore based on
a) what the system was required to do ?
and bearing this in mind
b) how this would be best achieved ?
Following this strategy it was imperative first to decide on the requirements
of the system from a clinical viewpoint. It was then possible to look at the available
computing options, both hardware and software, that would meet this clinical need.
Having explored the various alternatives a decision could then be taken on the minimum,
or perhaps optimum, hardware and software requirements which would permit the
development and implementation of the proposed system.
232 Clinical aspects of computer development
The objective of the eventual prospective system was to produce a dynamic
picture of Crohn's disease in Tayside. This would increase the understanding of the
disease, provide a disease audit and, if designed correctly, help in patient management.
Facilities would obviously be required to record data on the system in a structured
relationship so that for instance the diagnostic information belonging to a patient was
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linked to epidemiological, investigation and treatment data and vice versa. Similarly it
would be important that update information (ie further radiological investigation,
treatment etc.) was linked to existing data in chronological order. If this were
accomplished an on-going follow-up case record would be created in date order similar in
concept to and hopefully more accessible than existing medical records.
If the computerised Register was to be used for audit, management and
research purposes data enquiry, manipulation and analysis facilities would also be
essential. These facilities should include a simple look-up and browse facility which
would permit hardcopy and screen presentations of data in chronological order. Both
numerical and non-numerical analysis facilities would be necessary as a large portion of
the collected data was non-numerical. The potential value of the register as a prospective
management tool would be greatly enhanced if a 'mailmerge/report' facility was also
incorporated into the system to enable letters and reports to be generated incorporating
the names, addresses and other data taken from the files.
Finally and importantly a mechanism for categorising or subdividing the
subjects would be required. This 'subset' structure would enable specific groups of
individuals to be selected for closer examination and analysis - for instance those over 60
years at diagnosis or those with symptoms for over 12 months. Secondly by creating
subsets in this manner it would be possible to generate letters and reports for specific
groups on the register - an important feature if the register was to be developed in a
prospective fashion when one might wish to write to a particular group of patients or their
general practitioners.
233 Aspects of hardware and software development
Bearing in mind the clinical requirements of the Register several points
required investigation before undertaking the development of the system.
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1. Hardware available / required
2. Operating system
3. Database system
4. Software to manage the Register
a) Hardware
The choice of hardware for the project was constrained by the availability,
cost and possible future developments.
Within the Faculty of Medicine Computing Unit (FMCU) it was possible to
obtain access to the University Dec 10 mainframe computer, however there were
limitations relating to access and availability of this machine for clinical purposes.
The Medical Faculty CTL Modular One minicomputer operated by the
FMCU had been used for clinical data storage,but this machine was nearing the end of its
lifespan and was being phased out in favour of distributed microcomputers connected to a
local area network permitting the sharing of peripheral devices such as printers or disc
storage media.
The increasing availability of powerful reasonably priced microcomputers
both within the FMCU and other hospital departments with their accompanying
development potential therefore suggested that this was the most feasible option. The
only major drawback of the microcomputer was the uncertainty as to whether a complex
register system could be created within the confines of a microcomputer environment.
Finally consideration had also to be given to the medium on which the data
was to be stored. The choice here lay between floppy diskette and hard disc media.
Although a floppy based system was less expensive the benefits accruing from a hard disc
system which included vastly increased data storage capacity and a manifold increase in
speed of operation, made it the only real viable option.
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Taking these individual points into consideration it was decided to base the
development of the computer system on an IBM Personal Computer containing
256Kilobytes of random access memory (RAM) which was linked to the local area
microcomputer network and could therefore utilise its hard disc storage medium.
b) Operating System
Before the emergence of MS-DOS as the universally accepted operating
system for the IBM PC type microcomputer there were many operating systems such as
CPM and AppleDOS in use on a variety of microcomputers. At that time the
programming language BASIC was not as developed as it is today and did not readily
lend itself to creating large software systems. With the introduction of microcomputers
and the local area network the FMCU had opted for a less well known but more versatile
operating system known as the UCSD p-system using the language Pascal, many features
of which have subsequently been incorporated into dialects of BASIC.
The UCSD operating system had its origins in the University of California at
San-Diego where it was developed in the mid 1970's. It was initially developed as a
solution to a particular problem within the University Computing Department by
Professor Kenneth L. Bowles. Interest, however, soon grew and by the late 70's several
implementations had been produced. The developers of these implementations were
given three prime design objectives:-
1. should be oriented to the novice but acceptable to the expert.
2. should operate within the confines of a microcomputer environment.
3 must provide a portable software environment to enable programmes to
run on different microcomputers.
Although never achieving widespread popular acceptance the p-system is
recognised as an ideal design and development tool and as such has been used by many
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educational and university establishments and commercial system designers. More
importantly however, the three prime objectives laid down by the developers exactly met
the criteria of the operating system required to develop the Register.
The UCSD system was developed around an imaginary 'ideal p-machine'
which resides between the host computer's own native operating system and the p-system
program code files. In short, programmes are written in the p-system Pascal language as
text files, compiled into p-code program code files and then run on any microcomputer
supporting the p-system. Each microcomputer has its own specific 'p-machine
interpreter' which interprets the p-code and enables it to run a program as if it were using
its own native operating system. Thus any computer which has a p-system interpreter will
be able to run a p-code program without modification.
This system has several important advantages over the more commonly used
operating systems. Its use would enable the development of the Register's programmes to
proceed on a number of microcomputers within the department and would not therefore
tie one machine to this single function. Secondly, and more importantly, the developed
programmes would run on any computer that supported the p-system, thus greatly
diminishing any future problems of hardware/software incompatibility. Indeed the p-
system now being used operates under a number of operating systems as well as the MS-
DOS system.
This system does incur an approximate 10% reduction in the running speed
of p-code programmes which occurs because the code is interpreted by the p-machine
emulator. This compared favourably with many implementations of BASIC available at




The choice of a database to support the register was restricted to one of
three possible options:-
1. buy a commercial package
2. write a dedicated database record structure in p-system pascal
3. use the database system being developed within the department
Commercial packages initially appeared the most suitable for adapting to the
Crohn's Register database with packages such as Knowledgeman, D-Base II & D-Base III
(Ashton-Tate) and Silicon Office (Bristol) seemingly being readily adaptable to store the
Crohn's data. Unfortunately this type of package has several disadvantages. Each is in
some way a closed system - the user therefore has no access to the source code and can
only utilise the facilities provided within the package. Furthermore most are directed at
the business user and are less well equipped to handle medical data much of which is
textual in form.
Designing and using a p-system Pascal record structure as the database was
briefly considered, however because of the volume of data to be collected this would
result in a very large data structure. Secondly because Pascal is a very strictly 'typed'
language the record structure would be very inflexible.
Attention was therefore turned to the database system within the
department. This database using what is now called the fourth generation principle of
conversationally generated record formats with medically orientated data types had been
developed and used on the department's mini-computer for several years. The concepts
and data types had been well proven, however the rewrite of the system for the
microcomputer environment was only at an early stage. In addition new features found
necessary from experience with the original mini-computer based system were still to be
incorporated.
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The main advantage of this database facility was that it had been developed
specifically to cater for medical data collection and storage. The data structures within
the database were superior and more flexible than those of most commercial packages
and coped equally well with non-numerical and numerical data.
Several important concepts and data structures not normally incorporated
within commercial database packages were contained in this system. Examples of those
thought to be of special value within the Crohn's register are described below.
The data field type 'multiple coded response' enabled the user to choose
several codes from a defined repertoire and enter them all in one data field. For example
for the question 'What were the histological findings ?' one could enter a string of codes
'ABG' where each character represented one particular finding for instance acute
inflammation, chronic inflammation and giant cells. In addition the system provided full
text expansion of input codes for example replying 'A' to the above question caused the
expanded text for that code to be displayed on the screen - 'acute inflammation' in the
above case. This greatly aids the accuracy of data input by giving immediate feedback of
the coding system.
Another field type, the 'conditional' or 'logical' type, enabled the streaming
of data input. Thus answering 'Y' to the question 'Did the patient have an operation ?'
would then prompt the user to answer questions on the type of operation, date of
operation, reason for operation and diagnosis at operation while answering 'N' would by¬
pass all these irrelevant questions.
Furthermore validity checking on input was an integral part of the system
and is essential if invalid or meaningless information is to be trapped before it is filed
away. This is important because the main weakness of any computer system is the
user/keyboard interface; once data has been entered into a system it is very difficult to
check its accuracy and validity.
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Therefore despite the drawbacks associated with developing a software
application based on an untried database it was felt that the advantages of using this
system far outweighed the potential problems. As will become evident this decision has
been fully vindicated.
d) Software Development
Two approaches to the software development were considered
1. To write a suite of programmes that were dedicated to the operation of a
functioning Crohn's disease Register.
2. To develop a collection of programmes as a set of tools which could be
used subsequently to support other similar applications using the department's database
system. The facilities required for full operation of the Crohn's Register were substantial
and could be used as an initial pilot in the development of a general purpose system.
The dedicated program solution appeared at first sight to be the more
attractive and less complicated option. However further thought and initial development
suggested that the large number of data fields being collected would create considerable
programming difficulties when it came to data enquiry and analysis routines.
At this time increasing demands were being placed on the medical
computing unit for microcomputer based data collection and management facilities as the
numbers of microcomputers increased within the district. Moreover with the recent
demand for audit within the Health Service accompanied by the significant reduction in
costs of microcomputer technology it was clear that demand for this type of system would
continue to increase significantly. Finally the new microcomputer systems were intended
to act as a replacement system for the faculty's mini-computer when it was eventually
withdrawn from service. Because the data structures would be of similar format it was
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anticipated that data would be transferable from the old system to the new thus retaining
the value of data sets which had been collected over many years.
The benefits that might accrue from such a general system were therefore
not inconsiderable and indeed were one of the aims the author had proposed in
application for the SHHD computing fellowship which had been obtained to support this
work. It was therefore decided to develop a suite of programmes around the facilities
required by the Crohn's Register. The programmes would be written so that they
addressed the data field types as opposed to specific field numbers. This would have the
effect of laying the foundations from which a general database management system might
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3.1 DATABASE FILE STRUCTURE FOR THE DISEASE REGISTER
The data to be collected fell into two distinct categories: non-recurrent (ie
date of diagnosis) and recurrent (ie investigations and operations). Because large
recurring data sets consume large amounts of computer memory it was decided to break
the data set into data files of more manageable size thus saving on both memory within
the computer and on its associated data storage medium. The data set was conveniently
divided into 4 data files - 2 files containing non-recurring data, Diagnostic and General
information, and 2 with recurring data, Investigation and Treatment/Morbidity data. A
data file can contain a maximum of 32,000 records with each record comprising the data
items related to that particular file. The diagnostic file for example could therefore grow
to a maximum size of 32,000 records (or 32,000 patients) each containing 33 separate
items of diagnostic information.
A subject entered into the register could have data records in all the data
files and would therefore require an 'index structure' to link all his or her data records
together. To achieve this link the concept of a 'Control file' was created. Each individual
entering the Register was assigned a unique record in the control file which acts as an
index to all that patient's data file records. This file was generated to permit up to 32
records or follow-up visits for each of the four files to be linked to a subject. This record
was also to contain other important information relating to the subject's unique register
number, subset membership (see page 49) and certain important dates (Fig 3.1).
In summary the Register's database file structure consists of a Control file in
which each subject has one record which indexes the data records in each of the 4 data
files and contains subset and other 'housekeeping' information (Fig 3.2).
A CONTROL FILE RECORD
subject nunber (0 to max study number)
file 1 1 45 90 98 126
file 2 76 77 each numbe ■ poin' s to a
file 3 reco ■d in ;he da1 a files
file 4 27 98
Subset type 1 + - (if + patient in subset)
markers type 2 + + - - -
type 3 - - + + +
Date subject registered
Date last had data entered
1. 3.85
3. 6.86
Format of control record
Figure 3.1
CONTROL FILE
patient / subject 1
record 1
patient / subject 2
record 2
patient / subject 3
record 3
DATA FILES






1 control file per study data files (Max of 4 per study)
Each subject has 1 record in the CONTROL file containing
record numbers which point to record in the DATA FILES
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3.2 PROGRAMME DEVELOPMENT
The suite of programmes required to generate the Crohn's register were
developed in a modular fashion. This modular approach enabled each programme within
the system to be generated independently and made the overall development more logical
and manageable.
Three main programme modules were created
1. Generation of the Register
2. Input of data to the register
3. Data enquiry and analysis.
In order to enable non-computer personnel subsequently to use the
computer facilities the control programme module has been created in such a way that it
is 'menu driven'. This enables those with no experience of the system to be led through
the facilities by answering simple questions. A 'help' facility has also been incorporated in
order to assist those who are not familiar with the operation of the system. This offers a
short and concise description of the options presented in a particular menu to be called
up if a user finds the simple menu unclear.
3^2.1 Generation of the Register
This module was designed to generate the database to the Register's
specification. The programme was developed as a 'user friendly interface to the data file
generator programme already existing in the department and permitted the generation of
the four data files associated with the register plus the control file structure.
Each data item was configured into a data field in the appropriate data file by answering a
series of simple questions related to:
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a) type of data (e.g. number, date, string characters, coded response or
logical formats)
b) question to be displayed on screen (e.g. Date of birth)
c) range of codes/values permitted (e.g. max & min ranges).






Once the data files had been generated the control file was created by
answering an additional set of simple questions.
322 Input of data to the Register
To achieve the intended goal of a dynamic register in which patient events
and data input were related to time several different forms of input pathway were





The registration or take on of a subject to the register occurs only once.
After a subject has been registered information contained within his or her data records
may require modification for instance changes in name/address or change of general
practitioner. Update of a subject's data will occur when new information is added and
associated with that subject's existing data. A deletion pathway was also included to
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enable correction of catastrophic user mistakes.
Once again it must be stressed that data input is a weak link of any computer
system. Once data has actually entered a database it is very difficult to check either its
validity or accuracy. To reduce this type of operator error validity checking has been
incorporated within each data field, thus if a Haemoglobin (Hb) value of > 20 is entered
into the Hb data field the system will reject the value and prompt a further reply. This
form of checking will prevent totally inappropriate data from being entered, however it
will not prevent the input of valid but inaccurate data (ie entering a Hb value of 11 rather
than 13). To help avoid this type of error all data entered is redisplayed on the screen for
checking - an option is also available to modify incorrect data before sending it back for
storage. Subsequent analytical audit of the data can also be used to seek out some of this
type of error if it can be detected as being contextually inconsistent.
To maintain efficiency with data transactions the concept of an 'Input form'
was introduced. These input forms select the questions necessary to carry out particular




The 'Registration form' will only display questions and prompt answers for the data fields
which relate to registration. Similarly the 'Investigation form' contains information on
data fields which relate to investigations. This form has been further classified into 5 sub-
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These mechanisms greatly reduce the time required for input by eliminating as many
unnecessary questions as possible. For subsequent prospective operation and
maintenance of the Register this is an important factor.
To summarise, all data entering the Register system must pass through the above input
pathways. The order and sequence of data input is optimised by the generation of 'Input
forms' which can be created, altered and deleted as required to match operational
circumstances.
323 Data management facilities
Once data has been entered into the Register any of the management
facilities contained in the system may be used to enquire, manipulate and/or analyse
information in the database.
The management menu is displayed below
1. Subsets
2. Data analysis
3. Browse and Print
4. Letters & Reports
5. File information
6. Sorter routine
Each of the headings represents a different utility which can be performed on data within
the Crohn's Register.
Subsets
The concept of subsets has already been introduced. This permits
individuals within the Register to be grouped together because they all meet certain
'criteria', for example all the males, all those under 30 at diagnosis, all those with a five
year follow-up. Once a subset has been created it can be named and then saved to disc
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(fig 3.3). All other management facilities can then utilise one or more of these subsets as
a cohort for further analysis, enquiry and report generation.
Although a maximum of 64 subsets can be held within the system at any one
time each can be deleted and regenerated at any time. Once generated subsets can also
be compared with each other to create more specifically defined groups; the 'males'
subset may be compared with the ' > 60 at diagnosis' and 'large bowel disease' subsets thus
creating a new subset of all the males who are over 60 at diagnosis and have large bowel
disease.
A number of conditional constructs have been created to define the criteria
for membership of a subset
1. manually entering patients with specified criteria which have not been
collected in the database (ie those with ginger hair).
2. specific criteria (ie all the females or those with Hb < 10 gms/dl) with up to 4
conditions specifiable each time.
3. related to the number of register entries each subject has (ie the third visit /
entry)
4. from the subtraction of dates or numbers (ie all those with no recurrence for 5
years / those who were not diagnosed as Crohn's until 1 year after presentation).
The subset concept provides great flexibility to the system enabling the creation of cohorts
or sub-populations which can then be used to submit recognised groups of subjects to
other register utilities for research, audit and management purposes.
Data analysis
Like a great deal of medical information the Crohn's database contains a
large proportion of non-numerical data items. To analyse the numerical data a suite of
standard statistical tests was incorporated into the system. A special tabular format was
devised to display non-numerical data in a numerical fashion. Database analysis utilities
SUBJECT CONDITIONAL SUBSETS
1 Females (188) 19/1 2 Hales (128)
3 >« 60 at diag (35) 19/1 4 not made
5 <20 at diag (52) 19/1 6 diarrhoea 203
7 <60 at diag (278) 19/1 8 <» 30 at diag 154
9 40 to 59 at diag (65) 20/1 10 20 to 39 at diag (161) 20/1
11 Sm. Bowel Dis (97) 21/1 12 Ileo-colic dis (94) 21/1
13 Large bowel (71) 21/1 14 Discontin Ois (44) 21/1
15 pain 220 16 wt loss 173
17 not made 18 PR bleeding 50
19 gross fd/crohns 172 20 females+biopsy 132
21 biopsy/crohns 72 22 granuloma all (157)
23 males 4 biopsy 93 24 Transmural all (85)
25 not made 26 crypt absc all (50)
27 not made 28 giant cell all (95)
29 not made 30 Radiol Crohns (189)
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were therefore developed to provide
a) Non-numerical data presentation and analysis
b) Numerical statistical analysis.
Non-Numerical Analysis
The one and two dimensional table format was chosen as the method of
representing this type of data. All field types can utilise this analysis facility. Fields may
be analysed singly or in pairs. Typical examples of this flexible analytical technique are
shown in figs 3.4, 3.5, 3.6 and 3.7. Figures 3.4 & 3.5 show a single field analysis (sex ratio)
and comparison of two fields ( sex ratio against site of disease). Figure 3.6 presents the
changing haemoglobin values of those in the register over sequential visits and finally
figure 3.7 represents the analysis of one field, the site of disease, against several previously
defined related subsets - in this case age at diagnosis.
Furthermore the ranges or intervals into which each parameter can be divided can be
varied. The system defaults to generating equal ranges for any field type being analysed -
for instance the Haemoglobin field will have 8 ranges generated starting at 5 and
incrementing by 2 to create each new range - however these can be overridden and
chosen to suit a particular analysis. For example the analysis of the Hb field would
perhaps be more appropriately analysed in three ranges (5-< lOgms/dl, 10-<12 gms/dl
and above 12gms/dl) especially when the data to be analysed is likely to be skewed.
Numerical Analysis
In order to provide standard statistical facilities for numerical data a suite of
standard statistical paired and unpaired tests have been included which can operate on
TABULAR PRESENTATION AMD ANALYSIS
Sex
317 data points from a Sample of 317 subjects
Sample is from a population of 319 selected from ALL subjects
RET for Y axis











N = number XT
? = empty fields XC
XR
■ X of Total
» Number as X of Column total
= Number as X of Row total
Simple analysis
Figure 3.^
TABULAR DATA PRESENTATION AMD ANALYSIS
Sex S Site of Disease
317 data points from a Sample of 317 subjects
Sample 1s from a population of 319 selected from ALL subjects
KEY for X axis
Field 36 in File crohns:c1nv - EXTENT DISEASE
A = SMALL BOWEL
B = ILEO COLIC
C =■ LARGE BOWEL
D = 0ISC0NTIN DISEASE
KEY for Y axis
Field 15 1n File crohns:cgen - SEX
1 ■ MALE
2 = FEMALE
? A B C D TOTAL
N! 0 0 0 0 1 ! 1
7 XR! 0.0 0.0 0.0 0.0 100.0 ]
XC! 0.0 0.0 0.0 0.0 2.3 ! OXT
N! 5 46 35 26 16 ! 128
1 XR! 3.9 35.9 27.3 20.3 12.5 !
XC! 45.5 47.4 37.2 36.6 36.4 ! 40XT
N! 6 51 59 45 27 ! 188
2 XR! 3.2 27.1 31.4 23.9 14.4 i
XC! 54.5 52.6 62.8 63.4 61.4 ! 59XT
TOTAL! 11 97 94 71 44 ! 317
XT! 3.5 30.6 29.7 22.4 13.9
N = number XT - X of Total
X = empty fields XC 1 Number as X of Column total
XR = Number as X of Row total
Two dimensional analysis
Figure 3.5
TABULAR DATA PRESENTATION AND ANALYSIS
Hb values 1st five visits
1050 data points from a Sample of 317 subjects
Sample is from a population of 319 selected from ALL subjects
KEY for X axis
visit
KEY for Y axis







? A 8 C D E TOTAL
N! 0 44 143 165 136 90 578
? XR! 0.0 7.6 24.7 28.5 23.5 15.6
XC! 0.0 13.9 51.3 76.0 92.5 100.0 55XT
N! 0 12 7 2 0 0 21
1 XR! 0.0 57.1 33.3 9.5 0.0 0.0
XC! 0.0 3.8 2.5 0.9 0.0 0.0 2XT
N! 0 76 36 8 1 0 121
2 XR! 0.0 62.8 29.8 6.6 0.8 0.0
XC! 0.0 24.0 12.9 3.7 0.7 0.0 12XT
N! 0 185 93 42 10 0 330
3 XR! 0.0 56.1 28.2 12.7 3.0 0.0
XC! 0.0 58.4 33.3 19.4 6.8 0.0 31XT
TOTAL! oo 317 279 217 147 90 1050
XT! 0.0 30.2 26.6 20.7 14.0 8.6
N = number
? = empty fields
XT = X of Total
XC = Number as X of Column total
XR » Number as X of Row total
Analysis "by Clinic visit
Figure 3.6
SINGLE FIELD ANALYSIS USING SUBSETS
TABULAR DATA PRESENTATION AND ANALYSIS
Site of disease
307 data points from a Sample of 307 subjects
Sample is from a population of 319 selected from 4 Subsets
KEY for X axis
Code and subset name
A = Hb <10 (12)
B = WCC >10 (127)
C = Protein <60 (65)
D = Albumin <34 (103)
KEY for Y axis
Field 36 in File crohnsrcinv - EXTENT DISEASE
1 = SMALL BOWEL
2 = ILEO COLIC
3 = URGE BOWEL
4 = DISCONTIN DISEASE
? A 8 C 0 TOTAL
N! 0 0 0 1 1 2
7 XR! 0.0 0.0 0.0 50.0 50.0
XC! 0.0 0.0 0.0 1.5 1.0 1XT
N! 0 2 43 27 36 108
1 XR! 0.0 1.9 39.8 25.0 33.3
XC! 0.0 16.7 33.9 41.5 35.0 35XT
N! 0 5 41 14 24 84
2 XR! 0.0 6.0 48.8 16.7 28.6
XC! 0.0 41.7 32.3 21.5 23.3 27XT
N! 0 2 30 14 23 69
3 XR! 0.0 2.9 43.5 20.3 33.3
XC! 0.0 16.7 23.6 21.5 22.3 22% T
N! 0 3 13 9 19 44
4 XR! 0.0 6.8 29.5 20.5 43.2
XC! n.n 75.0 in.7 13.8 18 4 141 T
TOTAL! 0 12 127 65 103 307
XT! 0.0 3.9 41.4 21.2 33.6
N = number XT X of Total
? = empty fields XC Number as X of Column total
XR Number as X of Row total
Analysis by subsets
Figure 3.7
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the data files. The tests presently available are







A file and field number are defined by the user and the data loaded into the statistics
programme either for the whole file or for a particular previously defined subset. Data
may also be entered manually so that the analysis facilities may be used as a stand alone
statistical package. Once loaded the values may be saved in a file on disc for later use.
Outlying or skewed values may be excluded and various data transformations may be
performed prior to processing.
The data analysis section thus provides two separate and powerful analytical
tools which between them will analyse any data item stored within the register. The
numerical analysis facilities may be insufficient to explore some complex relationships to
which end a utility has been developed to convert the system's numerical values into a
format that can be transferred to more sophisticated statistical packages running on mini
or mainframe computers.
Data enquiry and Print facilities
This facility has been included to permit simple data enquiry operations
either for presentation on the screen or as hardcopy. The function allows the operator to
choose any field or group of fields within the register and then display all the data relating
to those fields, on the screen or printer, for an individual or subset of individuals. The
facility therefore enables the user to examine sequentially an individual's radiological or
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haematological/biochemical tests over a period of time. In the same way a summary of an
individual's clinic attendances can be presented. These facilities are of considerable value
in presenting a concise summary of one aspect of a patient's record for clinical
management decision making.
Letters and Reports
To help in the prospective management and retrospective data enquiry a 'mailmerge'
utility has been incorporated as an integral part of the computer system. This section
includes a basic word processing unit which permits letter or report templates to be
created. By using specific symbols within the template (fig 3.8) information can be drawn
from the Registers database to generate a personalised letter or report (fig 3.9).
A 'bank' of standard letters and reports can be prepared for use in
producing recall letters to patients and general practitioners, clinical summaries, extra
questionnaires etc.
Other utilities within the register
Other general housekeeping functions have been included to help in the
running of the register. These include an enquiry facility to examine the structure and
content of both the data and control files. A 'sorting' option has also been included which
will sort any field type alphabetically or numerically thus permitting the generation of lists










has not been seen at the Gastroenterology clinic since
$4:19:0:-1$ and has failed to attend 2 appointments since this date. We would be grateful if you











This patient of yours David Williams
23 Thurso Cres
Dundee












Example of sample REPORT
Figure 3.9
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3.3 USING THE REGISTER'S FACILITIES
Creation of the Crohn's database in the proposed format using the generator
programme confirmed the feasibility of developing the computerised register within a
microcomputer enviroment. The data input software was then fully tested by entering the
information that had been collected on the retrospective data forms. Appropriate 'input
forms' were created to expedite the retrospective data entry. This retrospective data
input proved a lengthy task and revealed a number of 'bugs' and potential operator
frustrations which were subsequently removed.
Once the retrospective database take-on had been completed attention was
turned to the management facilities. Many of the facilities required in the operation of
the prospective register were also required for analysis and enquiry of the retrospective
information and therefore provided a good test for them. The findings of the enquiry and
analysis of the retrospective database are described in the following chapters. These have
been compiled mainly using the subset, analysis and printout routines, however in addition
•2Students t-test and Chi tests have been used for some simple numerical analysis. This
retrospective analysis has proven the data manipulation facilities to be both flexible and
valuable in operation.
Several important additional enhancements have been incorporated into the
system as a result of this initial use. An example was the requirement to create a subset
'manually' using criteria which were not recorded in the database - for instance a group
with a cow milk allergy. It was also found necessary to permit the comparison and
analysis of a field using several existing subsets (fig 3.7). Further additions and
refinements to the software continue, the system evolving as its use continues both in the
form of the Crhn's Register and through its wider application.
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The pilot study has therefore shown the computerised Register to be both
versatile and easy to use and demonstrated the value of the facilities included within the
system.
Chapter 4
CHECKING THE VALIDITY OF THE REGISTER
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4.1 COMPLETENESS OF CASE ASCERTAINMENT
Before embarking on epidemiological analysis of the retrospective data it
was, as previously noted, essential to check the validity and accuracy of the data.
In chapter 3 the method of case ascertainment and cross checking was
described in some detail. Table 4.1 shows the number of possible cases derived from each
of the sources used.
Tayside Coimnuriity Health Index (CHI) 1974-83 394
Scottish Morbidity Returns (SMR1) 1968-74 99
General Practitioners 43
Table 4.1 Sources used in initial case capture
Possible cases of Crohn's were initially obtained from computer listings from
the Tayside CHI (1974-83) and SMR1 returns (1968-73) respectively. Each individual
listed was then subjected to the Register's scoring system before being considered a
confirmed case of Crohn's disease. In June 1985 each general practice in Tayside was
contacted and asked to ratify that those patients who had been identified as being on their
practice list and confirmed as Crohn's disease were still under their care. By leaving this
18 month gap it was hoped to pick up patients who may have had symptoms from 1983 or
before but were not diagnosed until post 1983 or had not had a hospital admission for
their disease before that time. Secondly the General Practitioner's were asked to include
on their reply form any additional individuals who were under their care and whom they
considered to be suffering from Crohn's disease.
This procedure revealed only a further 16 individuals with genuine Crohn's
disease who did not already appear within the Register.
Prior to 1979 routine mortality statistics did not differentiate deaths from
Crohn's disease from that of Ulcerative Colitis and other chronic enteritis. Since this time
Crohn's mortality statistics have been collected separately and have shown between 6 to
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30 deaths each year in Scotland. The Tayside figures support the low mortality suggested
by the Scottish figures; only 11 patients were considered to have Crohn's disease as a
primary cause of death over the 16 years of study. Crohn's disease was considered a
secondary cause of death in a further 23 patients dying during the period of study.
Computerised statistics from the Pathology department were also examined
for the years 1976-83. Although it was not possible to identify all those with a diagnosis of
Crohn's disease - using systematised nomenclature of pathology (SNOP) -because of
inadequate and inaccurate labelling of specimens no new cases of Crohn's were
uncovered. Furthermore a positive pathological diagnosis is often difficult with terms such
as 'consistent with Crohn's disease' or 'impossible to exclude Crohn's' being
understandably common. Use of such statistics without validity checking might therefore
prove unreliable.
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4.2 ACCURACY OF ICD CODING IN TAYSIDE
As it was intended to base the initial case capture upon inpatient ICD codes
for Crohn's disease it was essential to check the accuracy of the coding for Crohn's and
related conditions (eg. Ulcerative Colitis and Non-Specific Colitis). This would provide
some measure of the number of patients with Crohn's disease that might be missed if the
Crohn's ICD code were the only method of case capture used. To test the accuracy of
ICD coding within Tayside for Crohn's and similar diseases a small pilot study was set up
to examine the accuracy of initial in-patient coding. Three groups of 50 patients each
from Tayside district who had been classified as Crohn's disease (ICD = 550), Ulcerative
Colitis (ICD = 556) and Non-Specific Colitis (ICD = 558) were picked from the Tayside
inpatient CHI computer diagnostic listings for 1980-81. Each group consisted of the first
50 individuals from the district who had been given one of the three relevant ICD codings.
The progress of each of those patients was monitored retrospectively through their out¬
patient clinic visits following their discharge. Each patient therefore had at least three
years of follow-up during which the original diagnosis could be confirmed or altered. All
patients initially identified were traced over the three year period. Table 4.2 reveals that
the initial ICD diagnostic codes for these groups were accurate in 76%, 90% & 87.5% for





Number with disease after 3 years of follow-up
Crohn's Ulcerative Non specific
















Table 42 Accuracy of inpatient ICD Coding after 3yrs Follow-up
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These diagnostic results were derived from information obtained on the
patients over the three year period. They compare the initial coding diagnosis with the
actual diagnosis three years later and do not take into account the relative accuracy of the
initial diagnosis. The figures are therefore a measure of the accuracy of the initial
diagnostic coding after three years of follow up.
The results of this small study therefore indicate that even after a 3 year
follow up period following hospital admission only 2% of those initially thought to have
Ulcerative Colitis and 6% of those classified as Non-Specific Colitis will be found to have
Crohn's disease. While these figures do not take into account patients who might yet
develop Crohn's disease there was no evidence from examination of the case records to
suggest that any of the remaining Non-Specific Colitics might have Crohn's disease. The
Ulcerative colitics were however more difficult to assess. Each patient from this group
was submitted to the scoring system suggested by the OMGE group and all had a total
score suggesting Ulcerative Colitis and not Crohn's disease.
These findings imply that some patients would be missed if case
ascertainment was based solely on Crohn's ICD codings. The numbers missed because of
incorrect coding would however appear to be small because even after three years of
follow up only 4% of patients have had their initial ICD code revised to one of Crohn's
disease. More importantly of those that were revised through follow up visits all were
subsequently classified with a Crohn's ICD code from a successive admission.
More significantly the pilot study revealed a marked variation in the number
of false positives (ie those thought to have the disease initially but subsequently found not
to have Crohn's disease) between the three groups (24% in Crohn's, 12.5% in Non-
Specific Colitics and 11% in Ulcerative Colitic groups respectively). These figures
confirm the findings of other groups from Glasgow (Smith 1975) and Northern Ireland
(Humphreys 1975) who found a large percentage of inpatients coded as Crohn's disease
did not have the disease - approximately 50% in each study. It was therefore felt that even
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though there would likely be a large number of false positives if case ascertainment was
based purely on Crohn's inpatient ICD coding it would provide a valid population on
which to base the initial screening.
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4.3 ACCURACY OF DIAGNOSTIC METHOD
To test the validity of the Register's diagnostic methodology the sensitivity,
specificity and predictive value were calculated for the Crohn's, Ulcerative Colitic and
non-specific Colitic groups respectively.
Every individual from each of the groups was submitted to the Register's
diagnostic criteria firstly for Inflammatory Bowel Disease (IBD) and then Crohn's or
Ulcerative Colitis. The results of step 1 - the diagnosis of IBD - are displayed in table 4.3.
no. with not bowel false false
N disease disease +ve -ve
Crohn's disease 50 42 2 1 5
Ulcerative Colitis 47 42 4 0 1
Non-Specific Colitis 48 3 42 0 3
All 145 87 48 1 9
Table 43 Accuracy of Inflammatory Bowel Disease scoring system
The diagnosis of IBD by the register's criteria was based on a score taken
from the addition of a maximum of 4 criteria - clinical symptoms, radiological,
pathological and endoscopic findings. To obtain the diagnosis of inflammatory bowel
disease the individual was required to have at least half of the performed investigations
relating to possible IBD showing some positive evidence of disease, and must have a total
score of 6 or more when adding the symptom score to the investigation score.
Of those 145 patients submitted to step 1 of the diagnostic procedure 87
were found to have IBD, there was 1 false positive, 9 false negatives while 48 did not have
IBD. This test on its own gave a sensitivity of 91%, a specificity of 98% and a predictive
value of 98%.
The OMGE group found a predictive value of 93% for their scoring system
used to separate Crohn's disease from Ulcerative Colitis. To test whether our
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interpretation and application of the scoring system was comparable, the 50 Crohn's
patients and 47 Ulcerative Colitic patients were checked to see whether our predictive
value was similar to the OMGE group. Taking those individuals who had passed the
initial diagnostic test for IBD from the Crohn's and Ulcerative Colitic groups and then
applying the OMGE criteria we found that of the 90 patients (47 Crohn's / 43 Ulcerative
Colitis) submitted to the test 43 had Crohn's, 42 had Ulcerative Colitis, there were 4 false
negatives and 1 false positive. This serial investigation gave a sensitivity for Crohn's
disease of 91%, a specificity of 98% and a predictive value of 98%. The overall accuracy
of the test for Ulcerative Colitis or Crohn's disease was 94%.
This type of serial testing is recognised to maximise the specificity and
positive predictive value although reducing the sensitivity of diagnostic testing.
Despite the small numbers examined the figures suggest that by using this
method the probability of obtaining the correct diagnosis of Crohn's disease has been
slightly increased compared to the method described by the OMGE group.
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4.4 ACCURACY OF DIAGNOSIS IN POTENTIAL CROHN'S POPULATION
Taking SMR1 and Tayside CHI returns produced a total of 493 individuals
who had at least one occurrence of an ICD coding for Crohn's disease. Table 4.4 reflects
the actual diagnosis of those described as Crohn's disease by Tayside SMR1 and CHI
returns.
confirmed not Crohn's notes not
Crohn's disease traced
diagnosis from CHI 260 106 12
(1974-83)
diagnosis from SMR1 42 49 24
(1968-73)
Table 4.4 Accuracy of inpatient ICD Coding
Only 65% of those with an ICD coding of Crohn's disease had proven
evidence of the disease while 7% of case records could not be traced and therefore
diagnosis neither confirmed or refuted. These figures indicate that the accuracy of ICD
coding for Crohn's disease in Tayside is poor although table 4.5 suggests that it has




Table 4.5 Probability of true Crohn's diagnosis from ICD code
Out of a total of 90 Primary Care practices in Tayside all replied to the
questionnaire posted to them. Only one single handed practice refused to confirm or add
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to the data supplied because of possible contravention of the data protection act. The
replies resulted in a further 43 patients being added to the list of potential Crohn's
patients who had been identified from SMR1 and CHI returns (Table 4.6).
confirmed not no trace diagnosed
Crohn's Crohn's records after 1983
Diagnosis from GP (43) 19 14 5 5
Table 4.6 GP Diagnostic pick up
Of the 19 cases that were confirmed 3 already appeared in the Register
having been entered while registered with a different practice. In retrospect it would also
have been of value to determine the number of individuals that met the Registers
diagnostic criteria for Crohn's disease but were not known to the general practitioner as
sufferers of the disease. Unfortunately the questionnaire was not laid out in a manner
that this data could be obtained.
A breakdown of the 169 labelled as Crohn's who did not meet the Registers
diagnostic criteria is shown in table 4.7
79 inappropriate / incorrect diagnosis
18 acute ileitis
72 related diagnosis
Table 4.7 Breakdown of incorrect ICD coding
The reasons why so many had an inappropriate diagnosis is unclear, however
in this group no information could be found in the case records to give any hint of IBD.
This suggests that the errors were made either in identifying the ICD code or in the
transcription to the SMR1 form.
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Overall 536 individuals were identified as possible cases of Crohn's disease
during 1968-83. In 41 (7.6%) of this group the diagnosis could not be confirmed or
refuted because no information could be found to check the diagnosis. Of the remaining
495 patients in whom it was possible to check the diagnosis 318 (64.2%) patients met the
Register's diagnostic criteria and were admitted to the Register.
Further examination of those admitted to the Register showed that 92%
passed the diagnostic criteria for IBD with the mean score being 9.0 (range 1-18) while
the median was 9.0. More importantly however table 4.8 shows the numbers of Crohn's
patients with radiological, endoscopic or pathological evidence of disease. Patients with
specific types of investigation performed were 'scored' on three levels. Those having no
evidence of disease and those having enough evidence to confirm the presence of IBD.
Individuals considered to fall between the two extremes were described as having some
evidence to support a diagnosis of IBD.
Of those entered into the Register 271, 193 and 267 had a radiological,
endoscopic or pathological investigation performed respectively prior to diagnosis.
The interpretation of written reports and case records by the author and the
interpretation of the investigations performed by the clinicians is of course open to
observer variation. The OMGE group were surprised at the uniformity of the
interpretation of the diagnostic proforma used in their study and also suggested that the
majority of clinicians were in agreement as to what constituted a case of Crohn's disease
or Ulcerative Colitis in the great majority of patients. With this in mind it was felt that the
author would likely fit into the same category as the majority of clinicians and that
observer error in this part of the diagnostic system would not be important. Error on the
part of clinicians performing investigation and the author's interpretation of the results
was also open to observer error. The diagnostic criteria used in the study were based on a
number of different types of observations and investigations. It was felt that an error in
one observation would be offset by the many other observations involved in reaching a
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diagnosis; using this form of serial observation should therefore reduce the likelihood of
an incorrect diagnosis.
Radiology Endoscopy Pathology
not performed 46 (15%) 124 (39%) 50 (16%)
no evidence 60 (15%) 88 (28%) 43 (14%)
some evidence 55 (17%) 19 (6%) 13 (4%)
good evidence 156 (49%) 86 (27%) 211 (66%)
Table 4.8 Types of Investigations prior to diagnosis & evidence of disease
All patients registered as having Crohn's disease had some gastrointestinal
symptoms of the disease at the time of diagnosis. The most common number of symptoms
at the time of diagnosis was 4 - few had 6 or more abdominal symptoms (Table 4.9).
Number of symptoms at diagnosis
unknown 1234567
number of
patients 11 0 41 65 98 80 17 5
3% 0% 13% 21% 31% 25% 5% 2%
Table 4.9 Proportion of patients against number of symptoms
One other interesting finding resulted from an examination of the number of
parameters measured before a diagnosis was made in each of the three related conditions
(Table 4.10). These figures describe the number of different investigation modalities
performed and the number positive for each of the three groups of Non-Specific Colitis,
Ulcerative Colitis and Crohn's disease which were included in the small pilot study. These
figures, perhaps surprisingly, show that Crohn's patients have fewer investigations
performed than those with Ulcerative Colitis or Non-Specific Colitis and that the
proportion of positive tests is less than that of Ulcerative Colitis.
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Non-Specific Colitis
of parameters total No. of +ve measurements
measured in group 1 2 3 4
1 1 1 - - -
2 2 2 - - -
3 11 8 1 2 -

















total 47 23 22
Crohn's Disease




in group 1 2 3 4
10 0 10 _ _
3 11 1 1 9 -
4 29 0 8 8 13
total 50 1 19 17 13
Table 4.10 Positive findings at diagnosis
When the OMGE criteria were applied to the Crohn's group 91% were
found to pass the criteria for Crohn's disease. This compares favourably with the large
retrospective survey undertaken by the OMGE group. Actual scores of Crohn's patients
varied widely with a range from 1 to 144 - the mean being 57.9 and the median being 59.
This serial type of testing has prevented several individuals - 2 with vascular lesions in the
bowel, 2 with endometriosis and 4 with post irradiation symptoms - from being incorrectly
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admitted to the Register because they had symptoms of IBD and had Crohn's by OMGE
criteria. Similarly using only the OMGE criteria other conditions such as acute ileitis,
gastroenteritis or individuals with post gastric surgery symptoms may inadvertently have
been classified as Crohn's or Ulcerative Colitis.
Summary
These results indicate that the retrospective survey based on inpatient
statistics is a valid method for initial case capture on which to base the retrospective
survey save for one major qualification. It must be appreciated that large numbers of
false positives exist within this potential Crohn's group and that this whole group must
subsequently be screened using a recognised scoring system to eradicate the large number
of false positives. The validity of this method is further confirmed by the few patients who
were picked up as sufferers of Crohn's disease from the primary care enquiry.
Furthermore, support for this argument is also suggested by the small numbers of patients
initially diagnosed as Non-Specific Colitis or Ulcerative Colitis following inpatient care
and who were subsequently diagnosed as suffering from Crohn's disease.
Figures also indicate that the accuracy of the inpatient diagnostic coding for
Crohn's disease has improved over the years and that Crohn's disease is still the most
difficult of the related bowel inflammations to diagnose.
These findings suggest that the retrospective database contains an accurate
and valid picture of Crohn's disease in Tayside between 1968-83.
Chapter 5
FINDINGS FROM THE REGISTER
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5.1 INTRODUCTION
The following sections demonstrate the potential value of this type of
computerised data collection where data is closely linked to powerful audit and analysis
facilities. It has not been the intention to look in depth at one particular aspect of
Crohn's disease but to take a broader view and attempt to demonstrate the advantages of
this type of approach.
The various sections therefore show how an overview of a topic can be
produced - the epidemiological aspects of the disease - and then how specific points
gleaned from this overview can be investigated in greater detail - Crohns in the elderly
and Crohn's in Arbroath. Other sections demonstrate how one particular aspect of the
disease - the sections on pathology and radiology - can be systematically audited and then
analysed in depth. The value of 'linked data' is also highlighted in for instance the
treatment section - where data relating to surgery can be analysed in conjunction with for
example pathogical or radiological findings.
By taking this approach the author hopes to have shown that this type of on¬
going data collection process can not only help further the understanding of the disease
through audit and analysis but also provide a facility which has the potential to help in
patient management.
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5.2 EPIDEMIOLOGICAL ASPECTS OF CROHN'S DISEASE IN TAYSIDE
The analysis of the epidemiological aspects of the retrospective data
collection is now presented. In order to smooth out any annual fluctuation in trends
individuals on the Register have been grouped into those diagnosed within particular four
year periods. Calculated trends have therefore been obtained from four such periods
covering the years 1968 - 1983; those diagnosed before 1968 have not been included in
these calculations because data collection is incomplete.
Incidence and Prevalence
Average annual age/sex specific and age/sex adjusted (using 1981 census
figures for Tayside) incidence rates are shown for each interval from 1968 (Fig 5.1).
Incidence has increased over each 4 year period though the rate of increase is perhaps
slowing. This trend is generally reflected in each of the age bands examined although the
increase appears to be maintained in the elderly population while in the 20-39 group there
has been a considerable decrease in rate over the last 4 years studied. A similar picture is
seen when incidence is related to sex. Incidence has increased in both males and females
until 1980-83 when there has been a marked reduction in the rate seen in females in the
20-39 and 40-59 age groups while there has been a substantial increase in the elderly
group; the rate for males has however increased across all age bands.
1968-71 1972-75 1976-1979 1980-83
averaqe annual incidence
time of diagnosis 2.2 4.3 4.9 5.2
onset of symptoms 2.2 4.2 4.9 unknown
point prevalance 16 31 47 65
Table 5.1 Average Annual Incidence / Prevalence rates (per 100,000) 1968-83
Average Age/Sex specific incidence rates per 100,000 per year
1968-1971 1972-1975 1976-1979 1980-1983
pop-397605 pop-401177 pop-400600 pop-396174
M-189413 M—191621 M-193658 M-188728
F-208192 F-209556 F-207002 F-207446
no. rate no. rate no. rate no. rate
0-19
All 4 .91 9 1.7 15 3.12 19 4.24
M 2 .90 3 1.15 5 2.02 9 3.94
F 2 .93 6 2.43 10 4.29 10 4.56
20-39
All 29 7.14 34 8.54 41 9.50 34 7.82
M 14 7.07 12 6.00 13 5.89 20 9.17
F 15 7.28 22 11.11 28 13.26 14 6.47
40-59
All 7 1.93 15 4.07 15 4.01 18 5.00
M 4 2.32 6 3.41 4 2.26 10 5.78
F 3 1.66 9 4.66 11 6.01 8 4.27
*60
All 1 .29 11 3.33 7 2.12 18 5.26
M - - 2 1.54 2 1.55 3 2.21
F 1 .44 9 4.49 5 2.49 15 7.25
Average Age/Sex adjusted incidence rates per 100,000 per year
standard 1968-71 1972-75 1976-79 1980-83
population
"No." diagnosed 1n standard population
0-19
M 57090 1.57 2.01 3.54 6.90
F 54836 1.70 4.43 7.82 8.31
20-39
M 54527 12.97 11.00 10.80 16.82
F 54090 13.46 20.53 24.51 11.96
40-59
M 43240 5.36 7.89 5.27 13.37
F 46781 3.55 9.96 12.84 9.13
60+
M 33871 - 4.55 4.58 6.52
F 51739 .85 8.68 4.81 14.01
396174 39.46 69.05 74.17 87.02
age/sex adjusted rate .99 1.74 1.87 2.20
Age/Sex incidence rates
Figure 5.1
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Table 5.1 refers to incidence rates related both to time of diagnosis and to
onset of symptoms using a standard population (396,000). The final value in the group
where incidence is related to the onset of symptoms has been omitted because only 75%
of those who develop symptoms within any 4 year period will in fact be diagnosed during
this period (Table 5.2).
Date symptom onset
68-71 72-75 76-79 80-83
Date 68-71 33
of 72-75 8 51
diagnosis 76-79 1 13 63
80-83 1 2 18 64
Table 5.2 Date of diagnosis & Date of symptom onset
Point prevalence rates (Table 5.1) have been calculated using the last day of
each 4 year period to calculate the rate. Figures again show an increase in prevalence of
the disease with no apparent slowing.
It has been suggested that a greater awareness on the part of clinicians has
played a role in the increasing incidence of Crohn's disease. If this were the case the time
from symptom onset to diagnosis might have been expected to fall during the period of
study. No evidence could be found to support this hypothesis; Table 5.3 shows that there
was no significant increase in the numbers diagnosed at less than 6 months from symptom
onset nor indeed was there any indication of a downward trend in the time to diagnosis in
the Crohn's population as a whole.
Most groups agree that there has been a genuine increase in incidence of the
disease (Miller 1974, Bergman 1974) over the period under examination. However, it
must be remembered that incidence rates might also alter through changes in diagnostic
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fashion - the use of onset of symptoms as opposed to date of diagnosis, the introduction of
more specific tests or new methods of investigation - such as endoscopic examination of
the colon or indeed from changes in referral patterns or geographical boundaries.
(in months)
1968-71 1972-75 1976-79 1980-83
< 6mths 50% 45% 56% 46%
6-llmths 14% 23% 14% 17%
2l2mths 36% 32% 30% 37%
Table 53 Time from Symptom Onset to Diagnosis
The frequency of cases by postcode (fig 5.2) taking the postcode of residence
at the time of symptom onset has shown significant clustering in the Arbroath area of the
region (DD11) over the 16 years under investigation (p< .05).
Age and sex of Crohn's population
Age at diagnosis (fig 5.3) shows the majority of patients with the disease are
diagnosed between the ages of 20-39 with the mean age being 36.8 years, the median age
32 years and the mode 26 years. When trends reflecting the age at diagnosis were
examined the most significant finding in the 16 year period (fig 5.4) was the rate of
increase of diagnosis in the elderly 60 age group. In this group it rose from 2% of those
diagnosed in 1968-71 to 25% of those diagnosed in 1980-83.
The sex ratio of Tayside's Crohn's population is M:F, 41:59. In comparison
the sex ratio of the Tayside population as a whole is M:F 48:52 the difference between the
populations does not however reach statistical significance. Figures for each 4 year









































Findings from the Crohn's Register 73
pre 1968 68-71 72-75 76-79 80-83 total
Male 19 20 23 24 43 129
Female 22 21 46 54 46 189
Table 5.4 Sex and Date of Diagnosis pre 1968-83
Interestingly figures show that an initial equality in sex ratio was replaced in
1972-75 with a sudden increase in the proportion of females. This ratio was maintained
until the 1980-83 period when the number of newly diagnosed males showed a marked
increase almost equalising the ratio. Therefore although there remains a preponderance
of females even for the 1980-83 period the most recent ratio suggests that the number of
males is increasing more rapidly than that of females.
Furthermore the sex ratio by age at diagnosis shows a significant variation in
the over 60 group where 79% were females (Table 5.5).
<20 20-39 40-59 60 and over
% males 45 43 43 21
% females 55 57 57 79
Table 5.5 Sex and Age at diagnosis
An increase in the number of females is to be expected in the over 60 group
(1981 census figures for Tayside's elderly population - 60 years or over - showed M:F
40:60). The differences between the 60 and over and the under 60 groups of Crohn's
patients and between the elderly Crohn's cohort and those in the elderly general
population were both significant (p< .05).
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Site of disease
Changes have also occurred in the site of disease at diagnosis (Table 5.6).
Although the frequency of both ileo-colic and small bowel disease has remained relatively
constant over the 16 year period there has been a significant increase in large bowel
disease (p< .01).
number of patients with disease in:-
smal 1 ileo- large discon¬
bowel col 1c bowel tinuous
68-71 14 18 3 6
72-75 24 19 16 7
76-79 22 23 20 13
80-83 25 15 29 14
Total 85 75 68 40
Table 5.6 Site of Disease & Date of Diagnosis
When the site of disease at diagnosis was compared with the age at diagnosis
(Table 5.7) the increase in large bowel disease was more evident in the over 60 age group.
In this group 48% were classified as large bowel disease at diagnosis. One other
interesting feature of this comparison was the relatively high proportion of the < 20 group
who had discontinuous or multiple sites of disease.
(percentage in each group)
<20 20-39 40-59 60 & over
small bowel 17 32 35 36
ileo-colic 26 40 22 9
large bowel 23 13 33 48
discontinuous 32 13 3 3
Table 5.7 Site of Disease & Age at Diagnosis
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Mode of presentation
The mode of presentation to the hospital service - either emergency/acute or
as an out-patient - was collected for all those on the Register. Not surprisingly the
majority of individuals initially presented to an out-patient clinic, however it was
interesting that as many as 37% of patients initially presented as a hospital emergency
prior to subsequent diagnosis. There was no age/sex variation in the mode of presentation
of the disease.
Clinical features
Data on both presenting symptoms and their duration (Table 5.8) showed
the most common symptom was abdominal pain (69%) closely followed by diarrhoea
(64%) then weight loss (55%). Only 18% had rectal bleeding, 20% lassitude and 12%
perianal symptoms. The majority of the 11 with mouth ulcers were in fact young children
of whom several were directed to their doctor by their dentist. Of those with mouth
ulcers at presentation 6 were diagnosed as discontinuous disease, 1 small bowel, 3
ileocolic and 1 large bowel disease. This finding tends to confirm that Crohn's disease
may affect any part of the gastrointestinal tract and suggests that a field of change may
exist or develop throughout the gastrointestinal tract in the disease.
Unfortunately it was not possible to determine the duration of some of the
presenting symptoms.
A total of 51 (16%) of those on the Register also had associated symptoms
on presentation, some indeed had several. Table 5.9 shows that 8% of those with Crohn's
disease also had some form of arthropathy and 8% had a dermatological problem on
presentation.
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time in months
symptom 1 2-5 6-11 12-33 24- 79 unknown total %
percentage of patients per period
diarrhoea 14 38 15 11 9 13 64
abdominal pain 21 35 12 14 10 8 69
rectal bleeding 16 43 17 9 5 10 18
lassitude 11 58 12 6 6 7 20
weight loss 3 50 16 14 8 9 55
Number of patients per period
fistula 0 1 0 0 0 4
anal symptoms 3 8 9 7 6 37
mouth ulcers 0 5 2 1 2 11
fever 4 2 0 0 0 6
others 1 3 1 2 3 11
Table 5.8 Presenting Symptoms and their Duration
Collection of information on past medical history showed 171 (54%) of those
on the Register had some previous medical history while 111 (35%) had some previous
gastrointestinal history. Small but notable numbers also had a past history of
genitourinary, respiratory tract & musculoskeletal symptoms (Table 5.10).
Arthropathy Eye Liver Skin Other
problems disease problems
26 7 3 27 1
8% 2% 1% 8%
Table 5.9 Associated Symptoms
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Gastro- Genito- Respiratory Musculo-
intestinal urinary skeletal
111 24 23 19
35% 8% 8% 6%
Table 5.10 Past Medical History
At the time of diagnosis 29% were single, 61% married and 7% widowed,
12% lived alone, 77% lived in a family unit and only 5 lived in a communal dwelling. The
majority (62%) of individuals lived in an urban environment while 38% lived in a rural
area. Unfortunately it was not possible to obtain similar official figures for the Tayside
population to permit a direct comparison to be made.
Within the Crohn's population 9 (2.8%) individuals were found to have a
first degree relative with a history of Ulcerative Colitis (4) or Crohn's disease (5).
Smoking habits were obtained in 264 patients (83%) on the Register, 150
(57%) were identified as smokers while 11 (4%) had previously smoked. Information on
alcohol intake was found in 241 (76%) of patients 70 (29%) of this group did not drink.
Accurate figures for alcohol intake were not possible in this retrospective data collection
exercise however the case records described 71% as being 'little' to 'moderate' drinkers.
The occupations of the Crohn's population is shown in Table 5.11. This
system was developed as it was thought to be appropriate for Crohn's disease.
Unfortunately the author was not aware at the start of this work of the availability of
census figures relating to occupation which would have made comparison possible with
the regional population.
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unskilled 53 17%
ski 1 led 39 12%
school/student 23 8%
clerical 42 13%





During the period under study 254 patients were diagnosed as suffering from
Crohn's disease - 34 Crohn's patients died, however in this group only 11 died as a result
of their Crohn's disease or a complication thereof. In June 1985 there were 255 patients
living in Tayside with Crohn's disease 55% of whom were being followed up, 29% had
been discharged and 21% lost to follow up. Figure 5.5 seeks to present survival and Life
Table data on the Crohn's population and is based on the group diagnosed between 1964-
1966 and diagnosed or dying within each subsequent two year period
Summary
Both incidence and prevalence of Crohn's disease in Tayside have increased steadily over
the period of study. Clustering has been identified in one geographical area of the region.
Although the majority of Crohn's patients are diagnosed when between 20-40 years of age
an increasing number of elderly patients are also developing the disease. There have also
been some variations in the sex ratio of the Crohn's population the most significant of
which was the high proportion of females over 60 being diagnosed with the disease. Large
bowel disease is becoming progressively more common particularly in the elderly patient.
Symptoms remain diverse, the most common being abdominal pain, weight
loss and diarrhoea. Associated symptoms appear relatively uncommon although as many
as 35% have a past history of gastrointestinal problems. A family history of inflammatory
Survivors in tabular format
nos. & date Survivors after 2 year periods
diagnosed 2 4 6 8 10 12 14
1966 11 11 10 10 10 10 9 8
1968 21 20 20 20 20 19 19 19
1970 20 19 19 19 19 19 19 19
1972 22 21 21 20 18 18 18
1974 47 46 45 45 42 40
1976 34 33 33 32 32
1978 44 44 41 41
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Survival & Life table ofCrohn's population based on initial diagnosis between 1964-1966
Figure 5.5
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bowel disease is uncommon in the Tayside Crohn's population. Although the disease may
carry a high morbidity, figures show that the mortality is relatively low.
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5.3 CROHN'S IN THE ELDERLY
Several workers (Carr 1982, Fabricus 1982) have looked at Crohn's disease in
the elderly patient and suggested that the disease shows different features from those
found in younger patients. Early analysis of the Tayside Crohn's population tended to
confirm this view and because this group has not been described as part of an
epidemiological study it was felt that they merited further examination.
The population was first divided into two cohorts those under 60 years and
those 60yrs and over at diagnosis. Data was analysed for each group independently then
compared. This age division was chosen because it permitted comparison with other
available data (Fabricus 1982).
Clinical findings
Of the 536 patients identified as possible Crohn's patients over the 16 year
period only 318 fulfilled the register's diagnostic criteria for Crohn's disease. Of these 318
patients 35 were aged 60 or over at the time of diagnosis. The incidence of the disease
(Table 5.12) in this elderly group has increased significantly over this period when
compared with the younger group (p<.01). The figures have been obtained using a
'standard' population of 396,000.
68-71 72-75 76-79 80-83
Age at diagnosis
*60yrs 0.6 3.19 2.03 4.65
<60yrs 3.2 5.3 5.72 5.72
Table 5.12 Annual average Incidence rates (per 100,000)
The sex ratio shows a marked preponderance of females M:F ratio of 20:80
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The difference between the groups reaches statistical significance (p < .05)
when the elderly female group is compared with the younger female Crohn's group and
also when compared with the over 60 years female Tayside population.
The differences in the site of disease at diagnosis are presented in Table 5.13
and show a large number of the elderly group with large bowel disease. These figures
show that large bowel disease is significantly more common in the elderly group
(pc.001).





12 34% 84 30%
4 11% 90 32%
16 46% 54 19%
2 6% 40 14%
Table 5.13 Site of disease at diagnosis
The increasing incidence of large bowel disease is reflected in Table 5.14
which shows this increase as a percentage of those diagnosed in the elderly group
compared to the younger group over the 16 year period. The Table also shows that large
bowel disease in general is becoming more common.
68-71 72-75
*60 group 0/1 7/11
<60 group 3/40 7% 9/58
76-79 1980-83
63% 2/7 29% 7/16 44%
16% 18/71 25% 22/71 31%
Table 5.14 Increasing frequency of large bowel disease
Data from the Register also showed that the mode of presentation to the
hospital service was similar in both groups, 39% emergency and 61% via a clinic
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appointment in the elderly and 41% and 59% in the younger group respectively. The
time to diagnosis from onset of symptoms is shown in Table 5.15 and displays no
significant variation between the groups.






Table 5.15 Time to diagnosis from symptom onset
Despite similarities in the mode of presentation and time to diagnosis,
symptoms were found to vary with abdominal pain being significantly more common in
the elderly group (pc.OOl). Weight loss and rectal bleeding were also more common in
the 60 and over group (Table 5.16) although the differences were not significant.
*60yrs <60yrs
n=35 % n=283 %
abdominal pain 21 60 49 18
weight loss 21 60 150 54
rectal bleeding 9 26 49 18
diarrhoea 22 63 179 64
Table 5.16 Presenting symptoms
Investigations
A histological diagnosis was obtained in 32 (91%) of the 60 and over cohort
and 192 (69%) in the under 60 group (pc.Ol). Examination of the specific findings in
each of the groups showed that the elderly patient was more likely to have evidence of
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granuloma, transmural inflammation, giant cells and crypt abscesses than in the younger
group (Table 5.17)
a60yrs <60yrs
n=35 % n-283 %
granuloma 21 60 135 60
transmural 12 34 72 26
giant cells 12 34 82 29
crypt abscess 7 20 43 15
Table 5.17 Histological findings
Comparison of the radiological investigations showed similar significant
findings. Only 10 (29%) of the elderly group had radiological evidence of Crohn's disease
r
while the younger group showed evidence of disease in 173 (63%) of individuals (p< .01).
Interestingly, of the 10 elderly patients with radiological evidence of disease 7 had the
diagnosis made on Barium enema and only 3 on Barium Meal & Follow-through.
Furthermore of the 7 who had a diagnosis made on Barium enema 3 showed evidence of
the disease in the terminal ileum.
Endoscopies carried out in each of the cohorts revealed that 80% of
sigmoidoscopies in the elderly group demonstrated macroscopic inflammatory changes in
the rectum (58% in the under 60 group). Conversely gastroscopic and colonoscopic
examinations showed more evidence of macroscopic inflammatory changes in the younger
group - 48% against 30% for gastroscopy and 60% against 55% for colonoscopy.
Certain haematological & biochemical parameters also varied at the time
of diagnosis (Table 5.18).
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a60yrs <60yrs
Hb <10gm/dl 7 n=31 39 n=231 p<.05
WCC >10,000 24 n=30 108 n=235 p<.001
Albumin <34gm/dl 18 n=24 95 n=195 p<.05
Protein <60gm/dl 14 n=24 49 n=203 p<. 01
Table 5.18 Haem/Biochem findings at diagnosis
In the elderly group 20% had a Hb < lOgm/dl against 14% in the younger
group. There were significant differences in white cell count, albumin and protein levels at
the time of diagnosis even taking into account the normal reduction in both albumin and
protein levels in the aged patient.
Treatment
Surgical treatment was more common in the younger group, 401 operations
being performed (1.4 operations per patient) against 35 in the elderly group (1.0
operations per patient). 8 patients (23%) in the elderly group and 65 (24%) in the under
60 group did not require surgery.
Overall, 17 (48%) of the elderly group had either a small bowel resection or
right hemicolectomy (168 (59%) in the under 60 group). Although large bowel disease
was more common in the elderly group the percentage requiring operation was no
different from that in the younger group with large bowel disease.
Only 3 (9%) of the 60 and over group required further surgery while 122
(43%) of the younger patients had at least two operations (p < .001). In the younger
group 80 had a second operation within 3 years of diagnosis.
The most common reasons for operation are shown in Table 5.19 - note
many individuals had more than one reason for operation.
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*60yrs <60yrs
n=27 % n=219 %
obstruction 8 14 73 11
abdo mass 9 15 37 6 p<. 05
peritonitis 6 10 71 11
failed medical Rx 3 5 97 15 p<.01
unknown diagnosis 20 33 101 15 p<. 01
Table 5.19 Reason for operation
Accurate retrospective data collection on medical management was hard to
obtain therefore notes were only kept on the types of medical treatment each individual
had received at some point in their management. Table 5.20 shows the more common
forms of medical treatment given in each group. Figures revealed that fewer of the
elderly required medical treatment and fewer were given steroids or salazopyrin.
Although treatment varied in each age group the differences between the age groups did
not reach statistical significance except for treatment with salazopyrin.
These findings perhaps suggest that Crohn's disease in the elderly patient is
less aggressive in nature and requires less treatment than in the younger patient.
However, they could also suggest that clinicians felt that treatment was in fact less
effective or the side effects too great to merit a trial in this elderly group.
a60yrs <60yrs
n=35 % n-=283 %
no medical Rx 8 23 32 12
steroids 16 57 177 64
salazopyrin 12 34 158 57 p<.05
azothiaprine 4 11 52 19
Table 5.20 Medical treatment in both age groups
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Outcome
During the period under study 11 of the elderly patients and 23 of the
younger group died. However of those deaths only 5 in the elderly and 6 in the younger
group were directly attributable to Crohn's disease.
Summary
Comparison of the elderly and younger Crohn's patients shows a significant
variation between the groups and suggests that in Tayside the rate of increase in incidence
in the elderly group is higher than that in the under 60 group. The elderly Crohn's patient
is more likely to be a female with large bowel disease. Large bowel disease was found in
almost half of the elderly patients diagnosed between 1980 and 1983.
Differences also occur between the groups in symptoms, radiological,
pathological, endoscopic and haematological / biochemical investigations, treatment and
reason for operation. The findings suggest that the disease is perhaps less aggressive and
the morbidity less than in the younger group.
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5.4 CROHN'S IN ARBROATH
For several years it had been the clinical impression of several clinicians in
the region that the incidence and prevalence of Crohn's disease was high in the Arbroath
area. Using postcode of residence at onset of symptoms it was found that there was a
significant difference in the frequency of proven Crohn's disease in the postcode area of
DD11 (Arbroath area) when compared with numbers resident in postcode areas
throughout the rest of the district during the period under examination (fig 5.2). This
apparent increase in frequency or 'clustering' has, as far as can be determined, not been
described previously. Miller's group (Miller 1975, Miller 1976) attempted, without
success, to identify 'time - space clustering' in Crohn's populations in their quest to
confirm an aetiological link with transmissible infective agents. Evaluation has been
understandably difficult because of the relatively small number of cases involved in an
area making it difficult to prove or disprove the existence of this phenomenon.
It was felt that this apparent clustering merited closer evaluation. The
Arbroath group was selected and epidemiological information obtained and compared
with the overall Crohn's population.
The total number of individuals being diagnosed as having Crohn's disease
has increased rapidly over the past few years (Table 5.21).
number diagnosed
Av.pop 60-67 68-71 72-75 76-79 80-83
Arbroath 21494 4 2 0 5 11
Tayside 372506 29 39 69 74 76
(exc.Arbroath)
Table 5.21 Frequency of diagnosis
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Average annual age/sex adjusted incidence rates, using 1981 census figures
for Tayside, have been calculated from this data for each 4 year period under
investigation (Table 5.22). These figures confirm that there has been a significant
increase in incidence over this period (pc.Ol) when compared to the rest the Crohn's
population of Tayside.
1968-71 1972-75 1976-79 1980-83
Age / sex specific rates for Arbroath
20
M — — 10.98 5.48
F -- - - 5.88
20-39
M 7.02 -- 6.66 25.90
F 7.27 - 6.84 6.64
40-59
M -- - 8.72 17.49
F - -- - 8.00
60
M
F -- -- - 15.00
3.57 — 8.30 17.35
no. diagnosed in standard population (in Fig 5.1)
26.31 — 64.24 126.88
age/sex adjusted rates in standard population
Arbroath .66 — 1.62 3.20
Tayside .99 1.74 1.87 2.20
Table 5.22 Average Annual age/sex adjusted incidence rates per 100,000
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The figures show in particular a significant increase in incidence over the
1980-83 period. Similar figures are obtained if onset of symptoms is used to calculate the
incidence (Table 5.22)
The sex ratio has been calculated (fig 5.7) and perhaps surprisingly shows
significant variation from that of the overall Crohn's population (p < .05).
In order to determine whether this variation in sex ratio is of recent origin
the sex ratio has been calculated for periods from 1960-67 and then each 4 year period
thereafter (Table 5.23).
60-67 68-71 72-75 76-79 80-83
Arbroath 2 1 0 4 7
Males
Tayside 17 19 23 20 35
(ex Arbroath)
Arbroath 2 1 0 1 4
Females
Tayside 20 20 46 53 41
(ex Arbroath)
Table 5.23 Changes in Sex ratio 1960-83
Although the total numbers of patients in the Arbroath area is small making
statistical analysis less clear there is a notable difference in the M/F ratio in the Arbroath
area over the last 8 years.
Ages at diagnosis have been calculated and compared within each group
(Table 5.24) and show that although more of the Arbroath group are under 20 at
diagnosis the differences do not reach statistical significance.
SEX RATIO BY POSTCODE
Ratio in Arbroath
37.0%
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Arbroath Tayside
Age (except Arbroath)
<20 6 27% 46 16%
20-39 11 50% 150 52%
40-59 4 18% 61 21%
*60 2 9% 33 11%
unknown 1 8
Table 5.24 Age at diagnosis
When the under 20 group was looked at more closely, 4 (17%) were found to
be school children at the time of symptom onset while in the rest of Tayside only 14 (5%)
individuals developed symptoms as school children (p< .01).
Site of disease at diagnosis is shown in (Table 5.25) - the difference between
these groups is not significant.
Arbroath Tayside
(except Arbroath)
Small Bowel 8 33% 89 31%
Ileo-colic 5 21% 89 31%
Large Bowel 7 29% 64 25%
Discontinuous 3 12% 41 14%
Table 5.25 Site of disease at diagnosis
There was no significant difference between the mode of presentation nor
the time to diagnosis between the groups however as one would expect in a younger
population a higher percentage were still single at diagnosis. There was no difference in
severity of disease at diagnosis as observed from comparison of the diagnostic score index
- Arbroath patients (65 median, 55 mean), Tayside patients (59 median, 57 mean).
Patients with the disease in the Arbroath area had similar numbers of radiological
investigations and operative procedures carried out suggesting that there was no
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difference in the method of investigation of this group nor did the disease appear to be
more aggressive in nature.
Summary
The Arbroath Crohn's population is similar in many respects to the rest of
Tayside's Crohn's population however there are significant differences in incidence rates,
sex ratio and age at onset of symptoms over the past 8 years which merit further
investigation. Figures show that the age / sex distribution of the Arbroath population is
similar to that for the rest of Tayside suggesting that direct population comparison is
valid. The cause of this apparent variation remains unclear. There appears to be no
obvious variation in the method of investigation or management with patients either being
referred to Ninewells or Stracathro Hospital for medical or surgical consultation. No
single consultant is therefore involved in investigating this group of individuals. Several
points and possible associations have however been observed and are worthy of note.
Arbroath is famous for its fish in particular the 'Arbroath smoke/ - literature
review demonstrates similar areas of high incidence in coastal areas Cardiff and Upsalla -
(Maybury 1979, Bergman 1975) where a high intake of seafood is also likely.
Of more interest perhaps is the observation that the Arbroath area is the
only area in Tayside that does not draw any of its water supply from the main water
purification plant which serves most of Dundee and Angus districts. These points will be
discussed further in a subsequent section of this thesis.
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5.5 THE RADIOLOGY OF CROHN'S DISEASE IN TAYSIDE
5.5.1 Radiological Audit
The 318 patients on the register had a total of 1,010 radiological or isotope
investigations performed between 1960 and early 1985. This figure does not include plain
abdominal or chest radiographs. The overall breakdown of investigations is given in
Table 5.26 which shows that barium meal and follow-through was the most common
investigation performed closely followed by barium enema.
Type Nos Normal (%) Abnormal Unknown
Invest
Barium meal & F-T 419 101 (24%) 312 6
Barium enema 363 120 (33%) 240 3
Small Bowel enema 64 25 (39%) 44 0
Barium meal 31 18 (58%) 10 0
Biliary investigation 8 23 (82%) 5 0
Intravenous pylogram 50 31 (62%) 19 0
Ultrasound 19 15 (78%) 4 0
others 86 ""
Table 5.26 Investigations
These figures show that even in the Crohn's population there are large
numbers of normal radiological investigations - 31% of all investigations in the Crohn's
group were reported as normal. More specifically 76% of the barium meal and follow-
through and 67% of the barium enema examinations demonstrated some abnormality.
Surprisingly in view of other reports (Truelove 1981, Keddie 1982) the small bowel enema
demonstrated fewer abnormalities than either of the other primary bowel investigations
with only 61% showing some evidence of disease. This may reflect a more careful
selection of patients for this investigation for instance only for those individuals who have
had negative barium meal and follow-through and barium enema investigations but yet
have clinical evidence of disease.
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Figures also demonstrate the relative increased risk of urinary tract problems
in those with Crohn's disease. Fifty Intravenous pylograms performed in 46 patients gave
a positive return in 19 investigations.
Of the 877 specific barium investigations (Table 5.27) performed, 416 were
considered to demonstrate evidence of Crohn's disease - that is 47% (416/877) of all the
bowel investigations performed and 69% (416/606) of those showing some abnormality.
Type Abnormal Inflamm Crohn's Ulcer Non-Spec Other
changes disease colitis colitis
Barium meal 10 0 4 0 0 6
Barium meal & FT 312 32 253 0 0 27
Barium enema 240 38 121 26 2 55
Small Bowel enema 44 3 38 1 0 2
total 606 73 416 27 2 90
Total number barium studies 877
Table 5.27 Findings from barium studies
Of those investigations labelled as Crohn's disease 61% were obtained from
barium meal and follow through, 29% barium enema, 9% from small bowel enema and
1% from barium meal.
The relative diagnostic return for each type of investigation performed within
the region (Table 5.28) reveals that barium meal and follow through gives the best
diagnostic return (60%) followed closely by the small bowel enema (55%). Barium
enema investigations give a significantly poorer return (33%) in comparison with the small
bowel investigations (p< .001).
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total +ve %
Type
Barium meal & F.T. 419 253 60
Small Bowel enema 69 38 55
Barium enema 363 121 33
Table 5.28 Diagnostic return
The average number of barium investigations per patient on the register is
2.75, the range being from 0-7. Each patient had a diagnosis of Crohn's disease made on
1.3 occasions.
Trends have been calculated for both type, and findings of the primary bowel
investigations performed on the Crohn's population during the period under study (Table
5.29).
Number of patients per group
Type 60-63 64-67 68-71 72-75 76-79 80-83
Barium meal & F T 9 19 52 95 130 77
Barium enema 4 12 58 72 89 98
Small Bowel enema 0 0 2 5 6 42
totals 13 31 112 172 225 217
Radiological
Diagnosis
Normal 3 3 21 57 101 128
Crohn's 6 17 60 92 109 86
Other inflam 4 9 21 15 23 23
no. newly diag
Crohn's cases 15 18 41 69 79 87
ratio normal/
abnormal x-ray .23 .1 .2 .35 .43 .54
ratio normal/
Crohn's diagnos .5 .18 .35 .62 .92 1.5
number x-rays/ .86 .94 1.5 1.2 1.00 .68
registered patient
Table 5.29 Trends in barium studies
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These figures suggest an increasing frequency of investigation as the
prevalence of the disease has increased or indeed that as the number of investigations
increases so the number diagnosed as Crohn's disease increases. However, it must be
remembered that these figures only deal with patients with a confirmed diagnosis of
Crohn's disease and do not take into account all the investigations performed on patients
whom it was thought might have had the disease. The fall in the number of barium meal
and follow-through examinations has probably resulted, at least in part, from the
increasing use of the small bowel enema examination.
Of more interest perhaps in these days of financial constraint is the
increasing number of investigations performed on the Crohn's population which are
reported as demonstrating no abnormality (fig 5.8). This is coupled with a rapidly
increasing ratio of normal investigations to those reported as demonstrating evidence of
Crohn's disease (fig 5.8). One could suggest that these figures represent a waste of
resources and speculate that the ratios are due to an increasing awareness of the disease,
the ease by which tests can be arranged or a reduction in clinical acumen. However one
could also argue that the free availability of such radiological investigations results in a
better service to the patient even though it may not be cost effective. Similarly in some
patients a negative investigation may in fact be a very positive finding - for instance by
preventing surgical intervention.
5.5.2 Radiology in the diagnosis of Crohn's disease
Of the 317 patients on the Register 270 (85%) had a specific radiological
examination for investigation of their Crohn's disease. In this group 211 (78% of those
having x-ray examinations) had some evidence suggesting inflammatory bowel disease. Of
the 270 undergoing radiological examination, 189 (70%) were described as having a
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(58%) were shown to have a proven radiological diagnosis when they were initially
diagnosed. This section has described a simple audit of investigations performed. The
figures do not take into account observer variation between radiologists which may well
be considerable, indeed, this point perhaps merits further clarification as the Register
moves into the prospective phase.
The number of patients with positive barium studies is shown in Table 5.30
along with the number who had a positive radiological diagnosis at the time of diagnosis.
Figures also show that 63% of those having barium meal and follow-through, 42% having
barium enema and 55% having small bowel enemas revealed changes sufficient to merit a
diagnosis of Crohn's disease at some point in their disease.
Type Number Crohn's % No. with Crohn's %
invest patients at diagnosis
Barium meal & F-T 232 147 63 116 50
Barium enema 233 96 42 65 28
Small Bowel enema 62 34 55 13 21
Barium meal 29 2 7 0
Table 530 Patients with a radiological diagnosis of Crohn's disease
This suggests that in Tayside the barium meal and follow through gives the
best diagnostic return in those shown to have a radiological diagnosis of Crohn's disease
followed closely by small bowel enema and then barium enema.
In each of the investigations which were reported as abnormal a note was
kept of the sites deemed abnormal. The gastrointestinal tract was split into oesophagus,
stomach, duodenum, jejunum, ileum, terminal ileum, caecum, ascending, transverse,
descending and sigmoid colon, rectum and anal canal. Examination of the sites of bowel
involvement in these barium studies showed that although the barium meal and follow-
through and small bowel enema are used primarily to identify small bowel disease a
significant proportion of those demonstrating disease were also reported as showing
Findings from the Crohn's Register 97
abnormalities in the large bowel - 96 out of the 516 (19%) of sites defined as abnormal
were in large bowel. Similarly barium enemas showed evidence of small bowel disease in
87 of the 397 sites shown to be abnormal on barium enema study (22%).
The most common radiological findings reported from each type of
investigation (Table 5.31) showed that 'disease', 'irregularity' of the mucosa, 'narrowing',
'dilatation', 'ulceration' and 'stricture' to be the most frequently described abnormalities.
Frequency of Finding
Finding Barium Barium enema Small bowel
Meal1 & F-T enema Total
narrowing 104 32% 55 23% 9 20% 168 28%
obstruction 12 6 3 21 3%
dilatation 70 22% 9 <1% 3 7% 84 14%
diverticulum 5 24 10% 2 31 5%
mass 14 3 0 17 3%
reduce function 36 25 63 10%
fistula 27 21 2 50 8%
polyps 6 10 1 17 3%
ulcers 39 12% 51 21% 4 9% 94 16%
stricture 43 13% 24 10% 5 11% 72 12%
skipareas 19 8 4 33 5%
thickwalIs 15 5 5 25 4%
cobblestoning 10 3 2 15 2%
irregularity 90 28% 80 33% 7 16% 177 29%
disease 105 33% 74 31% 15 34% 194 32%
Total abnormal 318 240 44 602
investigations
Table 531 Radiological findings from barium studies
In those investigations which showed some abnormality the most common
findings were 'disease' (32% of abnormal x-rays), 'irregular mucosa' (29%), and
'narrowing of the lumen' (28%). Other common findings were the presence of 'ulcers',
'dilatation' (14%) and 'stricture formation' (12%). Barium meal and follow-through
examinations revealed narrowing and/or disease and/or irregularity on the mucosa for 1 in
3 of abnormal investigations and although definite obstruction was only present in 4% of
the reported findings dilatation was found in 22% of follow-through procedures. Barium
Findings from the Crohn's Register 98
enema examinations demonstrated slightly more 'ulcers' (21%) and a lower incidence of
'narrowing' (23%) than in the follow-through procedures.
Despite being well recognised radiological features the frequency of 'skip
areas', 'fistula', 'thick walls' and 'cobblestoning' was surprisingly low - each being present
in less than 10% of abnormal investigations.
5.53 Clinical Radiological Aspects in the Crohn's Population
Closer scrutiny of the 189 patients with radiological diagnosis of Crohn's
disease showed some variation between groups. When the population was grouped by
age at diagnosis (Table 5.32) 73% of the 20-39 group were found to have radiological
evidence of Crohn's disease while in the elderly group only 29% had radiological evidence
of disease.
There was no variation in sex ratio with 60% of each sex showing radiological
features of Crohn's disease. Nor was there any significant variation in radiological
diagnosis in patients presenting with different symptoms although those presenting with
pain gave a slightly higher (67%), and those with PR bleeding (48%) a slightly lower rate
of positive radiological investigation.
Whether a radiological diagnosis was obtained did however depend on the
site of disease at diagnosis. Whilst only 25% of patients with large bowel disease at
diagnosis showed radiological evidence of disease, the figures for small bowel, ileocolic
and discontinuous disease were 67%, 74% and 72% respectively. This difference is highly
significant (p < .001) when those with large bowel disease are compared with the other
sites of disease.
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number Radiological % total
diagnosis
Aqe qroup
<20 52 29 56
20-39 161 117 73
40-59 65 30 46
*60 35 10 29
Sex
Male 129 76 59
Female 189 113 60
Symptoms
diarrhoea 203 123 60
pain 220 148 67
wt loss 173 104 60
PR bleeding 50 24 48
Site of disease
smallbowel 97 65 67
ileocolic 94 70 74
large bowel 71 18 25
discontinuous 44 32 72
Table 532 Clinical radiological features
Summary
Radiological enquiry has shown that although less than half of those on the
Register had a radiological diagnosis of Crohn's disease before diagnosis almost 80% of
those having a barium study showed radiological evidence of disease at some point in
their disease. In Tayside the barium meal and follow-through still provides the best
positive return of all the barium studies performed.
Although the number of radiological investigations, particularly of small
bowel enemas has increased in parallel with the Crohn's population, an ever increasing
number of these investigations are proving to be normal which may relate to poorer
patient selection or over-investigation. It was also noted that one third of all barium
studies in the Crohn's population were reported as normal.
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Both age at diagnosis and site of disease appear to influence the frequency of
radiological diagnosis. Finally, in Tayside, narrowing and irregular mucosa are the most
commonly reported abnormalities from barium studies in patients with Crohn's disease.
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5.6 THE PATHOLOGY OF CROHN'S DISEASE IN TAYSIDE
5.6.1 Pathology Audit
A total of 688 specimens from the registered Crohn's population were
submitted for examination to the Pathology departments in Tayside. Only information on
specimens directly or indirectly related to the patients' Crohn's disease was entered into
the Register. Of the total, 401 were biopsies and were subjected to microscopic
examination only, while 287 gross specimens underwent both macro and microscopic
examination. The findings in 350 were sufficient to merit a diagnosis of Crohn's disease.
The increasing number of specimens demonstrating features of Crohn's disease is shown
in Fig 5.9. The rate of increase has however slowed over the past 4 years. Only
prospective study will show if this trend is to continue.
Figures also reflect the increasing frequency and importance of endoscopic
procedures as a source of specimens for examination with proportionately many more
biopsies being obtained over recent years (Fig 5.10).
The majority of gross specimens submitted were either ileum (66%) and/or
right colon (44%). Other samples submitted for examination included transverse colon
(15%), left colon (17%), rectum (11%), anal canal (6%) and jejunum (3%).
The most commonly reported macroscopic findings were thick wall, reported
in 93% of gross specimens, and ulcerated mucosa which was evident in 98% of specimens
examined. Other common features were lymphadenopathy and narrowing/stricture
formation present in 46% of gross samples while serosal injection and thickened
submucosa were found in 38% of specimens respectively. Less common findings were
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Audit of microscopic examination demonstrated 252 (37%) instances of
rectal tissue, 180 (26%) of the terminal ileum, with the right and left colon being reported
in 16% and 14% respectively. All other areas of bowel were described in less than 6% of
specimens examined. The most commonly reported microscopic findings were chronic
inflammatory changes, granuloma formation, acute inflammation, giant cells and
transmural inflammation (Table 5.33). Other recognised features were plasma
cells/macrophages/eosinophils (11%), fibrosis (7%), reactive hyperplasia (11%),
reduction in goblet cells (6%), and crypt abscesses (9%).
number %
chronic inflammation 424 62
acute inflammation 217 32
granuloma 231 34
giant cells 118 17
transmural inflammation 102 15
Table 533 Microscopic Findings
5.6.2 Clinical Pathology
A total of 280 of the 318 registered patients (88%) had at least one specimen
submitted for examination. Of this group 226 (81%) were found to have a pathological
diagnosis of Crohn's disease. A pathological diagnosis was therefore obtained in 71% of
those on the Register. Of this group 172 (76%) had a diagnosis based on at least one
gross macroscopic specimen while the remainder (54) had the diagnosis based on simple
biopsy and microscopic examination.
Table 5.34 shows some of the findings from the clinical pathological enquiry.
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number with number with pathology
Crohn's diagnosis and %
sex
males 129 93 73
females 189 132 70
ape qroups
<20 52 39 75
20-39 161 105 65
40-59 65 48 73
=60 35 32 91
site of disease
small bowel 97 49 51
ileocolic 94 76 81
large bowel 71 59 83
discontinuous 44 35 80
duration of symptoms
<6mths 174 126 72
6-llmths 43 36 83
=12mths 80 56 70
symptoms
rectal bleeding 58 54 93
wt loss 173 127 73
pain 220 156 71
diarrhoea 203 155 76
Table 534 Clinical Pathological Findings
Equal numbers of males and females demonstrated a positive pathological
diagnosis.
When the population was split by age 91% of the 60 and over population
showed a histological diagnosis of Crohn's disease while 75%, 65% and 73% of the under
20, 20-39 and 40-59 groups respectively had pathological evidence of the disease. The
difference between the elderly and the rest of the Crohn's population was significant
(pc.Ol).
The frequency of pathological diagnosis also varied with the site of disease.
Those with small bowel disease demonstrated a pathological diagnosis on significantly
fewer occasions than those with other sites of disease (p< .001).
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When the duration of symptoms before diagnosis was examined it was found
that individuals with symptoms for 6-11 months had positive histology in 83% of cases
whereas those with symptoms for less than 6 months and a year or more had positive
histological evidence of disease in 72% and 70% respectively. The presence of rectal
bleeding as a presenting symptom was a good indicator that a pathological diagnosis
would be obtained with 93% of those with this symptom demonstrating at least one
positive biopsy showing Crohn's disease. The frequencies of pathological diagnosis in
those presenting with diarrhoea, pain or weight loss as one of their symptoms were
similar.
These figures suggest that the patient most likely to reveal pathological
evidence of disease is one who, at the time of diagnosis, is over 60, with symptoms for 6-11
months - one of which is rectal bleeding - and who is thought to have large bowel disease.
5.63 Histological Findings
The microscopic findings of those with pathological evidence of disease were
examined closely (Table 5.35). The four most common microscopic findings have been
taken and compared with sex, site of disease and age at diagnosis. Results show that both
site of disease and age at diagnosis vary with the histological findings. Several points were
noted. Those with small bowel disease had a scarcity of microscopic findings compared to
those with other disease sites. Granulomas became progressively more common in the
distal bowel. Patients with discontinuous disease more commonly had evidence of
granuloma formation than in the other groups. Microscopic findings also varied with age
at diagnosis with granuloma formation being more common in the groups aged under 20
and 60 years and over at diagnosis.
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% of each group with finding
gran trans giant crypt
uloma mural cell absc
pathology diagnosis (226) 69 38 42 22
specimens submitted (280) 56 30 33 18
Sex
male 53 27 26 20
female 47 26 32 13
Site of disease
small bowel 26 22 14 3
ileocolic 55 35 36 10
large bowel 63 18 38 8
discontinuous 66 36 43 14
Aqe at diagnosis
<20 65 25 33 19
20-39 43 25 30 12
40-59 48 29 25 20
*60 60 34 34 20
Table 535 Histological Findings
Further interesting facts emerged when the sites of biopsies and microscopic
findings were compared with the actual site of disease (Table 536). Figures demonstrate
that in those with small bowel disease chronic inflammatory changes occurred in 39% of
rectal/anal canal biopsies. Granuloma were however not found in any of these biopsies.
Furthermore, in ileocolic disease a greater number of ano-rectal biopsies revealed
microscopic changes - 31 (51%) showing chronic inflammatory changes and 14 (23%)
demonstrating granuloma formation. As one would expect in discontinuous disease
histological changes occurred throughout the gastrointestinal tract.
Microscopic changes in the upper gastrointestinal tract in those with large
bowel disease were less common with only 3 of the 9 reported gastroscopy biopsy
specimens showing evidence of chronic inflammation. This however still represents a
relatively high positive return in those with large bowel disease.
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These findings confirm the importance of endoscopic biopsy, particularly of
the rectum, when investigating a patient thought to have Crohn's disease. The findings
also lend support to the view that in Crohn's disease a field of change exists throughout
the gastrointestinal tract.
The following is a key to Table 5.36 which demonstrates the microscopic
findings by site of disease.
Key to table 5.36
D = duodenum J » jejunum
I - Ileum TI = terminal ileum
RC - right colon TC = transverse colon
LC - left colon R - rectum
A - anal canal
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Frequency of finding
The 97 patients had 41 microscopic reports relating to
rectal or anal canal biopsies
Small bowel disease
D J I TI RC TC LC R A
chron inflam 3 8 5 32 8 2 3 16 0
giant cell 0 2 2 9 3 0 0 0 0
<goblet cell 0 0 0 0 0 1 0 2 0
crypt absc 0 0 1 0 0 1 0 1 0
transmural 0 0 2 20 3 0 0 0 0
granuloma 1 2 4 22 4 0 0 0 0
Ileocolic disease
The 94 patients had 60 microscopic reports relating to
rectal or anal canal biopsies
chron inflam 4 3 7 57 42 10 10 24 7
giant cell 0 0 3 25 18 3 1 4 5
<goblet cell 0 0 0 0 0 0 0 5 2
crypt absc 0 0 0 7 8 2 2 3 0
transmural 1 1 3 30 25 5 3 1 1
granuloma 0 3 6 43 33 4 1 10 4
Large bowel disease
The 77 patients had 9 biopsy reports relating to the
stomach or duodenum
chron inflam 1 2 1 4 8 13 37 78 7
giant cell 0 0 0 0 3 5 13 15 3
<goblet cell 0 0 0 1 2 3 11 22 1
crypt absc 0 0 0 1 3 4 10 27 2
transmural 0 0 1 0 3 7 5 5 1
granuloma 0 0 1 0 5 10 21 37 5
Discontinuous disease
44 patients had 21 biopsy reports relating to stomach
and duodenum and 63 relating to rectum and anal canal
chron inflam 9 3 4 24 18 7 23 38 7
giant cell 0 0 1 11 6 3 4 10 2
<goblet cell 0 0 0 0 0 0 0 4 1
crypt absc 0 0 0 1 2 2 3 3 0
transmural 1 2 3 12 5 2 1 3 2
granuloma 1 1 5 18 15 5 13 18 5
Table 536 Microscopic findings by site of disease
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5.6.4 Granuloma in Crohn's disease
A closer examination was made of those with histological evidence of
granuloma formation.
Pathological evidence of disease was, as previously described, most common
in those presenting with symptoms of 6-11 months duration. Similarly and perhaps not
surprisingly granulomas were also found more frequently in this group (28/42 - 66%)
when compared with those with symptoms for <6months (84/174 - 48%) and for
12months (41/80 - 51%) prior to diagnosis.
Those found to have granuloma formation were grouped by sex and then
compared with the site of disease at diagnosis and by age at diagnosis. Results showed
considerable variation between the groups (Table 5.37).
Males n=68 & Females n=88
with granuloma
Site of disease
small bowel 19 28% 7 8%
ileocolic 23 34% 30 34%
large bowel 12 17% 34 39%
discontinuous 14 21% 15 17%
Age at diagnosis
<20 17 25% 17 19%
20-39 33 48% 37 42%
40-59 14 21% 17 19%
*60 4 6% 17 19%
Table 537 Variation in Granuloma formation
Although there is no significant overall variation in the ratio of males (68/129
- 53%) and females (88/189 - 47%) with granuloma, when each group was looked at more
carefully it was noted that there was a significant difference in the sex ratios of those with
granuloma when compared with the site of disease at diagnosis. When a similar
comparison was made with the age at diagnosis the 60 and over female population was
found to have a much higher proportion of their overall population with granuloma than
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in the 60 and over male population; perhaps a reflection of the percentage of elderly
women with large bowel disease.
The presence of granuloma in a patient with symptoms of inflammatory bowel
disease has been recognised to be a good indicator of Crohn's disease. The frequency of
granuloma per specimen was calculated as a measure of the liklihood of a pathology
specimen in a Crohn's patient demonstrating a granuloma. Calculations showed that 49%
of gross specimens submitted were found to contain granuloma and that the figure for
biopsy specimens was much lower at 21%. These figures suggest that even in a patient
being found to have or known to have Crohn's disease only 1 in 2 of macroscopic
specimens and 1 in 5 biopsy specimens will demonstrate granuloma.
The prognostic significance of granuloma formation was examined by comparing those
with and without granuloma with the rate of re-operation and present Register status.
The number of operations required in each group is shown in Table 5.38 which shows that
those found to have granulomas have more operations than those without evidence of
granuloma formation.
n 1 2 3 4
with granuloma 157 124 79% 62 39% 33 26% 6 4%
without granuloma 160 99 62% 43 26% 10 6% 2 1%
Table 538 Number ofOperations
One could argue that it is the operation itself which provides the macroscopic specimen
from which a granuloma was found. However when the numbers requiring re-operation
were examined in each group (Table 5.39) those with granuloma were not only found to
have a greater probability of having an initial operation but also of having further
operations after the first and subsequent procedures. The figures show that over 50% of
those who have one operation will have a second procedure and 50% of this group will go
on to have a third operation.
Findings from the Crohn's Register 110
operation number
1st 2nd 3rd 4th
granuloma
with 124/157 79% 62/124 50% 33/62 53% 6/33 18%
without 99/160 69% 43/99 43% 10/43 23% 2/10 20%
Table 539 Percentages requiring further operation
Further figures show that 54% of those known to have granuloma formation
are being 'followed up' (38% in those without granuloma) and that 39% of those with
granuloma have been 'discharged' or 'lost to follow-up' (47% in those without
granuloma). Mortality statistics showed that of those who died during the study period
(34) exactly half were noted to have shown granuloma formation.
These findings therefore suggest that the discovery of granuloma in a
pathology specimen increases the morbidity firstly by increasing the likelihood of one or
more surgical procedures being performed and secondly by increasing the likelihood of
hospital follow-up.
Summary
In summary this section has shown that the increasing numbers of positive
histological reports parallels the increase in incidence of disease and has demonstrated
the increasing importance of endoscopic procedures as a means of obtaining specimens
for histological examination.
Results also show that age, symptoms plus their duration and site of disease
affect the pathological findings. Importantly a sizeable number of histological
abnormalities can be found at sites distant to confirmed areas of disease.
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Interesting facts have emerged in the group found to have granuloma
formation, the most important of which is the suggestion that those with granuloma have a
greater morbidity than those without granuloma.
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5.7 ENDOSCOPY IN CROHN'S DISEASE
A full retrospective audit of endoscopy procedures was impossible because
the documentation of procedures was often incomplete. Only those investigations which
had been well documented were collected and subsequently analysed. Data relating to
type and date of procedure, sites examined, findings and suggested diagnosis was
collected and entered in the Register. Table 5.40 shows the number of procedures logged
with the Register and the number of individuals who have undergone that particular
investigation.
Type of total % number of % of total
endoscopy biopsied patients Crohn's pop
gastroscopy 94 56 74 24
sigmoidoscopy 229 77 159 50
colonoscopy 84 76 64 20
Table 5.40 Endoscopy procedures
Despite a careful search of case records for evidence of endoscopy
procedures only 50% of individuals had fully documented evidence of a sigmoidoscopy,
20% a colonoscopy and 24% a gastroscopy.
A total of 190 (60%) of the Crohn's population were identified as having had
either a colonoscopy or sigmoidoscopy performed at some stage in their disease. The
features of large bowel endoscopy were very non-specific with narrowing or stricturing
only being noted in 21 (6%), polyps/pseudopolyps in 8 (2%), granular mucosa in 5 (1%)
and cobblestoning in 2 occasions. The total number of auditable findings from large bowel
endoscopy was 342. Figures also reflect the small number of endoscopies which were
considered to demonstrate sufficient features to merit an endoscopic diagnosis of
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Crohn's. A diagnosis was documented in 219 of the reported endoscopies, however in
only 40 (18%) was the diagnosis of Crohn's disease made.
Endoscopic findings were graded 0, +, + +, or + + + of inflammation.
Table 5.41 describes an audit of all those with at least ' + ' of inflammation. Of the 159
individuals who had a sigmoidoscopy 98 (62%) were noted to have inflammatory changes
on at least one occasion while 52 (32%) never had any evidence of inflammatory changes.
number number with % with
patients inflamm changes
sigmoidoscopy 159 98 62
colonoscopy 64 38 60
gastroscopy 74 34 46
Table 5.41 Inflammatory changes on endoscopy
Similarly 38 (60%) of those individuals having a colonoscopy had evidence of
inflammatory changes in some part of the large bowel. Interestingly of those with
inflammatory changes on sigmoidoscopy, 15% had small bowel disease and 15% had
ileocolic disease while in those with evidence of inflammation at colonoscopy 10% had
small bowel disease and 15% ileocolic disease (Table 5.42). Furthermore 30% of those
with colonoscopic and 19% of those with sigmoidoscope evidence of inflammatory
changes had discontinuous disease.




small bowel 15 (15%) 4 (10%)
ileocolic 15 (15%) 6 (15%)
large bowel 47 (48%) 16 (42%)
discontinuous 19 (19%) 12 (30%)
Table 5.42 Endoscopy - changes & site of disease
Of the 74 individuals having a gastroscopy 34 had inflammatory changes -
35% of this group had discontinuous disease, a higher proportion than might be expected
with only 13% of the overall population having discontinuous disease.
Of the 190 individuals undergoing a large bowel endoscopic procedure 124
(65%) were found to have at least one occasion when inflammatory changes were
observed. In this group only 39% (38/97) with a Crohn's diagnosis on barium enema
showed evidence of inflammatory changes on endoscopy.
Of the 226 individuals with a confirmed pathological diagnosis of Crohn's 98
were from the group of 124 with evidence of large bowel changes on endoscopy. Similarly
of the 189 with a confirmed radiological diagnosis of Crohn's disease, only 62 were from
the group with inflammatory changes on large bowel endoscopy. Therefore only 43% and
33% of those with confirmed pathological and radiological changes respectively were
shown at some stage to have endoscopic changes in the large bowel.
Endoscopic changes in the large bowel did not vary with sex or age at
diagnosis however those presenting with diarrhoea, rectal bleeding, pain or weight loss
had evidence of large bowel endoscopic changes in 50%, 90%, 30% and 35% respectively.
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Summary
Although the retrospective endoscopy audit was incomplete it was noted that
65% of individuals having large bowel endoscopies performed showed evidence of
inflammatory changes at some stage in their disease. Though the changes noted were
often non-specific a significant proportion of those with small bowel disease were found
to have large bowel endoscopic changes. This confirms the importance of these
investigations particularly if rectal bleeding or diarrhoea are presenting symptoms.
Pathological and radiological evidence of disease are both relatively poor
indicators of the likely presence of inflammatory changes at endoscopy.
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5.8 HAEMATOLOGICAL & BIOCHEMICAL FINDINGS
The retrospective collection of haematological and biochemical data was a
tedious task. Both Angus and Dundee district have had computerised biochemical
laboratory systems since the early 1970's making time related collection of biochemical
data possible for the majority of those on the register.
There were two aspects to this data collection:-
1. Results which relate to parameters at the time of diagnosis.
2. Results collected over a period of time following the diagnosis.
An attempt was made to generate a full haematological and biochemical
profile at the time of diagnosis thus permitting analysis at this time. The initial results
were then supplemented as the disease progressed from further investigations reported
and subsequently filed in the case record. Where several values existed for a specific
period the most abnormal result was collected - repeat investigations often related to
periods of increased disease activity or hospital admission.
Results are therefore presented in terms of values at diagnosis followed by
results appearing at some point in the patient's disease. Finally groups with abnormal
results were looked at more closely to see if there were any associations with age, sex, site
of disease and time to diagnosis.
5.8.1 Values at diagnosis or soon after diagnosis
The most commonly performed haematological and biochemical
investigations are displayed in Table 5.43.
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number %
abnormal performed




WCC 127 269 47
Urea <2.9umol/l 108 270 40
Bilirubin >17mmol/l 10 209 5
Alk Phos >120iu 23 218 11
GGT >42 iu 32 115 28
Protein <60gms/l 65 231 28
Albumin <34gms/1 103 223 46
Table 5.43 Abnormal haematological / biochemical tests at diagnosis
The table shows that the ESR, WCC, urea and albumin are all commonly
abnormal at the time of diagnosis. Perhaps surprisingly only a few individuals had
haemoglobin values of < lOgm/dl at diagnosis. Similarly a total of 53 of those on the
Register (17%) had either a raised bilirubin, alkaline phosphatase or GGT at diagnosis.
Folate, vitamin B12, iron and TIBC measurements were also collected and
analysed if the measurement had been made within 6 months of diagnosis (Table 5.44).
number %
abnormal performed
Folate (4-20p.gm/ml) 67 111 60
B12 (230-800p.gm/ml) 10 109 9
Iron (9-27mmol/ml) 71 94 78
TIBC (250-410ngmdl) 43 98 44
Table 5.44 Abnormal vitamin & iron at diagnosis
These figures demonstrate that even at diagnosis a not insignificant number
of individuals already have low folate and iron levels.
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Table 5.45 demonstrates the potential of the computer system's numerical
analysis routines. Means, medians, modes and standard deviations have been calculated
for commonly performed investigations at the time of diagnosis (Table 5.45).
standard
points mean median deviation
Hb 273 12.25 12.00 1.808
WCC 269 10.03 9.00 3.878
ESR 107 38.93 33.00 26.460
Albumin 224 34.52 34.00 6.683
Protein 231 64.77 66.00 8.717
Urea 270 4.23 3.30 3.512
Table 5.45 Haem/biochem statistics at diagnosis
Similar calculations have been made for these parameters measured over the
period following diagnosis (Table 5.46).
standard
points mean median deviation
Hb 201 2.60 13.00 1.760
WCC 200 9.47 9.00 3.763
ESR 46 25.17 16.50 24.194
Albumin 203 36.37 37.00 6.414
Protein 205 62.85 64.00 9.035
Urea 200 4.75 3.90 4.307
Table 5.46 Haem/biochem statistics post diagnosis
Comparison of these parameters shows that the post diagnosis values show
no significant variation from the values at diagnosis.
5.8.2 Abnormal values during the period of disease
Further analysis of all haematological / biochemical investigations held on
the Register (Table 5.47) revealed that as few as 20 individuals had a recorded
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haemoglobin value of less than lOgm/dl. Similarly a total of 169 individuals had WCC
> 10,000cc , 92 a protein level < 60gm/l, 127 an albumin of < 34gm/l and 145 a urea of
< 3mmol/l at some point in the disease. Abnormal LFT's remained uncommon over the
course of the disease with only 80 (25%) being found to have an abnormal liver related
parameter at some point during their disease.
no. of patients number %
with measurement abnormal
Haemoglobin 273 20 7
WCC 269 169 63
Protein 231 92 40
Albumin 223 127 57
Urea 270 145 54
Table 5.47 Abnormal haem/biochem at any time
5.83 Associations between Haematological / Biochemical parameters
Protein, albumin, white cell count and urea values were the most frequently
abnormal haematological/biochemical parameters at the time of diagnosis. Each
parameter was examined more closely to see if abnormal values varied with sex, age, site
of disease and time to diagnosis (Table 5.48).
Results show that abnormal WCC, urea, protein and albumin values do not
vary with the sex of the individual.
Figures for age at diagnosis, time to diagnosis and site of disease are
displayed in Table 5.48. As one might expect the elderly patient's serum albumin and
protein levels were below the normal range in up to 40% of individuals at the time of
diagnosis - also notable is the large discrepancy between the number of under 20's with
low protein (19%) and the number with low albumin (40%). Perhaps surprisingly the
percentages of individuals with low protein or albumin levels did not appear to vary with
the time taken to diagnosis. Those with small bowel and discontinuous disease more
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commonly had reduced protein and/or albumin levels although the differences were not
significant.
Number of patients & % with:-
WCC Protein Albumin Urea
>10000 <=60gm/dl ;34gm/dl <3mmol/l
aqe at diaqnosis
<20 (52) 14 27% 10 19% 24 46% 19 37%
20-39 (161) 69 43% 19 12% 37 23% 67 42%
40-59 (65) 25 38% 20 31% 24 37% 14 22%
*60 (35) 17 49% 14 40% 16 35% 6 17%
Site of Disease
Small bowel (97) 43 44% 27 25% 36 37% 30 31%
Ileocolic (94) 41 44% 14 15% 24 26% 40 43%
Large bowel (71) 30 42% 14 20% 23 32% 20 28%
Discontinuous (44) 13 30% 8 20% 19 44% 18 41%
time to diaqnosis
<6mths 83/156 53% 34/130 20% 62/127 49% 59/174 34%
6-llmths 22/38 58% 9/32 28% 12/29 41% 19/42 33%
*12mths 32/60 55% 17/56 30% 23/55 42% 29/80 36%
Table 5.48 Abnormal haem/biochem associations
Although WCC was raised in just under 50% of individuals at diagnosis there
was no variation in age, time to diagnosis or site of disease in this group.
A low urea value was not associated with the site of disease although
individuals with discontinuous or ileocolic disease demonstrated a slightly higher
percentage with a urea <3mmol/l. Similarly the length of time to diagnosis did not
appear to vary with the urea level at diagnosis however there were significant differences
between those diagnosed at less than 40 years of age and those 40 years or over (p < .001).
Summary
Although few individuals were found to have abnormal haemoglobin values
either at diagnosis or subsequently, many were shown to have low protein and albumin
values even at diagnosis. Furthermore a relatively high proportion of patients also had
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low iron and folate at diagnosis. Information on follow-up data suggests that there is no
obvious continued and / or permanent deterioration in the recorded parameters as the
disease progresses.
There were no significant clinical associations when the abnormal
haematological and biochemical values were compared with age, sex, site of disease or
time to diagnosis.
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5.9 TREATMENT
From the retrospective survey it was impossible to determine accurate
information on the medical treatment regimens of the Crohn's population. It was
however possible by careful scrutiny of the patient records to identify many of the
different types of medication that individuals had been treated with during the period of
their disease. This, it was hoped, would create a baseline which could be developed more
accurately in the prospective phase of the Register. The extraction of this data also
revealed the difficulties associated with the retrospective collection of this type of
information.
The documentation of operative procedures performed on each individual
was more complete, therefore information on the date, reason for and type of operation
was collected for each procedure performed. The analysis of this data was therefore
more accurate. All procedures performed under general anaesthetic were audited except
those described as an examination under anaesthetic.
5.9.1 Operative findings
A total of 455 operations were performed on 243 of the Registers' patients
(77%) - that is 1.9 operations per patient having an operation, or 1.4 operations per
registered individual.
The number of operations performed per patient is shown in fig 5.11. This
figure shows that in the Crohn's population 23% had no operation at the time of the
survey. Of the patients having an operation 54% had a second operation, 49% of this
group had a third operation while a further 24% had a fourth procedure. At the time of
the survey 77% of individuals on the Register had had one operation, 40% had two and
20% three operations.







Findings from the Crohn's Register 123
number
Rt hemicolectomy 112



















Table 5.49 Operative procedures
The grounds given for operation are displayed in Table 5.50 and show that
failed medical treatment, uncertain diagnosis, obstruction and peritonitis are the most
common reasons for operation. The table is divided into columns and displays the
'reason' compared with 'all operations', the 'first operation' and the 'second and
subsequent' operation.
Findings from the Crohn's Register 124
All Ops 1st Op 2nd &
other op
obstruction 81 18% 43 18% 38 18%
stricture 39 9% 16 7% 23 11%
fistula 53 12% 14 6% 39 18%
abdo mass 46 10% 34 14% 12 6%
abscess 69 15% 22 9% 47 22%
perforation 22 5% 12 5% 10 5%
peritonitis 78 17% 50 21% 28 13%
failed Medic Rx 100 22% 53 22% 47 22%
uncertain diag 122 26% 102 42% 20 9%
growth retard 4 -- 3 -- 1 —
other 40 9% 23 9% 17 9%
recurrence 48 23%
TOTAL OPERATIONS 455 243 212
Table 5.50 Reason for operation
The table shows that uncertain diagnosis is by far the most commonly stated
reason for initial operation. Approximately 20% were found to have failed medical
treatment, peritonitis and/or obstruction as a major reason for initial operative
intervention. Abscess formation, failed medical treatment and, as one might expect,
recurrent disease are the most frequently reported indications for further surgery.
A summary of the different components of these operations is displayed in
Table 5.51. The Table reveals that large bowel was resected as often as small bowel while
the majority of those undergoing resection had an end to end anastomosis. Very few had
an end to side anastomosis - side to side anastomosis being relatively more common.
Although multiple resections are well described only a small percentage in
this study had multiple resection, however it was noted that within a single resected
segment there were often several discrete areas of disease. Radical resections were
performed slightly more often than localised resections demonstrating that surgeons were
divided as to which was more successful. The presence of intra-abdominal abscess was
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another fairly common finding 12% of operations requiring drainage of some intra¬
abdominal abscess.
small bowel resection 215 47%
large bowel resection 199 44%
end to end anastomosis 192 42%
end to side anastomosis 8 <10%
side to side anastomosis 21 <10%
one area resected 167 37%
2 areas resected 12 <10%
3 areas resected 4 <10%
local resection 82 18%
radical resection 88 19%
drain abscess 57 12%
ileo/colostomy 76 17%
bypass 18 <10%
laparotomy & biopsy 38 <10%
other 37 <10%
Table 5.51 Operation included
Colostomy or ileostomy was performed on 76 occasions however several of
these were re-fashioning of existing stomas. A total of 60 individuals (19%) had a
colostomy or ileostomy fashioned at some stage in their disease.
Eight out of the 243 patients having a Crohn's related operation died
following the operation (3.3%). However the operative mortality for all the Crohn's
related operations was less at 1.7% (8/455). In this group of eight 5 were under 60 and 3
over 60 at the time of diagnosis. It is perhaps also of some note that of the 34 deaths in
the Crohn's population 12 were considered directly attributable to Crohn's disease and 8
of these were related to recent operation.
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5.9.2Who Requires Operation
The Crohn's population was divided into two groups those having had an
operation and those who had not. The age, sex, site of disease and time to diagnosis were
compared in each group to see if these factors influenced whether a patient was likely to
require an operation or not (Table 5.52).
No operation Operation
Sex
Male 29 39% 99 41%
Female 45 61% 143 59%
Aqe at diagnosis
<20 19 26% 33 14%
20-39 36 49% 125 52%
40-59 10 14% 55 23%
£60 8 11% 27 11%
Site of disease
small bowel 22 30% 75 31%
ileocolic 10 14% 84 35%
large bowel 28 38% 43 18%
discontinuous 13 18% 31 13%
Time to diagnosis
<6months 42 57% 132 54%
6-llmonths 9 12% 33 14%
£l2months 18 24% 62 26%
Table 5.52 Associations between operation & no operation
The Table showed that neither the sex nor the time to diagnosis affected the
requirement or otherwise of an operation. Figures also demonstrated that fewer of those
under 20 at diagnosis required an operation while conversely a higher percentage of the
40-59 group required operative treatment - the difference between the under 20 group
and the rest of the Crohn's population was significant (p<.05). Finally there was a
significant difference between the groups in relation to the site of disease, where it was
found that fewer than expected with large bowel disease required an operation (pc.001)
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when compared against those with disease outwith the large bowel, while many more of
those with ileocolic disease, as opposed to other sites, required an operation (pc.OOl).
These results suggest operation is most likely in those with ileocolic disease and least
likely in large bowel disease. A diagnosis before the age of 20 also reduces the likelihood
of an operation.
5.93 Operative morbidity
The average number of operations per individual was chosen as a crude
measure of patient morbidity. Using this crude indicator it was hoped to identify features
known at an early stage which might point to multiple operations and therefore increased
morbidity. Factors examined included:
a) time to diagnosis
b) time to 1st operation from diagnosis
c) time to 1st operation from symptom onset
d) sex
e) age at diagnosis
f) site of disease.
Figures displayed in Table 5.53 suggest that the time to diagnosis did not
alter the likelihood of the patient requiring at least one operation, between 76% and 79%
of individuals having at least one operation in each of the intervals examined. Of those
having an operation however a decreasing percentage required a second operation as the
time to diagnosis lengthened. The group taking less than 6 months to diagnosis required
more operations than those taking greater than 6 months to diagnosis though the
differences were not significant. A similar trend is shown when the chance of an
individual having 2 operations is examined - this again demonstrates that the shorter the
time to diagnosis the more chance there is of having 2 or more operations.
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number of operations % with overal1
0 1 2 3 chance
Ops 2 Ops
Time to diagnosis
<=6mths (174) 42 24% 132 76% 57 49 43%
7-12mths (42) 9 21% 33 79% 48 50 38%
>12mths (80) 18 28% 62 78% 43 52 33%
Aqe at diaqnosis
<20 (52) 19 o\«CO 33 63% 61 49 35%
20-39 (161) 36 22% 125 78% 58 46 45%
40-59 (65) 10 15% 55 CO en o\° 55 57 46%
>=60 (35) 8 23% 27 77% 22 67 38%
Site of Disease
small bowel (97) 22 23% 75 77% 55 37 42%
ileocolic (94) 10 11% 84 89% 51 49 44%
Large bowel (71) 28 39% 43 61% 43 47 27%
Discontinuous (44) 13 30% 31 70% 77 67 55%
Sex
Female (188) 45 24% 143 76% 51 44 39%
Male (128) 29 25% 99 77% 57 55 44%
Table 5.53 Number ofOperations
Although the sex of an individual did not affect the probability of a patient
requiring an operation a slightly higher proportion of males required 2 or more
operations (57% against 51%) - the figures however were not statistically significant.
As previously noted the likelihood of surgery seemed to be related to the age
at diagnosis with 85% of the 40-59 group requiring at least one operation compared with
63% of those in the under 20 group. Interestingly, although fewer of those in the under 20
group required an operation more required a subsequent operation when compared with
the other groups (61% in <20 group against 45% >20 group). This increase was not
related to the number of 'patient years with disease' within each group. Furthermore
significantly fewer of the 60 and over age group required a second operation, only one in
five, compared with those in the under 60 group (p< .001).
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The site of disease also had some bearing on the rate of operation. Almost
90% of those with ileocolic disease required operation against 61% of those with large
bowel disease. Those with discontinuous disease who had one operation required
significantly more second operations (77%) than those with other sites of disease
(pc.OOl). Conversely those with large bowel disease required fewer second operations
(43%) although this difference was not significant when compared with other sites of
disease. Finally, it was noted that if at the time of diagnosis the patient was recognised to
have large bowel disease the chance of having two operations was significantly less than
those with ileocolic, small bowel and discontinuous disease (p< .01).
These figures suggest that if the number of operations is used as a measure
of the morbidity of disease then it is better to have large bowel disease be over 60 at
diagnosis, be female and have symptoms for a year before diagnosis. Similarly the patient
with the greatest 'morbidity' is someone with ileocolic or discontinuous disease who is 40-
59 at diagnosis, is male and who has been diagnosed within 6 months of symptom onset.
The pattern of those requiring 2 or more operations is perhaps also worthy
of note. Over the period of study of those who required repeat operation 61 had their
second and subsequent operations within three years of their first while in 42 at least
three years elapsed between first and subsequent operations. Furthermore, only 19 had a
second operation within three years and yet later had a subsequent operation at least
three years after the first. The longest duration between Crohn's related operations in
any patient was 22 years.
5.9.4 Medical Treatment
A simple audit has been kept of commonly used medication. No effort has
been made to collect the dose or duration of each different treatment regime nor its
efficacy. It is hoped that the prospective phase of the Register might provide more useful
information on the efficacy of different treatment regimens over a period of time. The
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retrospective audit was therefore carried out to investigate the scope and variability of
medical treatment. Despite a careful search of each patient's case record the accuracy
and completeness of this audit must be held in some doubt principally because some
patients had very few hospital attendances. However, the relative percentages requiring














Table 5.54 Frequency of drug utilisation
Table 5.54 shows that 60% of those on the Register had been treated with
steroids at one time or another while over half have had salazopyrin. Surprisingly few
were noted to require anti-diarrhoeal treatment (24%) and perhaps more interestingly
5% required laxatives. No evidence of specific drug treatment could be found in 13% of
those on the Register. Antibiotics were used in a small number of individuals and were
more common in those with discontinuous disease rather than small, ileocolic or large
bowel disease.
The different types of medical treatment have been compared with the sex,
site of disease, age at and time to diagnosis.
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It was found that fewer of the elderly group (8/35) required medical therapy
when compared with the younger group (32/284). However, the difference barely reaches
statistical significance (p = .05). Furthermore of those in the elderly group significantly
less were treated with salazopyrin and fewer were prescribed steroids or anti-diarrhoeals
(Table 5.55).
2=60 <60
steroids 16 45% 176 62%
salazopyrin 12 34% 157 55% p<.05
anti-diarrhoeal 5 14% 72 25%
Table 5.55 Medication & Age at Diagnosis
Medication was most frequently used in those with discontinuous disease a
greater number in this group requiring anti-diarrhoeals, steroids and/or salazopyrin than
in those with a different site of disease (Table 5.56).
Small Ileocolic Large Discontinuous
bowel bowel
no Rx 19 20% 12 13% 6 9% 2 5%
anti-diarrhoeal 19 29% 24 26% 17 24% 15 34%
steroids 52 53% 59 63% 44 62% 34 77%
salazopyrin 47 48% 48 51% 43 60% 29 65%
Table 5.56 Medication and Site ofDisease
Sex and time to diagnosis did not influence the type of medical treatment
required by those on the Register.
Summary
Almost 77% of those registered required an operation for their Crohn's
disease, 40% had two and 20% three operations described at the time of the survey. The
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commonest performed operation was a right hemicolectomy with the most frequent
reason for initial operation being uncertain diagnosis. Subsequent surgery was most
frequently required for recurrent disease, abscess formation and failed medical therapy.
Operative treatment and 'morbidity' was greatest in males aged 40-59 who
were diagnosed less than 6 months after symptom onset with discontinuous disease.
Morbidity was least in those females with symptoms for over a year who were diagnosed
at 60 years of age or over and who were found to have large bowel disease.
Steroids and salazopyrin have been used in over half of those on the
Register. Fewer of the elderly required medication while more of those with




The work which has been presented has revealed a significant amount of
information relating to the diagnosis, further investigation and treatment of Crohn's
disease in the population of Tayside. Aspects of this are discussed in this chapter.
The wider implications resulting from the development of the
microcomputer system used to facilitate this work are also presented.
6.1. MEDICAL ASPECTS
The introduction has demonstrated how little progress has been made in
furthering the understanding of Crohn's disease.
A large number of individuals have looked at specific aspects of the disease
for instance evidence of transmissible agents (Heatley 1975), the presence of granuloma in
rectal biopsy (Thompson 1981), measurement of disease activity (Harvey 1980) or
malignant disease in Crohn's patients (Gyde 1980). However, it appears that although
several have described their personal or hospital experience of the disease (Farmer 1981)
few groups have produced accurate data using a well defined population (Evans 1964,
Maybury 1979, Hellers 1979) - essential if valid and accurate epidemiological information
is to be obtained. The lack of progress in our understanding of the disease, despite highly
specialised scientific investigation, suggested that a further re-examination of
epidemiological data might be worthwhile especially if the powerful data-processing
potential of a computer was utilised to investigate the collected data. An accurate
epidemiological study would further corroborate the few existing epidemiological reports
and provide a valuable contrast to the neighbouring Grampian Region where
epidemiological data has been collected for a number of years in a prospective fashion.
More particularly however, if this was combined with a comprehensive data collection
mechanism based on a computer system containing multifactorial enquiry and analysis
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facilities, then previously unrecognised associations may be uncovered which would then
merit more careful and intensive investigation.
In order to monitor the disease over a period of years in a prospective
fashion it was decided to create an on-going data collection mechanism. Despite the
many recognised and previously described problems, a register appeared to be the most
valid method for instituting this type of data collection mechanism. The concept of a
Crohn's disease Register was therefore born.
The work involved in maintaining such a register would normally be
considerable particularly if a large volume of information was to be collected on each
patient over a period of years. To help administer this data collection it was decided to
investigate the possibility of developing a Register based on a microcomputer system.
This would facilitate rapid data processing and subsequent data analysis.
In order to test this working hypothesis a pilot study has been set up to
investigate the potential return of such a system. The initial development and
retrospective data collection has been used to explore the feasibility and value of the
system in terms of its audit and research capability. The system has however been
designed to permit the initial retrospective system to be run prospectively. It is hoped
that an ever changing dynamic database will be created which will not only continue to
provide an audit and research capability but may also help in the management of
individual patients.
The initial phase of system development, retrospective data collection, audit
and analysis has been completed and the wider implication and application of the system
assessed.
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6.2 THE REGISTER'S DEVELOPMENT
6.2.1 Case Ascertainment
The early problems with development of the Register related to the
definition of what was to be considered a case of Crohn's disease, the retrospective
identification of the Crohn's population within Tayside and evolution of the Crohn's data
set.
Inaccuracies in the Scottish in-patient morbidity returns have previously been
recognised by Lockwood (1971) and more significantly by Patel (1976). Similar
substantial inaccuracies in Crohn's disease returns have also been demonstrated
(Humphreys 1975, Smith 1975), however, it was felt that this would be the only practical
and effective method of initial case capture. In order to use Scottish Morbidity Returns
(SMR1) it was therefore felt necessary to firstly validate their accuracy in Tayside. The
number of individuals discharged from Tayside hospitals with diagnostic ICD coding of
either Crohn's disease, Ulcerative Colitis or Non-Specific Colitis is large. A small pilot
study was therefore carried out to investigate the accuracy of each of the three in-patient
ICD diagnostic codes within Dundee District. This small study showed that there were a
large number of false positives within the group labelled with the Crohn's ICD coding but
few false negatives. More significantly all those recognised as false positives at the
original admission were eventually labelled with a Crohn's coding during a subsequent
admission.
The inaccuracies in SMR1 ICD coding highlight the potential hazards of
using these routine statistics as a measure of Crohn's disease within Tayside. These errors
further support the inaccuracies in inpatient morbidity statistics reported by other groups
such as that of Smith (1975) and Patel (1976). Furthermore if similar discrepancies were
present in all SMR1 returns then their value as a basis for future health care planning and
distribution of resources must be questioned. These findings also raise the question of
responsibility for completion of SMR1 forms. Until recently the method of SMR1
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completion in Tayside varied between specialties and departments - a fact which could
have led to significant differences in the quality of SMR1 returns.
In order to minimise the proven inaccuracy in Crohn's disease statistics all
those given an SMR1 diagnosis of Crohn's disease were subjected to the Register's
diagnostic scoring system before being accepted onto the Crohn's disease Register. It is
not suggested that this method is infallible, however statistics show that it will be correct
in between 93% and 94% of cases. These in-patient statistics have been further checked
and supplemented by mailing a list of Crohn's patients to each practice in Tayside
requesting confirmation of these cases and the addition of others whom they consider to
have the disease. This had the effect of capturing a small number of cases who had not
been admitted to hospital, some who have had symptoms for some time but only recently
diagnosed and others who have only developed symptoms since 1983 and who are
therefore excluded from this present survey. The response to the mailing was excellent
with only one practice unhappy to confirm our original list because of the Data Protection
Act. Perhaps this good response was due to the fact that good quality data was used in
the GP mailing or that Crohn's disease remains one of the few disease's about which so
little is known.
622 Obtaining a working diagnosis for the Crohn's Register
The diagnosis of Crohn's disease is often difficult. A large proportion of
those with the disease do however present with a classical history of abdominal pain,
weight loss and diarrhoea and the diagnosis is then confirmed by a combination of
radiographic, pathological, endoscopic or operative means. There also exists a group in
which the symptoms suggest the diagnosis but confirmation is either not conclusive using
existing investigative techniques or investigation is frankly misleading. This group,
reported as between 10-20% of cases by Morson (1971), lie in a 'grey area' either between
inflammatory bowel disease or some other unrelated bowel disorder or between Crohn's
disease and Ulcerative Colitis. It is for this reason that scoring systems have been
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introduced. Many definitions exist as to what constitutes Crohn's disease (Gjone 1966,
Kirsner 1973, Korelitz 1974). Most definitions are simple to implement and relate to the
presence of specific radiological, endoscopic or histological findings. The OMGE group
have taken a more logical if slightly more complicated approach by calculating the
probability of a particular feature being present in Crohn's disease and Ulcerative Colitis
(Myren 1979) - a positive score for a finding suggests Crohn's disease while a negative
suggests Ulcerative Colitis. A total is calculated for the observed findings, the higher the
positive score the greater the probability that the individual has Crohn's while a negative
total score suggests Ulcerative Colitis. This method has introduced the concept of
weighting to the scoring system. With a calculated accuracy of 93% this appears a
realistic and statistically sound approach to diagnosis particularly in the difficult case.
Although this system has a predictive value of 93% it has not been designed to separate
those individuals who have IBD from those who have a Non-Specific Colitis. This study
has shown this distinction to be of some importance as some individuals with ischaemic
colitis, radiation proctitis and even endometriosis can have symptoms suggestive of IBD
and therefore may inadvertently be submitted to the OMGE scoring system. The author's
additional step attempts to predict the liklihood of an individual having IBD and is based
on clinical, pathological, radiographic and endoscopic findings. The excellent predictive
values using this test, albeit on a relatively small population of patients, were 98% for
Crohn's patients and 100% for those with Ulcerative Colitis. The specificity for those
with Non-Specific Colitis was 100%. It is to be hoped that others will begin to use this
type of scoring system which is indeed only a numerical refinement of other diagnostic
criteria (Kyle 1971, Lennard-Jones 1976, Lee 1981) already in use.
The use of the scoring system in this present study has confirmed the OMGE
figures. The introduction of the additional step to determine whether or not an individual
has inflammatory bowel disease is however considered to be of importance on several
counts. Firstly the OMGE group do not appear to have considered this very relevant
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point which in this study has resulted in the exclusion of several patients with symptoms
highly suggestive of Crohn's disease. Secondly the introduction of this serial type of
testing in the scoring system tends to maximise the specificity and predictive value of the
performed tests (Fletcher 1984). Experience to date therefore suggests that this system is
marginally a more accurate predictor than the original OMGE system.
623 The Crohn's Database
The development of an appropriate database around which to base the
Register was without doubt the most contentious part of the Register's implementation.
The collection of diagnostic and basic epidemiological data was considered mandatory
and a relevant data set was established without difficulty. However, the greatest dilemma
concerned the decision as to what else to collect. Several points required consideration.
Firstly the idea of the Register was to produce a general overview of the
disease for Tayside. This would necessitate the collection of a large data set covering
many aspects of the disease - the collection of such a broad based data set as far as the
author is aware has not previously been attempted. It was this concept that would then
permit a wide ranging enquiry from which any apparent associations revealed could be
further investigated from within the Register's database.
Secondly although the Register was to be implemented using a retrospective
data collection mechanism it was hoped to continue the data collection prospectively. A
continuous on-going data collection system would therefore evolve enabling the Register
to provide information on the disease over a period of years. It was therefore important
to structure the data in a way that would lend itself to easy collection and entry into the
computer's database.
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Finally, it was equally important not to fall into the trap of collecting
everything that was thought 'might be of value'. To attempt this would result in an
unmanageable database.
Overall the chosen format, with separate distinct groups of data for recurring
and non-recurring information, has certainly stood up to the initial retrospective data
capture. The retrospective proforma questionnaires (appendix 5)have been shown to be
more than adequate and should with a few minor alterations be satisfactory for use in
prospective data collection. Much thought has also gone into the prospective contact
form which will utilise elements of appendix la,b,c,2,3,4 & 6b. It is hoped to use parts of
appendix 3,4,6a,b,c for follow up data to be used both in clinics or as a periodic mailing.
The analysis of the retrospective database has demonstrated the value of the
initial data set. The major proportion of this data has been shown to be of proven value
and will continue to be collected in the prospective phase. Minor and irritating
difficulties with the data set included the failure to use the occupational groups generated
by the Registrar General and the difficulty in assessing social class from information
supplied in case records. With the benefit of hindsight it is now felt that more time should
have been spent in assessing available health-care related and census statistics produced
for each geographical area. More of the health statistics produced for Tayside could then
have been used, for instance occupation and type of dwelling, as the control group
enabling direct comparison with the Crohn's population.
Major changes will be made in the 'Investigation' part of the data set where
some biochemical information will be dropped including urea and electrolytes - though
retaining liver function tests. Similarly it is hoped to monitor serum iron, B^ and folate
as recurring data as opposed to initial diagnostic data.
Furthermore the retrospective collection of endoscopy data has shown that
endoscopy reporting is sadly lacking in accuracy and consistency - probably a result of the
large numbers of clinicians performing the investigations. Much more valuable data could
Discussion 140
be obtained from the endoscopies in respect of audit and research if a more structured
report format was introduced. This highlights several problems when attempting clinical
audit within the health service. Firstly the accuracy and consistency of initial data
recording must be considered. The transcription and interpretation of this recording
must then be closely monitored to ensure that clinical findings for instance diagnostic
category fit into one of the recognisable standard diagnostic groups. Indeed the author is
presently involved in introducing a new system for recording all endoscopy data produced
in the clinical measurement area in Ninewells hospital. This includes the implementation
of a computer system based on the facilities contained in the Register. Aspects of this
development will be discussed later in this chapter.
The data set used for both pathological and radiological investigation will be
retained without change. Analysis of these aspects have been fruitful. One interesting
observation in this section was the finding that the diagnostic index from the Pathology
department did not always correlate with the Register's diagnosis. This is perhaps to be
expected as there are often no specific indicators of disease and lends support to the idea
and value of serial diagnostic testing in this disease. Reporting of radiological
investigations was on the whole more consistent. More valuable information could
therefore be extracted from the database. The time involved in collecting this data would
have been greatly reduced if there had been a computerised index within the radiology
department. This type of index would be invaluable in monitoring the cost effectiveness
of the many expensive investigations performed, particularly in the present economic
climate, as well as providing important data on which to base and help in clinical research.
Indeed our initial survey of the investigations performed on the Crohn's patients suggests
an ever decreasing positive return over recent years for barium studies. This need not
however, necessarily imply a waste of resources as a negative x-ray may represent a very
positive result in a patient's management.
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Few changes would be made to the treatment side of the database in any
prospective phase. The operative data set was found to be concise and provided a
chronological sequence of operative events for each registered individual. By contrast
little valuable data has emerged from the retrospective collection of medical treatment
data; however as the quality of collected data relating to medical treatment improved
during the prospective phase it will be possible to explore the use and efficacy of
treatment regimes using disease activity and morbidity scores.
Specific extra data items which will be included in prospective collection
include the number of hospital admissions, days in hospital, consultant responsible for
patient and date last seen by a hospital doctor. The weight of the patient will also be
recorded as a recurring piece of data. Provision will be made within the database for a
regular comments section and a number of 'blank markers' will also be included.
These markers could at any stage be given a specific meaning (eg. entered
into drug trial or on sugar free diet) without altering the database structure.
The inclusion of this extensive and yet expandable data set in conjunction
with the available computing facilities has created the equivalent of a Crohn's disease
patient management system based on a microcomputer. Patients can be registered with
the system, then followed over the years, data being added to their file structure every
time they visit outpatients or following hospital admission. Data on the system can then
be used to prompt events or some action for instance a clinic visit or reminders to patient,
general practitioner or hospital doctor that a patient has not been reviewed for perhaps
three years. All the data generated in the patient management phase is then available for
routine or ad-hoc audit and indeed can be used as the basis of further research if
appropriate.
In summary, although many groups have collected data on diverse aspects of
Crohn's disease none, as far as the author can ascertain, have accumulated and collated
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such an extensive and wide ranging data set. It is suggested that this offers a significant
overview of the disease, the findings of which are now discussed.
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6.3 FINDINGS OF THE RETROSPECTIVE ANALYSIS OF THE REGISTER
63.1 Epidemiological findings
In order to obtain valid epidemiological information using a retrospective
case study it is important first to define exactly what the study considers to be a case of
Crohn's disease and secondly to define the control group (Mausner 1974).
The author has attempted to overcome the first of these problems by
adapting the OMGE scoring system as previously described.
Gilat (1983) has suggested that epidemiological data generated from
accurate population studies of Crohn's disease could act as a 'gold standard' for the
disease. The patient group was collected from the whole of Tayside and the general
population used as the control group. Use of the general population as the control group
permitted the Crohn's group to be compared with a well defined population, imperative if
accurate epidemiological data was to be obtained. This facilitated the use of routine
statistics produced for Tayside Region by the Registrar's Office . Tayside is a good area
for epidemiological study, firstly because the population of the area has remained static
over the past 90 years (394,824 / 388,433 / 397,605 / 391,846 for 1891, 1921, 1971 & 1981
respectively). Secondly, examination of cross boundary flow statistics shows that Tayside
health authority is a net importer of 50,000 patients from neighbouring Fife and Grampian
region - estimated 1983 population 394,895 actual catchment population 445,249 - it is
therefore unlikely that any patient with Crohn's disease resident in Tayside will be seen in
hospitals outside the area. Specific figures for cross boundary flow for Crohn's disease
reflect the general trends. Furthermore in an effort to ensure complete data collection,
information has been obtained from several sources. Of equal importance is the accuracy
of diagnosis in each potential Crohn's patient; great care has therefore been taken to
ensure this accuracy by examining each candidates case record carefully.
The gradual increase in incidence observed in many studies (Gilat 1979,
Maybury 1979, Gilat 1982) has been confirmed by this study. The apparent reduction in
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this increase in Tayside during the late 1970's has also been noted elsewhere by others
(Hellers 1979, Medeloff 1982). Analysis has shown that variation in the definition of
disease onset does have some effect on calculated incidence rates. Figures (Table 5.1)
showed that only 75% of individuals developing symptoms within any 4 year period will be
diagnosed within that period. A lag period of 4 years must elapse before over 95% of
those developing symptoms within the original 4 year period have in fact presented and
been diagnosed with the disease.
The Crohn's population of Tayside compares favourably with most other
epidemiological studies however it contrasts with the neighbouring Grampian population.
Interestingly the calculated incidence figures for Tayside as a whole, for Arbroath and
figures obtained from Grampian region all show considerable variation. Why there
should be such variation in adjacent geographical areas is a point which requires closer
investigation. Comparison of the Tayside and Grampian region show similar trends for
both areas with an apparent lead of some 10 years in Grampian (fig 6.1). It will be
interesting to observe the Arbroath figures over the next few years to see if they also
plateau. This demonstrates the variability of the disease even in neighbouring areas. It is
perhaps unwise to speculate whether the recent increased prosperity in the North East
may be partly responsible for the apparent ten year difference in trends between
Grampian and Tayside.
These findings certainly require further investigation. The first step should
be to confirm that the method of case ascertainment and diagnostic criteria are
comparable and therefore the differences noted authentic. Initial enquiry suggests that
the studies are likely to be comparable. A further more specific epidemiological survey
could then be undertaken using groups of Crohn's patients and groups of 'normal'

























Use of the computer system has enabled the point prevalence to be
calculated for each 4 year period without difficulty. The prevalence rate per 100,000 has
steadily increased over the 16 year period and continues to rise. The rates compare
favourably with Aberdeen 32.5 (Kyle 1971), Uppsala 50 (Bergman 1973) and Malmo 75
(Brahme 1973) (all per 100,000). There appears to be no other study available to
compare point prevalence calculated at 4 yearly intervals although the group in Malmo
measured point prevalence at several stages of their study (Brahme 1973). The increase
we have shown is consistent with the chronic nature of the disease and its low mortality
even in the elderly patient.
The clustering observed in the Arbroath area merits further investigation.
The prevalence of the disease is recognised to be higher in the more densely populated
industrialised centres (Kyle 1971, Bergman 1975, Maybury 1979) than in rural areas.
However it should be noted that many of these centres, like Arbroath, are situated on the
coast where intake of fish and seafood products is likely to be high. Initial enquiry has
also revealed that the domestic water supply to the Arbroath postcode area is only
partially treated being the only part of the region which does not draw any of its water
from the main regional purification plant. Furthermore this supply has a high lead
concentration and since the early 70's - as a result of EEC regulations - has required the
addition of lime to reduce the acidity and hence the lead concentration. It is perhaps
speculative to suggest that lead, which is recognised as a cause of gastrointestinal mucosal
damage, may be one of the factors contributing to the increased incidence in this area.
The majority of studies, for example Smith (1975), Miller (1974) and this
present study, show an overall preponderance of females however figures presented here
have shown that there is a significant shift in the sex ratio towards males within Tayside
particularly over the last 4 year period under study. The number of males increased
significantly over this period, furthermore this type of change was also noted in Grampian
region some 10 years ago. Once again these changes appear most marked in the
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Arbroath area where, despite the relatively small numbers involved, there has been a
marked increase in the number of males over the past 8 years. The reason for this
variation remains unclear for both the Tayside and Arbroath populations are matched for
sex with the ratios for male/female being .471, .476 and .475 in Tayside for years 1961,
1971, 1981 respectively while in Arbroath the male/female ratio was .474 in 1971 and .471
in 1981.
The low familial incidence in Tayside is in sharp contrast to Kisner (1973)
Chicago and Korelitz (1981) New York but similar to that seen by Kyle (1971) in
Aberdeen.
The significant increase in large bowel disease has previously been well
described (Kyle 1971, Hellers 1979, Mendeloff 1980, Weterman 1981). This increase
appears more prevalent in the elderly Crohn's patient - a feature also described by other
groups (Brahme 1975, Maybury 1979, Carr 1982). The Tayside figures also show that
there has been a real increase in incidence in large bowel disease in the elderly over the
16 year period and confirms that this is a more significant rise than that found for the rest
of the Crohn's population. This elderly group reveals several other interesting features.
Only a few studies have examined the elderly group of Crohn's patients in a
defined population. The Birmingham group (Fabricus 1985) found 8% of the overall
population to be over the age of 60 at the time of diagnosis, a figure which is similar to
that for Tayside and that of Goligher (1980). The Tayside figures also show a definite
increase in incidence over the 16 year period under study and confirm that the increase in
numbers of aged patients is not fully explained by an aging population. Kyle (1971),
Miller (1974) also showed an increasing number of elderly Crohn's patients and similarly
found that there was a preponderance of females in this elderly group. Although Carr
(1985) noted a similar proportion of elderly women with inflammatory bowel disease the
very high proportion of women in this series, even allowing for the increased proportion
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of women expected in this elderly group, has not previously been reported and requires
confirmation by other groups.
There appear to be no comparable figures for mode of initial presentation
although the relatively high emergency presentation is perhaps surprising. Despite a
greater awareness and an increasing availability of investigations the time taken from
onset of symptoms to diagnosis has not changed over the 16 year period suggesting that
neither an increasing awareness nor the advent of endoscopy has significantly affected the
recognised increase in incidence.
The epidemiological review therefore suggests that the incidence rates in
neighbouring areas, the elderly Crohn's population and the group resident in the
Arbroath area merit closer investigation and examination.
632 Investigations
Pathology
The pathology audit identified almost 700 Crohn's related specimens from
these patients of which 350 demonstrated features indicative of Crohn's disease. Further
analysis appears to reflect the changing trend in incidence with an apparent slowing in the
increase of both samples submitted and number of positive reports over the past 4 years.
The relative increase in the proportion of biopsy specimens submitted is also noted and
probably reflects the increasing role of endoscopic investigation in the Crohn's patient.
The distribution by site and macroscopic findings of submitted specimens in
this study are similar to those found by other groups (Farmer 1975). The majority of
resected specimens contained either segments of ileum and/or right colon while the
common macroscopic findings included thickening of the bowel wall, narrowing,
lymphadenopathy, mucosal ulceration and serosal injection. Transmural inflammation,
granuloma formation and the presence of giant cells remain the most useful microscopic
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pointers to the disease. Overall, the frequency of these histological findings were similar
to those of other groups (Cook 1973, Chambers 1979, Mekhjian 1979). Although evidence
of granuloma formation was found in only 34% of specimens examined 56% of those on
the Register demonstrated granuloma formation at some point in their disease. Similar
figures were noted by Piris (1983), who reported 50%, and Thompson (1983), who
described some 62%, with granuloma formation.
Examination of the submitted specimens by patient revealed that 90% of
those registered have had at least one specimen submitted for histological examination -
of this group 80% demonstrated positive evidence of Crohn's disease. For slightly less
than one quarter of those with histological evidence of disease the diagnosis was based on
biopsy only, whereas the diagnosis for the remainder was based on both macro and
microscopic examination.
It has been shown that a histological diagnosis is more common in those
diagnosed under 20yrs or 60yrs of age and over. The increased frequency of histological
diagnosis in the elderly group is probably explained by the relatively large number with
large bowel disease and subsequent ease of endoscopic biopsy.
The presence of rectal bleeding is a strong indicator that histological
evidence of disease will be obtained. It should also be remembered that 59% of this
group had large bowel disease. Furthermore histological evidence of disease was more
common in those with symptoms for 6-11 months before diagnosis.
More significantly perhaps was the finding of inflammatory changes and
granuloma in the rectum and anal canal in a sizeable percentage of those patients
considered to have ileocolic and small bowel disease. Of similar note were the 20% of
individuals with discontinuous disease who had chronic inflammatory changes in the
duodenum.
Granuloma are recognised to be present in the early part of the disease
(Warren 1948, Chambers 1978). The Tayside figures suggest that the optimum time for
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identifying granuloma formation is between 6 and 11 months after symptom onset.
Further interesting findings were demonstrated when this group was examined in more
detail. Although there was no difference in the proportion of males and females with
granuloma formation it was clear that there were differences between the male and
female groups. Significantly more females with granulomas had large bowel disease and a
greater proportion were aged 60 or over at diagnosis.
Evidence of granuloma formation is recognised as a good indicator of
Crohn's disease (Morson 1972 Cooke 1973, Farmer 1968) however it is clear from this
study that even in patients with Crohn's disease slightly less than 50% of gross specimens
showed evidence of granuloma formation on microscopy. Although Chambers and
Morson (1980) emphasise the value of large bowel biopsy they found, as in this study, that
no more than 20% of specimens demonstrated evidence of granuloma - this it must be
remembered is in patients with known Crohn's disease. It has also been suggested that
granuloma formation is a good prognostic indicator (Glass 1976, Chambers 1979)
however the Tayside figures suggest that those with granuloma have a greater morbidity
both in terms of hospital admissions and re-operation.
Radiology
Despite recent advances in the radiological techniques used in the
investigation of Crohn's disease which include such techniques as ultrasound (Bluth
1979), indium scans (Saverymuttu 1983) and computer tomography (Goldberg 1983) the
mainstays of radiological investigation remain the barium meal & follow through, the
small bowel enema, which is being increasingly used, and the standard barium enema.
The radiological findings in Crohn's disease are known to fluctuate widely
(Brahme 1975, Marshak 1976). This study demonstrates some of these features and
reports on a variety of findings related to the radiological investigation of Crohn's disease
in Tayside.
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Perhaps of most interest in the radiological audit were the figures confirming
the large number of barium studies performed and reported as showing no abnormality in
those known to have Crohn's disease. Just less than one third of all barium studies were
reported as normal - figures which confirm the fluctuating nature of some of the
radiological changes associated with the disease. More significant than the number of
normal barium studies performed in this group however, were the ratios associated with
the changing trends of normal/abnormal and normal/Crohn's investigations over the
period of study. The change was most pronounced in the normal/Crohn's features where
the ratio of normal to Crohn's increased as shown in Table 6.1
Crohn's Normal ratios
features appearance
64-67 6 1 6:1
72-75 3 2 3:2
80-83 2 3 2:3
Table 6.1 Ratios normal/Crohn's features
As one would expect there were only a few patients on the Register with no
evidence of a Crohn's related radiological investigation. Almost 80% of those Crohn's
patients undergoing radiological investigation were found to have some radiological
evidence of inflammatory bowel disease. The great majority (90%) not only had findings
supportive of Crohn's disease but also demonstrated these findings at the time of
diagnosis. The smallish number who were subsequently shown to have evidence of
disease on x-ray confirm the fluctuating and often rapidly changing nature of the
radiological features of the disease (Jones 1969, Brahme 1970).
Of the 47% of all barium studies which were reported as showing evidence of
Crohn's disease the majority (61%) were obtained from barium meal & follow through
examinations, 29% from barium enema procedures and only 9% from small bowel
enemas. The surprisingly small percentage of small bowel enemas is probably a reflection
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of the numbers of these investigations performed. Furthermore and unexpectedly the
relative diagnostic return for the small bowel enema is less than that of barium meal and
follow-through. This is surprising because the former is commonly accepted to be more
accurate by many clinicians (Truelove 1981, Keddie 1982). The reason for the poorer
diagnostic return in this area could well be explained by the fact that this investigation is
kept mainly for the difficult case where other barium studies have shown no evidence of
disease.
Although only 29% of positive barium investigations were from barium
enema examination the number of individuals eventually showing evidence of Crohn's
disease on barium enema was higher at 42%. Of some diagnostic value was the finding
that in the elderly Crohn's patient barium enema gave the best diagnostic return even
though fewer had positive radiological investigations (12/35). Of further note was the
finding that 20% of those with evidence of disease on barium enema had evidence of
disease in the small bowel, and a similar percentage had small bowel studies
demonstrating disease in the large bowel.
The nature and reported frequency of specific features found on barium
investigation is similar to that reported by others (Marshak 1955, Nolan 1980). The
relative rarity in the reporting of certain radiological features in this study is also of
interest. Of note were the few with 'skip areas' - reported elsewhere as 10% (Kyle 1972) -
'fistula formation' - also uncommon - and the 'cobblestone appearance'; all are normally
recognised to be more common (Nolan 1980) than in this study. This inconsistency might
well be due to observer error and might disappear if each of the radiological
investigations were reviewed by a radiologist with a specific interest in Inflammatory
Bowel Disease
Closer examination of the group with radiological evidence of disease
revealed several other interesting findings. Figures showed that the 20-39 age group most
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commonly had a radiological diagnosis (75%) while the over 60 age group were shown to
have a radiological diagnosis in less than a third of cases. In addition it was clear that
those with large bowel disease only demonstrated radiological evidence of disease in 25%
of cases which is in marked contrast to the 80-90% figure suggested by Kyle (1972).
Goldberg (1981) has previously noted the value of retrograde filling of the
terminal ileum by barium enema a finding which perhaps reflects damage to the
ileocaecal valve from a diseased distal ileum.
Endoscopy
Since the introduction of the fibreoptic endoscope in 1958 (Hirschowitz
1958) its use in gastroenterology has expanded rapidly. The first colonoscopes were
introduced in Europe in the early 1970's and as the instruments have improved so the
number of investigations has increased. Although the colonoscope allows examination of
the whole colon - and even the terminal ileum (Gabriellson 1977) - it is not an essential
component of the investigation of the Crohn's patient (Williams 1978) even though it can
be performed with relative ease in most patients (Geboes 1975).
While the Tayside endoscopy audit was incomplete it was adequate to
demonstrate the increasing trends in endoscopic procedures over the period under study.
The endoscopic findings in both colonoscopy and sigmoidoscopy were on the
whole very non-specific with the classical 'cobblestone' appearance, recognised to be an
important diagnostic finding (Williams 1978, Waye 1980) being very rare. The presence
of the apthoid ulcer - acknowledged to be an early endoscopic feature of the disease
(Morson 1972) - was similarly uncommon or at least recognised only rarely.
Although 60% of individuals were noted to have some inflammatory changes
at sigmoidoscopy or colonoscopy fewer than 20% of endoscopies performed in the
Crohn's patients merited an endoscopic diagnosis of Crohn's disease. Similar non¬
specific changes on rectal biopsy have been noted in those with small bowel disease (Dyer
1970) while Kyle (1972) described as many as 75% of those with large bowel disease with
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non-specific changes on endoscopic biopsy. The small number whose findings merited a
diagnosis of Crohn's disease supports the views of Axon & Dickson (1983) who suggest it
unwise to make a Crohn's diagnosis based purely on endoscopic features alone. Further
support for this view is demonstrated by the fact that only 47% and 33% of those with
confirmed pathological and radiological changes of disease were shown to have
endoscopic changes in the large bowel.
Findings however emphasise the importance of biopsy and confirm that
changes are relatively common in the anal canal, rectum and colon in cases of small bowel
disease. Although evidence of inflammatory changes on endoscopy in the Tayside
Crohn's population was similar to that found by Hogan & Hensley (1980) the Tayside
figures suggest that inflammatory changes on sigmoidoscopy in the elderly group were
more common than in the younger patients. These findings were similar to those of Hill
(1979) who suggested that this was a simple reflection of the frequency of large bowel
disease in this group.
It was perhaps not surprising that 90% of those with rectal bleeding showed
large bowel endoscopic changes. This figure was contrasted by the few with diarrhoea
that showed similar changes.
Slightly less than half of the Crohn's patients who had a gastroscopy had
evidence of inflammatory changes - as one might expect 35% of this group had
discontinuous disease. Fielding (1971) suggested that there was some evidence that
peptic ulcer disease was more common in Crohn's patients however the lack of histology
in many of those undergoing gastroscopy makes any clear statement on this finding
unwise. The non-specific findings however tended to confirm the view that gastro-
duodenal changes although not particularly common are easily recognised (Danzi 1976).
Haematology/Biochemistry
Although alterations will be made to this data set as the register is continued
prospectively the retrospective analysis of data revealed some interesting features. The
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majority of abnormal results at diagnosis related to ESR and white blood cell count
(WBC) which were both raised. Kyle (1972) in his series noted that 85% of individuals
had an ESR of 20mm/hr or more - similar to Krause (1971) in Uppsala. The WBC values
also compare favourably with Kyle's series when the number of individuals with WBC
counts of 12,000/mm or more were compared. Haemoglobin (Hb) results were
commonly in the normal range, with a mean of 12.25gm/dl, not only at diagnosis but
through the whole period of disease. This was in marked contrast to Kyle (1972), who
found a mean Hb value of 10.4gm/dl, Fielding (1971), who found two thirds of his series
with a Hb value of less than 12.5gm/dl when the disease was active and Beekin (1975)
who noted over half his patients became anaemic. There was no variation in any of the
other parameters measured over the period of the disease.
More interesting perhaps were the low serum concentrations of vitamins and
iron noted at the time of diagnosis. Low serum folate measurements are well recognised
(Hoffbrand 1968, Smith 1971, Elsborg 1979) however it must also be noted that treatment
with sulphasalazine may compound the recognised reduced folic acid absorption because
of mild drug induced haemolysis. Even in the group diagnosed within 6 months of
symptom onset a large number were found with low folate, iron and/or Total Iron
Binding Capacity (TIBC) levels (65% folate, 72% iron 43% TIBC) suggesting that
functional changes in the mucosa may well exist for some time before symptoms of the
disease develop.
As one would expect, there were more in the elderly group with protein
levels below the normal range - the result of loss from the gut and normal physiological
response to aging. More of the younger group have discontinuous disease and therefore
have several non contiguous areas of disease which probably accounts for the relatively
high numbers (40%) with low albumin. Surprisingly the time taken to diagnosis did not
appear to correlate with the number of individuals with low albumin or protein levels.
Low protein/albumin levels in those with small bowel and discontinuous disease have
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The 77% requiring surgery in the Tayside series is similar to that described
by Fielding (1972) and Farmer (1975). The high crude re-operative rate in this series is
confirmed by Higgens (1980) who using actuarial methods found that similar numbers
required a second, and then a third operation. Greenstein (1975) also using these
methods found that the numbers requiring further operation rose with each operation.
Indeed at the time when the analysis of treatment was performed 20% of those on the
register had at least 3 operations. These figures demonstrate the not inconsiderable
morbidity caused by operation and re-operation on those with the disease. As one might
expect right hemicolectomy was the most common procedure accounting for almost 25%
of all operations performed. This figure reflects the numbers who have distal ileal or
ileocolic-colic disease and the fact that colonic disease on the whole carries a better
prognosis (Allen 1986).
In Tayside a relatively large number of patients required their first operation
because of uncertain diagnosis (42%) and/or peritonitis (27%). They probably reflect the
not inconsiderable number of patients (30%) who presented acutely and required
laparotomy for both diagnostic and therapeutic reasons as an emergency or semi-elective
procedure. This to some extent contrasts with the views of others (Fazio 1983 Brooke
1977) who suggest that operation can almost always be performed electively except in the
presence of acute complications. Figures also confirm what others have shown (Kyle
1972, Brooke 1977, Farmer 1975) that obstruction, stricture formation, failed medical
treatment, abscess formation and fistula formation are the major causes for operative
intervention. It is also evident from this data that operation played a major role in the
diagnosis of 143 patients.
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As one would expect recurrence of disease is the prime reason for second
and subsequent operation although failed medical treatment is once again common.
Abscess and fistula formation also cause an increasing number of individuals to have
further operations.
The few by-pass procedures performed suggest that most surgeons in
Tayside accept that resection is superior to by-pass (Alexander-Williams 1972, Homan
1978). Analysis also shows that segments of small and large bowel (very often in
combination) are resected in equal numbers. It is also clear that end to end anastomosis
is used in over 90% of bowel resections and that although segmental disease is not
uncommon, most surgeons, at least in this area, where possible attempt to include all the
diseased areas in one segment thus avoiding the need for multiple anastomosis. Brooke
(1977) suggested that for small bowel or localised large bowel disease the minimum
resection should be carried out with end to end anastomosis. This preserved bowel and
avoided blind ends which can predispose to steattorrhoea while for more generalised
disease colectomy should be performed. The recent practice of strictureplasty used by
some, including Williams in Birmingham, has not been tried in this area.
Colostomies and / or ileostomies were fashioned relatively frequently, 25% of
individuals on the Register had a stoma at some point in their disease, figures which are
borne out by others but particularly Farmer (1976).
Closer scrutiny of the data showed that there is no difference in the sex or
time to diagnosis of those requiring surgery. It is however noticeable that although fewer
of the under 20 group required operation they coincidentally were more likely to have a
second procedure, a finding previously noted by de Dombal (1971), than any other of the
age groups. Why the 40-59 age group are more likely to require an operation than the
other age groups is unclear.
One valuable statistic to emerge as far as long term morbidity is concerned
was that significantly fewer patients with large bowel disease required one operation
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(p < .001) and then subsequent operations. Conversely, significantly more of the group
with small bowel disease required surgery (p < .001) and overall had more operations -
facts which have been previously recognised by Farmer (1975) and Hellars (1979). One
further measure of potential morbidity relates to the length of time to diagnosis. As this
time increases the percentage of the group with one operation who subsequently required
a second operation decreased, and secondly, the overall percentage risk of requiring two
operations at the point of diagnosis also decreased. It therefore appears that time to
diagnosis may also be an indicator of long term morbidity.
The age at diagnosis similarly reflects the chance of 2 operations, for almost
1 in 2 of the 20-39 group required 2 operations against 1 in 5 of the 60 and over age group.
Furthermore this study confirms the findings of Fabricus (1985) that elderly patients (60
years and over) are less likely to require surgery than those in the under 60 group,
particularly if they have large bowel disease. As in de Dombals series (1971) and the
Birmingham series (Fabricus 1985) we found that this elderly group rarely required
further surgery for treatment of their disease.
These findings suggest that if the number of operations is used as a measure
of morbidity then those with the least morbidity are those that take 6 months or more to
be diagnosed, have large bowel disease and are 60 and over at diagnosis. Similarly the
patient with the potentially greatest morbidity at the time of diagnosis is the individual
who is diagnosed within 6 months of symptom onset, has ileocolic-colic or discontinuous
disease, is male and between the age of 40-59 at diagnosis.
Medical management
Review of medical therapies used in Crohn's disease illustrates our lack of
understanding of the disease process. A multitude of therapies have been used and
although patients have improved on each therapy, controlled trials have often failed to
confirm the occasional successful case report. However steroids (Malchow 1984),
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azothiaprine / mercaptopurine (Wiloughby 1971), sulphasalazine (Summers 1979),
metronidazole (Ursing 1975) and total parenteral nutrition (Elson 1980) are all
recognised to help under different circumstances. Levamisole (Wesdorp 1978),
cromoglycate (Williams 1980), Vitamin A (Wright 1985) oral BCG vaccine (Burnham
1979) and many others have been tried without proven success other than the occasional
anecdotal improvement.
Although no measure of efficacy could be made on the different types of
medical treatment used during the period of study several interesting findings emerged
from the audit of medical treatment. Over half of those registered required steroids and
or salazopyrin, however some 40 patients as far as could be ascertained had not required
specific medication for their disease. A surprisingly small number were noted to require
anti-diarrhoeal medication while 5% were known to have taken laxatives at some point in
their disease.
Sex and time to diagnosis showed no association with the types of medication
required to control the disease. However, it was apparent that fewer of the elderly
Crohn's population were prescribed or required steroids, salazopyrin and anti-diarrhoeal
medication. Similarly, and as one might expect, more of those with discontinuous disease
required steroids, salazopyrin and anti-diarrhoeal medication to control their symptoms.
The value of this retrospective audit of medical treatments has therefore
been small. The importance of this section however, is in the mechanism that has been
created which will, in the prospective phase, permit some measure of the efficacy of
specific treatments and enable controlled trials to be undertaken on groups selected from
the database.
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6.4 FUTURE DEVELOPMENT OF THE REGISTER
The development of the computerised register and the subsequent analysis of
the retrospective data clearly demonstrates that this type of computerised disease register
can readily be developed and managed on a microcomputer. The system operates
successfully with the large storage capacity of the hard discs now commonly used in
microcomputers. The speed of operation of the system, perhaps a little slow during
complex analysis operations, is more than offset by the flexible nature of the data
manipulation and enquiry facilities.
More of a problem however will be the practicalities of setting up a scheme
of operation for the prospective development of the Register. Several points have
emerged while implementing the Register retrospectively. Firstly it was clear that many of
the clinicians in the area looked after what were often small groups of the Crohn's
population. Furthermore although there were several recognised gastrointestinal
outpatient clinics each had a number of Crohn's patients as regular attenders. There was
no specific inflammatory bowel disease clinic which would have made the introduction of
the prospective Register a much easier task.
Even with the best intentions it was felt unlikely that all clinicians involved in
the care of Crohn's patients would regularly remember to complete proformas or conform
to the required protocol which would enable the Register to develop in a prospective
fashion. This would create a situation where the Register would become incomplete and
therefore inaccurate and by the Registers own defined criteria would merit its closure.
Other methods of implementing the Register have therefore been explored.
The most practical of these appears to be a compromise and would involve a Register
'controller', who would be a doctor, paramedic or medical secretary, working perhaps five
half days a week in conjunction with several 'enthusiastic' clinicians. Patients would be
identified from proformas returned to the Register controller from the wards and clinics
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by those participating in the Register scheme. Other patients would be 'captured' as they
were filed with the health board morbidity returns. The name and CHI number of each
individual with a Crohn's or related ICD code being relayed to the Register controller for
further investigation. This would not only allow the identification of those with Crohn's
disease but would also facilitate the identification of all those with inflammatory bowel
disease thus promoting the development of a truly prospective Register for inflammatory
bowel disease. This would have obvious advantages over the present Crohn's disease
Register.
Individuals who went for prolonged periods without further addition to their
existing data set could periodically be mailed to enquire about their progress. This facility
could also be used to undertake periodic but regular checks on disease activity and
morbidity of all those remaining 'active' on the Register. An example of the type of
proposed 'mailing questionnaire' is shown in appendix 6a & 6b and could be combined
with a periodic morbidity questionnaire (appendix 6c). It is felt that with this approach
and using pathological and radiological reports as validity checks to the primary data
capture process the Register could function in a prospective manner.
Although the database was created with prospective data collection in mind
several other data items would require to be added to the data set to enable those with
Ulcerative Colitis and Non-Specific Colitis to be identified within the system. It is
proposed that those with Ulcerative Colitis would have a data set similar to those with
Crohn's disease but the non-specific colitics would have a small subset of the overall data
set. Additional information would also be collected concerning the number of times
patients were admitted and the number of inpatient days that accrued through these
admissions.
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6.5 THE VALUE AND IMPLICATIONS OF THE COMPUTER SYSTEM
The initial data input from the retrospective data collection has shown that
the computer system is both easy to use and effective and proficient in its operation. The
specialised repertoire of data types for the efficient storage of clinical information has
well matched the data set required. The flexibility of the 'input form' concept whereby
information relating to one type of data transaction, for instance 'take-on' or 'repeat
investigation', has been of considerable value. Furthermore the inclusion of several steps
which check the validity of data entered into the database - a major concern with any data
collection mechanism - has prevented the collection of any 'hash data'.
Analysis of the retrospective data has clearly shown that the data
manipulation facilities are powerful tools. The subset facility, which enables individuals to
be grouped by certain user defined criteria (ie males with large bowel disease and over 60
at diagnosis), has given extra power to the data processing capability of the system and
greatly enhanced its analytical potential. When the numerical and non-numerical audit
routines are used in conjunction with the subset routines a rapid, powerful and versatile
audit tool emerges. Any data item held on the Register can be analysed by one or
combinations of these utilities. The value of this facility is maximised when performing
specific types of complex audits. For instance the site of disease and age groups at
diagnosis can be displayed in one table (Fig 6.2). Note each age group has been created
as an individual subset.
The enquiry and evaluation performed on the Crohn's population using the
analytical facilities has also demonstrated the potential value of the Register as a research
tool. The initial idea of providing an overview of the disease on which further more
specific research might be based has been established. The discovery of the high
frequency of Crohn's disease in the Arbroath area and the differences in the elderly
Crohn's population are probably the clearest examples of this concept to date.
;
TABULAR DATA PRESENTATION AND ANALYSIS
Site disease & Age at diagnosis
313 data points from a Sample of 313 subjects
Sample is from a population of 317 selected from 4 subsets
KEY for X axis
Code and subset name
A = <20 at diag(52) 19/1
B = 20 to 39 at diag(161) 20/1
C = 40 to 59 at diaq(65) 20/1
D = >=60 at diag(35} 19/1
KEY for Y axis
Field 36 in File crohns:cinv - EXTENT DISEASE
1 = SMALL BOWEL
2 = ILE0 COLIC
3 = LARGE BOWEL
4 = DISCONTIN DISEASE
E A B C D TOTAL
N! 0 1 5 4 1 ! 11
E %R! 0.0 9.1 45.5 36.4 9.1 !
%C! 0.0 1.9 3.1 6.2 2.9 ! 4%
N! 0- 9 52 23 12 96
1 %R! 0.0 9.4 54.2 24.0 12.5
%C\ 0.0 17.3 32.3 35.4 34.3 31%
N! 0 14 62 14 4 94
2 %R! 0.0 14.9 66.0 14.9 4.3





















N! 0 16 21 3 2 1 42
4 %R! 0.0 38.1 50.0 7.1 4.8 !
















%1 = % of Total
%C = Number as N% of Column total
%R = Number as N% OF Row total
Age groups and Sex
Figure 6.2
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The retrospective analysis and data collection has not been concerned with
patient management. It is clear however, that the prospective development of the
Register would enable the subset, mailmerge and analytical functions to be utilised to aid
in patient management. A subset of patients could be generated of those who had failed
to attend clinics for over two years or of those who had been lost to follow-up. A
personalised letter could then be produced to either a patient or his or her GP suggesting
further follow-up or asking for information regarding the patient's health or whereabouts.
The inclusion of disease activity and morbidity scores prospectively would also permit
crude but direct comparisons over a period of time or between different forms of
treatment.
These observations suggest, therefore, that the existing computer system can
be used as a basis for the implementation of a microcomputer based area Crohn's disease
Register. The inclusion of data enquiry, analysis and mailmerge facilities has confirmed
the system's value in audit and research, and alluded to its potential in patient
management.
The features described have had far reaching implications for the computer
system.
Clinicians who saw the system in operation felt that it contained many
facilities which would be of value in their own clinical practice. This period coincided
with a rapid increase in the number of microcomputers within the medical workplace,
brought about mainly by a significant reduction in their cost. The purchase of machines
mainly for word processing and data collection projects highlighted the scarcity of
medically orientated database software packages. Although many good commercial
database systems exist most require some knowledge of computers. Furthermore because
most have been directed at the business user they have been developed primarily to
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handle numerical information and are less supportive of non-numerical data. Although
some medical data is numerical, a great deal is non-numerical (eg symptoms, treatment)
and is therefore less suited to these commercial packages. This, in conjunction with the
cost of the few commercially available medically orientated systems, suggested that there
would be an ever increasing demand for a software package which incorporated many of
the facilities included in the Crohn's disease Register system.
The demand in Tayside for this type of software grew so rapidly that it was
decided to develop the facilities created for the Crohn's disease Register system into a
general database management package. This would allow individual users to set up
studies or applications around their own data sets. Once created they would then have
access to all the existing data input, enquiry and analysis routines.
The package, which has become known as 'CRAFT' (Clinical Retrieval
Analysis & Follow-up Template), contains programme modules for the generation of a
database, data input and data management. Over the past 18 months ten different
departments in the hospital have utilised CRAFT for one or more applications (discussed
in the following chapter). At the time of writing most applications generated using the
system have been set up to perform medical audit or have been used to help in research
projects. More recently however further modules have been developed to enhance the
patient management potential of the system. Two further more dedicated systems have
therefore been created -CRAFTLIST - which is a waiting list system used to help in the
management and audit of a department's or health board's surgical or outpatient waiting
lists. The waiting list system contains a special module which has been dedicated to the
operations required to arrange and manage a waiting list. It produces lists of patients, for
example a week's admissions which can be sent to wards, medical and x-ray filing, and
sends personalised letters to patients requiring admission. One such system runs the
district Urology waiting list while a further system is presently being configured for the
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district inpatient and outpatient Orthopaedic service. Parties both within and outwith our
health authority are examining the potential of its more widespread use.
The second system - CRAFT-CLINIC - has been directed at specific hospital
clinics and general practice. The initial aim was to provide a clinic or practice with a
database which was appropriate to their needs. Each system is based on an age/sex
register and has a number of 'clinics' or sections associated with it, for instance diabetics,
geriatrics, well-woman, cardiovascular-risk screening, depending on the interest of the
practice. Several practices have chosen this package to monitor and audit areas of their
practice which are of particular interest. The system can easily be set up with any
combination of 'clinics', most contain an age/sex register, and have one or a number of
other 'clinics' such as diabetic, geriatric, paediatric, cardiovascular-risk screening and well
woman. Indeed the list of available 'clinics' continues to expand. The CRAFT-CLINIC
system has other added facilities directed specifically at data display, either on the screen
or as hardcopy. It is particularly useful in the clinical situation where it permits the user
rapidly to display information in a number of appropriate formats. Indeed these display
options have led some hospital clinicians to look at the CLINIC system as an option to aid
there specialised hospital clinics. This interest has resulted in the author obtaining
support from a pharmaceutical company for the diabetic hospital clinic system, which is
geared to diabetic shared care. The first of these systems was on site in early 1988.
It is suggested that the implementation of CRAFT systems into general
practice should run alongside the well established GPASS system and be complimentary
to it.
Summary
The value and implications resulting from the development of the initial
computer system have been discussed. This has not only confirmed the value and
potential of the system in the management of the Crohn's disease Register but has also
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highlighted its more general potential in medical practice. The existing applications are
briefly discussed in the next section.
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6.6 APPLICATIONS USING THE CRAFT COMPUTER SYSTEM
Applications created using the present CRAFT system and the more recent
CRAFT-LIST and CRAFT-CLINIC developments have been set up to help in one or a
combination of medical audit, research and patient management.
6.6.1 Clinical Audit
The system is particularly valuable in this area because all data contained in
a particular application can be audited in a variety of ways. Several disease registers have
been generated apart from the initial Crohn's disease register. A Culposcopy clinic
register will shortly be supplemented by the development of a Gynaecological Cancer
Register for the area. A Bladder Cancer Register, one of the first applications to be set¬
up using the CRAFT system, at present contains data on all patients with bladder cancer
in the area and contains information dating back as far as the late 1960's. These types of
applications provide valuable epidemiological information on diseases within the area
while the database can also act as a focal point for further specific research. This type of
data is also valuable to the management team in measuring the size of a problem and
hence resource requirements. For example in Tayside 3,420 cystoscopies have been
performed on individuals with bladder tumour over the past 16 years. Trends can also be
calculated from this data and projections made as to the future need for resources.
Similarly the cost effectiveness of radiological investigation has been highlighted in the
Crohn's study where it was found that the proportion of radiological investigations
reported as normal in the Crohn's population has increased dramatically over the past few
years, and confirms that the rate of positive return for the standard radiological
investigations has decreased significantly (Table 5.29) over the years.
In 1986 the package was used to audit deliveries in the obstetric departments
of Tayside and has been used to produce the annual returns to the health board and the
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Scottish Office. CRAFT systems also operate in the Paediatric department where similar
information is collected as required by the Scottish Office on neonates and over the
perinatal period - the SMR11 official data collection form. Facilities have been
developed to transfer data to other computer systems and with a little co-operation it
would be possible to transfer this SMR11 information to the system in the Scottish Office
either via modems or floppy disk. A similar local audit of the Special Care Baby Unit also
uses the CRAFT system. A module has also been developed which utilises the SMR11
database to create and generate discharge letters on each baby leaving the neonatal
paediatric unit.
For several years the psychiatric services in Tayside have logged patient
contact data with a system based on the Health Authority's mainframe computer. For a
number of reasons clinicians have been unable to readily retrieve information from this
mainframe system. The imminent demise of this system has resulted in the Psychiatric
service choosing the CRAFT system to continue this data collection. One main reason for
this choice being the type of "hands on approach" which CRAFT has adopted and which
enables clinicians to analyse data themselves as required. Three similar systems have
therefore been created to manage each of the three health district's psychiatric contacts.
6.6.2 ResearchWork
Many of the applications created for basic audit can utilise CRAFT's flexible
analysis facilities to facilitate further research on the collected data.
Several applications have been set up specifically as research projects, a
gastric cancer trial sponsored by the MRC, a study into the effect of gut stimulant on
post-op ileus and a project investigating various parameters in normal and abnormal
pregnancies are all on-going projects which will begin to produce their results in a few
months time. The department of Neurology has also recently begun a long term study to
monitor and investigate the epileptic population of the area.
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The department of Dermatology and Photobiology have also embarked on a
long term data collection project which will act as a research and audit tool over many
years.
Although many of these studies have been generated as research projects the
databases created can also provide information on which to base further research. The
ability to perform true adhoc enquiry and analysis gives great flexibility and power to the
system which normally produces regular routine audit. This is only made possible by the
rapid processing capability of the computer.
6.63 Patient management
Several of the recent systems have moved into the area of patient
management and have resulted in the development of the CRAFT-LIST and CRAFT-
CLINIC systems. This is however a different type of situation with the data being more
dynamic in nature and where speed of operation is an important consideration with the
secretarial staff using the system in real time as part of their routine work.
A Urology waiting list system has been created to oversee the waiting list and
to perform basic monthly audits required by the health board. The system also generates
admission and filing room lists each week as well as generating admission letters for
patients. Ranked and ordered lists can be produced by age, date put on list, type of
operation, consultant or indeed on any of the data contained within the system. A similar
system is presently being set-up to oversee and manage Orthopaedic outpatient clinics
and inpatient waiting lists.
A second and ambitious system has also be generated for General Practice.
Many systems exist for use by General Practitioners and all have advantages and
disadvantages. Those opting for the CRAFT-CLINIC system felt that the flexible and
complex data manipulation facilities plus the potential for further development lent itself
to their practices where audit and research were given some degree of priority. The
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systems contain a combination of 'clinics' or sections; an age/sex register, cardiovascular-
risk screening file, a diabetic recall monitoring section and well woman data which
includes cervical smear data and recall, contraceptive data and breast examination
information being a common combination. It is hoped that this will be a precursor to
further GP orientated systems - indeed it is very easy to create further 'clinics' as
appropriate to a particular practice. Finally endoscopy, breast and lithium clinic,
intensive care and general surgical and vascular audit systems are all at varying stages of
development.
Modular development of the system from a set of basic computing "tools" has
enabled further modules to be created to perform specific tasks within a system with
comparative ease - of particular relevance in patient management systems. The gastric
cancer register has a "front end module" which registers and randomises patients before
entry into the study. The success of the neonatal audit has resulted in the development of
an "intelligent" discharge summary based on information contained within the neonatal
database which generates discharge summaries in letter form for those discharged from
the neonatal unit.
The computerisation of diabetic clinics has long been at the forefront of
computer utilisation in the medical field - we have therefore developed specific facilities
to help in the monitoring of this group of patients and have created a data set which will
enable a shared care scheme to operate.
Commercial interest in the software has also resulted in a module being
developed to enable the CRAFT system to be integrated with a commercially produced
urodynamics system. This integration permits data produced within the urodynamic
system to be downloaded into the CRAFT database where it can then be stored and
manipulated with the package's facilities.
Although all applications discussed relate directly to medical data collection
this need not be the case. At present one application has been created in the form of a
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breast reference bibliography. Reference data is logged with the system which can then
be searched by keywords, authors, journal etc and then summaries or abstracts from the
bibliography printed out.
This short summary highlights the versatility of the CRAFT software.
However it would be wrong to suggest that the system is the answer to all clinician's
computerisation ideas. It merely demonstrates one pathway a clinician may take and one
possible approach to software development in the medical field.
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6.7 FUTURE DEVELOPMENTS
The development of CRAFT's facilities is an on-going process. Many of
CRAFT's existing facilities continue to undergo further development. The impending
introduction of mainframe Patient Administration Systems has also placed the
development of a truly multi-user system and communication modules on CRAFT's
critical pathway of development. The CRAFT project which initially required only my
own time has grown and now involves all members of the Medical Computing Unit plus




The development and analysis of the Register has confirmed the clinical
impression of a high incidence of Crohn's disease in Tayside region. Incidence and
prevalence rates are higher than in some areas of the country but more interestingly
are also at variance with those rates and trends from neighbouring Grampian region.
The retrospective audit and analysis of the Crohn's population has confirmed
that much useful medical data can be gleaned from the Register. The value of the
Register as a research tool has also been demonstrated; some of these findings
require more detailed investigation. This illustrates the value of rapid data
processing techniques and endorses the epidemiological approach as a means of
identifying facts or associations which merit further investigation. No attempt has
been made to use the Register in a prospective patient management role. However,
the facilities incorporated in the computer system, which have subsequently been
shown to be of proven value in other management type applications, confirm the
potential for this role as the Register proceeds to the prospective phase of
development.
The retrospective development of the Register has demonstrated that it is
quite feasible to develop a disease register on a microcomputer system. It has been
established that many facilities can be built into the system to firstly reduce the time
required to manage the Register, and secondly to enable detailed and extensive ad-
hoc enquiry of collected data. Although this development lends itself to the
prospective implementation of the Register, both geographical and local practical
difficulties place an obstacle in the path of immediate prospective implementation.
Although the present register relates to patients with Crohn's disease other
chronic diseases such as diabetes and rheumatoid arthritis could similarly be
monitored using this mechanism.
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The demand for the computer system which has evolved from the Register's
implementation and which has become known as CRAFT (Clinical Retrieval &
Analysis Follow-up Template) has highlighted the need for a microcomputer based
database management system directed specifically at the medical user. The
implementation of applications in over ten departments within Tayside and others
outside this region has shown the value of the 'hands on approach' to computerised
data collection and has proved the system to be a valuable tool in aiding general
medical audit, research and patient management. The recent development of the
more dedicated 'CRAFTLIST' and 'CRAFTCLINIC' concepts shows that the
continued growth of the system is assured at least in the short to medium term. The
success of the computer package can be attributable firstly to the scarcity of
commercially available medically orientated database management systems and
secondly because the 'fourth generation techniques' used in its development permit
the implementation of other applications with relative ease without recourse to
further programming.
APPENDICES
DIAGNOSTIC SCORING SYSTEM FOR THE REGISTER
Appendix 174
A. Scheme to determine IBP or otherwise
1. Symptoms
score 1 for each symptom related to possible IBD
Sub-total
2. Radiological criteria
no evidence IBD = 0
some evidence IBD = 2 Sub-total
definite evidence IBD = 4
3. Endoscopic criteria
no evidence IBD = 0
some evidence IBD = 1 Sub-total
good evidence IBD = 2
4. Pathological criteria
no evidence IBD = 0
some evidence IBD = 1
good evidence IBD = 3 Sub-total
diagnostic Crohn's/UC =5 TOTAL
SCORE 6 ORMOREWITH AT LEAST HALF OF ALL CROHN'S RELATED




B. Scoring system to determine Crohn's / Ulcerative colitis
(Clinical section)
Clinical
1 Age 8 Blood Pr
<19 1 nil 6
50-59 -1 slight -2
>70 -2 + + -5
2 Duration 9 Mucus











4 Patient history systemic 1
appendicitis 3
anal fissure 7 11 Nutrition 2
fistula 4
nil -1 12 Tenderness
R lower 10
5 Site pain upper 1/2
l1/2
-2
R lower 10 -3






central 2 13 Abdo findings
distend 2





































































IF INVESTIGATION + CLINICAL SCORE > 10 THEN PATIENT




























Breast fed as child
Number in family






































































restriction to normal life
who educated patient about disease
lost work





affect of menstrual cycle
Appendix 4
Appendix 180
Appendix 5 which follows in the following pages is an
example of the questionnaire used in the initial case
capture of the retrospective data.
Appendix 5








IS THIS IBD OR NOT
SCORING SYSTEM
CLINICAL ENDOSCOPIC RADIOLOGICAL PATHOLOGY





BO EVIDENCE OF IBD =0
SOKE EVIDENCE OF IBD =1
GOOD EVIDENCE OF IBD =2
SC0RE=
NO EVIDENCE OF IBD =0
SOKE EVIDENCE OF IBD =2
DEFINITIVE EVIDENCE IBD=4
SC0RE=
NO EVIDENCE OF IBD =0
SOKE EVIDENCE IBD =1
GOOD EVIDENCE OF IBD =3
DIAGNOSTIC FOR CR0HNS/UC=5
SC0RE=
IF the total score is >=6 and at least two oF the above questions have a score
O then consider the patient to have IBD.
IF THE ABOVE SCORE >6 THEN IS THIS CROHNS OR ULCERATIVE COLITIS
CLINICAL INVESTIGATIONS
A AGE: H BLOOD PR: N RADIOLOGY: S LAB TEST
<19 *♦1 NIL =♦4 N0RKAL =♦3 HB< 10 =-1
30-59 =-! SLIGHT =-2 CONTINUOUS =-1 NCD20000 =M
>70 =-2 ♦+ =-5 SE6NENTAL =♦11 PLAK150 =-4
B DURATION: I NUCUS PR: 0 SITE: PLAT>400 =♦!









C FAKILY HISTORY: LT COLON =-1





D PATIENT HISTORY: SYSTEHIC =♦1 STENOSIS =♦4
APPENDICITIS =♦3 ULCERS =-1
ANAL FISSURE =♦7 K NUTRITION: DILATATION =♦4




E SITE OF PAIN: RT LONER QUAD =♦10 9 ENDOSCOPY: TOTAL SCORE=
RT LONER OUAD =♦10 UPPER 1/2 =-2 N0RKAL =♦12 IF SCOREMO THEN
LT LONER 3UAD =-1 LT 1/2 =-3 ULCERS =-1 THIS IS CROHNS
RT 1/2 =♦2 CENTRAL =♦2 STENOSIS =♦2 DISEASE
LT 1/2 =-4 NIL =-! BLEEDING =-4
CENTRAL =♦2 DIFFUSE =-2
NIL =-! K ABD0 FINDINGS
DISTENSION =♦2
PATCHY =♦14
F TYPE OF PAIN: HASS =♦10 R BIOPSY:





S 30NELS: SRANULOKA =♦27
N0RKAL =♦1 MUCOSAL =-1










1.protestant 1.preschool 7.farier I.Caucasian
2.catholic 2.school 8.white collar 2.negro
3.Jewish 3.student 9.aanagerial 3.oriental
4.other 4.unskill.aanual lO.profesional 4.aixed
5.not known 5.skill.aanual ll.hoaeaaker 3.other
6.none 6.clerical 12.other
SOCIAL CLASS








if UK postcode ie DD3
DURATION LIVED IN THIS HOUSE
INTENSITY OF POPULATION
l.live on own
2.1ivt in faiily unit
3.cofl«unal dwelling
A.<aver population in house
8.aver popultion in house



















































Rl=»ST MEED X HISTORY
8 haeaorrhage C anaeaia
E stricture F fistula
H ileus I obstruction
K pericolitis L peritonitis
N polyps 0 aalignancy










V nutrit.defic N other
c.eve
A iritis 3 other
d.Neuroosychiatric
A psychosis 8 neurosis
f.Deraatoloqy
A pyodera gan B erytheaa nodosua
C other D abcess




A Rh fever 3 avocarditis C endocarditis
D phlebitis E IHD F CVA
S hypertension H other I PVD
J DVT
q.Senito/urinary
A UTI 8 nephrolith. C period irreg.
D subfertility E other
h.Musculoskeletal
A arthralgia 8 arthritis C spondylitis
D osteoporosis E sacroileitis F other
i. Respiratory tract
A TB 8 sarcoid C asthaa
fibrosing alveolitis
j.Hiscelan.
A diabetis 9 druq reactionC collagen dis.
D aayloid dis. E allergy
Smokes
1.never






in units per week
BREAST FED AS A CHILD Yes/No
NOS. OF CHILDREN IN FAMILY
ANY CHILDREN HAD 81 DISEASE
Naae the disease:
FAM II Y HISTORY
















J psychiatric diseasel grandp. pat














1 now in saie house
2 prev.in saae house
3 within 50 ailes
4 > 50 ailes
Degree o-f contact
















































































THE CHANGES ON COLONOSCOPY/SIGHOIDOSCOPY/PROCTOSCOPY SUGGESTED A DIAGNOSIS OF
1 UC 5 Diverticular disease
2 Crohns 6 pseudoaesbranous colitis
3 Non specific colitis 7 No abnoraality
4 Tusour
A DEFINITIVE DIAGNOSIS »as knoan / uas susoected / «as not susoected BEFORE THIS INVESTIGATION.
INVESTIGATIQNS
RADIOLOGY Fill in the table with the appropriate letters/numbers
ANATOMICAL SITE TYPE OF EIAN FINDINS
A oesophogus A plain abdo I IVP I possible 2 definite
8 stoaach 3 8a aeal J fistulograa 3 benign 4 aalignant
C duodenua C Ba aeal t FT K CAT scan 3 partial b coaolete
D jejunua D Ba eneaa L isotope scan 7 single 8 aultiple
E ileua E saall bowel eneaa galliua/lab wc/indiua use the above to help decribe those below
F terainal ileua F oral clolecyst. other
S saall bowel S IVC A narrowing H shallow ulcers
H appendix H Ultrasound B obstruction N deep ulcers
I caecua C fluid levels Q longtitudinal ulcers
J asc colon DIA6N0SIS D dilatation P transverse fissures
K trans, colon A noraal I cholilithiasis E perforation 8 stricture
L desc. colon 8 no signif abnora. J renal calculi F diverticuli R sinus tract
M sigaoid colon C inflaa disease ?type K obstructive uropathy 8 abdo aass 3 skip areas
N whole colon D Crohns disease L abscess H reduced function T thickened walls
0 rectua E ileo-colitis H other I calculi U cobblestone pattern
P anal canal F Ulcerative colitis J cavity V abscess
S skin 8 non specific proctitis K fistula K pseudopolyps
R bladder H peptic ulcer disease L polyps
S pancreas


























6R0SS / NAKED EYE APPEARANCE
A one area
8 > one area
C skip lesions
D thickened bowel Mall
E thickened subaucosa
F ulcerated aucosa
6 fistula to the skin
H fistula to other organs
1 aesentery thickened
•MICROSCOPIC APPEARANCE
A acute inflaa exudate
8 non specific infiltration withchronic inflaa cells




H signs of proxiaal obstructionD fibrosis
N other E giant cells
F grranuloaatous lesions
S reactive hyperplasia in the lyaph nodes
H goblet cell depletion
I crypt absces-













mqrb i n> i ~rv
Symptoms cause trouble
1.daily





Symptoms restrict normal Where
li-fe about
Most a job 1.hospital doctor
2.caused a change in job 2.SP
3.restrict sport/hobbies 3.nurse
♦.affect social life ♦.aaqazine
5.affect sex life S.books
6.reluctance to plan future activities friends







How much do you know
about your disease
l.none 3.wish to knoa aore
2.little ♦. lot
SYHPTONS HAVE CAUSED LOSS OF SLEEP YES/NO
HAS RENTAL HEALTH SUFFERED YES/NO
ARE YOU A MEMBER OF THE CROHNS/CQLQSTOMY/ILEOSTOMY ASSOC. YES/NO
MOULD YOU JOIN ANY OF THE ABOVE ASSOCIATIONS YES/NO
DO YOU FEEL YOU LEAD A FULL PRODUCTIVE LIFE DESPITE YOUR DISEASE YES/NO
DOES YOUR DISEASE AFFECT YOUR MENSTRUAL CYCLE MORSE/NO CHANGE/BETTER
DOES YOUR PERIOD AFFECT YOUR SYMPTOMS MORSE/NO CHANGE/BETTER
DISEASE: ACT I V I Y TREATMENT date
I NDEX
MS LIQUID STOOLS IN ONE NEEK MEDICAL SURGICAL
SCORE A None INDICATIONS
none =0 A obstruction S peritonitis
1-4 =1 SYHPTQHATIC 3 stricture H failed eedical Rx
5-9 =2 3 antidi'orrhoeel C fistula 1 uncertain diagnosis
10-19 =3 SCORE C laxative D abdo tass } cholelithiasis
20-49 =4 D analgesia E abscess I growth retardation
50-99 =5 E psychotherapy P perforation L other
SUN OF SEVEN DAILY ABDO RAIN READINGS ANTI-INFLAN/MNUNOSUPPRES. OPERATION
none=0 .1Id=I «od=2 severe=3 F steroids date
SC0RE= S salaaodyrine type
H aaothiaprine INCLUDED:
SENERAL NELL 3EINS SUN OF 7 READ INS A seal 1 boael resection
■el 1=0 <oar=l poor=2 very poor=3 DIETARY 3 large bonel resection
terrible34 I diet end to end anastoeosis
SCORE3 J elemental diet D side to side anastoeosis
K TPN E one area resected
SYNPT0NS RELATED TO CR0HNS L vitaams F 2 areas resected
A arthritis 3 skin/eouth lesions N other: S j* areas resected
0 iritis/uveitis D perirectal problees H localised resection
E Febrile episode in past «eek N15CELANEDUS I radical resection
F presence of fistula N antibiotics J drainage of abscess
score 1 for eecb SCORE3 0 eetronidazole K ileostoey/colostoiy
P iron oreo L byoass operation
ABDO NASS BODY NT 1 strictureplasty












It is now nine months since we were last in contact with you regarding your
Crohn's disease - we hope you are well.
We would again be grateful if you would fill in the enclosed questionnaire on the
progress of your disease. This information will enable us to further understand this disease
and hence improve our methods of treatment.
If you wish any further information on your disease please contact us directly or
ask your doctor to contact us and we will send him the information directly.
Yours Sincerely,
Please answer the following: -
Since we were last in touch have you
a. seen your GP about your Crohn's disease
b. seen a hospital doctor about your Crohn's disease
c. been admitted to hospital with your Crohn's disease
if yes
i. which hospital
ii. when was it
iii. can you name investigations











joint / eye / skin / other problems
2.Seasonal pattern
symptoms have been worse in
summer / autumn / winter / spring




















Disease activity score for past week
1. Nos of liquid stools per week
0 / 1-4 / 5-9 / 10-19 / 20-49 / 50-99
(please circle as required)
2. Sum of seven daily abdo pain readings
none / mild / moderate / severe
3. General well being - sum of seven daily measurements
well / slighly below par / poor / very poor / terrible
4. Symptoms related to Crohn's in past week






HOW DOES THE DISEASE AFFECT YOUR DAILY LIFE
1. Symptoms cause trouble
daily / few times week / several times month / every
few months / seldom / never
2. Over past 9 months my symptoms have caused
loss of job / change in job / restricted sports hobbies
affect social life / affect sex life / reluctant to
plan future activities
3. Symptoms have caused loss of sleep
4. Have you lost work
every month / every 3 months / once a year
5. Has mental health suffered because of your disease
6. How much do you know about your disease
none / little / a lot / wish to know more
7. Do you lead a full productive life despite your disease
8. For women
a.Does yor menstrual cycle affect your symptoms
worse / same / better
b.Does your disease affect your menstrual cycle
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